UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM10-K

ANNUALREPORTANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 20172023

or

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number1-13879

INNOSPEC INC.

(Exact name of registrant as specified in its charter)

DELAWARE

98-0181725

State or other jurisdiction of

incorporation or organization

(I.R.S. Employer

Identification No.)

8310 South Valley Highway

Suite 350

Englewood

Colorado

80112

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code:(303) (303) 792 5554

Securities registered pursuant to Section 12(b) of the Act:Securities Exchange Act of 1934:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

N/ACommon stock, par value $0.01 per share

IOSP

N/A

NASDAQ

Securities registered pursuant to Section 12(g) of the Act:Common stock, par value $0.01 per share

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes No

Yes  ☐    No  ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of RegulationS-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes No

Yes  ☒    No  ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of RegulationS-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form10-K or any amendment to this Form10-K.

    ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

☐    (Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).

Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Act).

Yes No

The aggregate market value of the voting andnon-voting common equity held bynon-affiliates of the registrant as of the most recently completed second fiscal quarter (June 30, 2017)2023) was approximately $954$1,349 million, based on the closing price of the common shares on the NASDAQ on June 30, 2017.2023. Shares of common stock held by each officer and director and by each beneficial owner who owns 5% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for any other purpose.

As of February 8, 2018, 24,350,319January 31, 2024, 24,867,989 shares of the registrant’s common stock were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of Innospec Inc.’s Proxy Statement for the Annual Meeting of Stockholders to be held on May 9, 201810, 2024 are incorporated by reference into Part III of this Form10-K.



TABLE OF CONTENTS

PART I

2

PART I

3

Item 1

Business

Business3

2

Item 1A

Risk Factors

9

10

Item 1B

Unresolved Staff Comments

19

20

Item 21C

Cybersecurity

Properties

20

Item 32

Properties

Legal Proceedings21

23

Item 3

Legal Proceedings

24

Item 4

Mine Safety Disclosures

21
PART II22

24

PART II

25

Item 5

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

22

25

Item 6

[Reserved]

Selected Financial Data24

27

Item 7

Management’s Discussion and Analysis of Financial Condition and Results of Operations

26

28

Item 7A

Quantitative and Qualitative Disclosures Aboutabout Market Risk

48

43

Item 8

Financial Statements and Supplementary Data

51

45

Item 9

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

97

87

Item 9A

Controls and Procedures

97

87

Item 9B

Other Information

98
PART III99

88

Item 9C

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

88

PART III

88

Item 10

Directors, Executive Officers and Corporate Governance

99

88

Item 11

Executive Compensation

99

89

Item 12

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

99

89

Item 13

Certain Relationships and Related Transactions, and Director Independence

100

89

Item 14

Principal Accountant Fees and Services

100
PART IV101

89

PART IV

89

Item 15

Exhibits and Financial Statement Schedules

101

89

Item 16

Form 10-K Summary

Form10-K Summary104

92

SIGNATURES

105

93


CAUTIONARY STATEMENT RELATIVE TO FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS

This Form10-K contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “could,” “believes,” “feels”“feels,” “plans,” “intends” or similar words or expressions, for example,)example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future. Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading “Risk Factors.” Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

1


PART I

Item 1Business

Item 1 Business

When we use the terms “Innospec,” “the Corporation,” “the Company,” “Registrant,” “we,” “us” and “our,” we are referring to Innospec Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.

General

General

Innospec develops, manufactures, blends, markets and supplies a wide range of specialty chemicals to customers in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Our Performance Chemicals business creates innovative technology-based solutions for use as fuel additives, ingredients forthe personal care, home care, agrochemical, construction, mining and other applicationsindustrial markets. Our Fuel Specialties business specializes in manufacturing and oilfield chemicals. Our products are sold primarily to oil and gas exploration and production companies, oil refiners, fuel manufacturers and users, formulators of personal care, home care, agrochemical and mining formulations, and other chemical and industrial companies throughout the world. Oursupplying fuel additives helpthat improve fuel efficiency, boost engine performance and reduce harmful emissions. Our Oilfield Services business supplies drilling, completion and production chemicals which make exploration and production more effective, cost-efficient and more environmentally friendly. Our performance chemicals provide effective technology-based solutions for our customers’ processes or products focused in the Personal Care, Home Care, Agrochemical and Mining markets. Our Octane Additives business manufactures a fuel additive for use in automotive gasoline.

Segment Information

The Company reports its financial performance based on the fourthree reportable segments described as follows:

Fuel Specialties

which are Performance Chemicals,

Oilfield Services

Octane Additives

The Fuel Specialties Performance Chemicals and Oilfield Services segments operate in markets where we actively seek growth opportunities although their ultimate customers are different. The Octane Additives segment is expected to decline in the near future as our one remaining refinery customer transitions to unleaded fuel.Services.

For financial information about each of our segments, see Note 3 of the Notes to the Consolidated Financial Statements.

Performance Chemicals

Our Performance Chemicals segment provides innovative technology-based solutions for our customers’ processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets.

This segment has grown through acquisitions, together with the organic development and marketing of innovative products in these end-markets.

Our customers in this segment include large multinational companies, manufacturers of personal care and home care products and global mining, agriculture and building products and other industrial companies.

On December 8, 2023, we acquired QGP Química Geral (“QGP”) which we believe will further strengthen our Performance Chemicals segment and add a manufacturing base in South America to compliment all of our end markets.

Fuel Specialties

Our Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives to a wide range ofin diesel, jet, marine, fuel oil and other fuels. These fuel additive

products help improve fuel efficiency, boost engine performance and reduce harmful emissions; and are most commonly used in the efficient operation of automotive,commercial trucking, marine and aviation engines, power station generators, heating oil and heating oil.other industrial machinery applications.

2


The segment has grown organically through our development of new products to address what we believe are the key drivers in demand for fuel additives. These drivers include increased demand for fuel, focus on fuel economy, changinghigher efficiency engine technologytechnologies and legislative developments.developments, including tightening global emissions regulations. We haveare also devoted substantial resources towards the developmentapplying these fuels technologies to an increasing number of new and improved products that may be used to improve combustion efficiency.non-fuel applications in a variety of industries.

Our customers in this segment include national oil companies,and multinational oil companies, fuel marketers and retailers, fuel retailers.

Performance Chemicals

Our Performance Chemicals segment provides effective technology-based solutions for our customers’ processes or products focused in the Personal Care, Home Care, Agrochemical and Mining markets.

This segment has grown through acquisitions and the development and marketing of innovative products. The focus for our Performance Chemicals segment is to develop high performance products from its technology base in a number of targeted markets.

Our customers in this segment include large multinational companies, manufacturers of personal care and household products and specialty chemical manufacturers operating in agrochemical, miningterminals, marine lines, coating & plastics producers and other heavy industrial applications.end-users.

Oilfield Services

Our Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations, chemical solutions for fracturing, stimulationdrilling, completion, production and completion operations and products for oil and gas production which aid flow assurance and maintain asset integrity.applications.

This segment has recently been growing strongly, driven by increased customer activity, following the increase in crude oil prices, as the industry recovers from the significant declines of the last two years.

Our customers in this segment include multinational public and independent exploration & production and oilfield services companies operating currently principally in the Americas.Americas and the Middle East.

Strategy

Octane Additives

Our Octane Additives segment, which we believe is the world’s only producer of tetra ethyl lead (“TEL”), comprises sales of TEL for use in automotive gasoline and provides services in respect of environmental remediation. We are continuing to responsibly manage the decline in the demand for TEL for use in automotive gasoline in line with the transition plans to

unleaded gasoline for our one remaining refinery customer. Cost improvement measures continue to be taken to respond to declining market demand.

Sales of TEL for use in automotive gasoline are principally made to state-owned refineries located in North Africa. Our environmental remediation business manages the cleanup of redundant TEL facilities as refineries complete the transition to unleaded gasoline.

Strategy

Our strategy is to develop new and improved products and technologies to continue to strengthen and increase our market positions within our Performance Chemicals, Fuel Specialties Performance Chemicals and Oilfield Services segments. We also actively continue to assess potential strategic acquisitions, partnerships and other opportunities that would enhance and expand our customer offering. We focus on opportunities that would extend our technology base, geographical coverage or product portfolio. We believe that focusing on the Performance Chemicals, Fuel Specialties Performance Chemicals and Oilfield Services segments, in which the Company has existing experience, expertise and knowledge, provides opportunities for positive returns on investment with reduced operating risk. We also continue to developexpand our geographical footprint, consistent with the development of global markets.

Geographical Area Information

Financial information with respect to our domestic and foreign operations is contained in Note 3 of the Notes to the Consolidated Financial Statements.

Working Capital

The nature of our customers’ businesses generally requires us to hold appropriate amounts of inventory in order to be able to respond quickly to customers’ needs. We therefore require corresponding amounts of working capital for normal operations. We do not believe that this is materially different to what our competitors do, with the exception of cetane number improvers, in which case we maintain high enough levels of inventory, as required, to retain our position as market leader in sales of these products.competitors.

The purchase of large amounts of certain raw materials across all of our segments can create some variations in working capital requirements, but these are planned and managed by the business.

We do not believe that our terms of sale or purchase differ markedly from those of our competitors.

3


Raw Materials and Product Supply

We use a variety of raw materials and chemicals in our manufacturing and blending processes and believe that sources for these are adequate for our current operations. Our major purchases are oleochemicals and derivatives, cetane number improvers, ethylene, various solvents, amines, alcohols, olefin and lubricity improvers.

polyacrylamides. These purchases account for a substantial portion of the Company’s variable manufacturing costs. These materials are, with the exception of ethylene for our operations in Germany, readily available from more than one source. Although ethylene is, in theory, available from several sources, it is not permissible to transport ethylene by road in Germany. As a result, we source ethylene for our German operations via a direct pipeline, from a neighboring site, making it effectively a single source. Ethylene is used as a primary raw material for one of our German operations in products representing approximately 4% of Innospec’s sales.

We use long-term contracts (generally with fixed or formula-based costs) and advance bulk purchases to help ensure availability and continuity of supply, and to manage the risk of cost increases. From time to time, for some raw materials, the risk of cost increases is managed with commodity swaps.

We continue to monitor the situation and adjust our procurement strategies as we deem appropriate. The Company forecasts its raw material requirements substantially in advance and seeks to build long-term relationships and contractual positions with supply partners to safeguard its raw material positions. In addition, the Company operates an extensive risk management program which seeks to source key raw materials from multiple sources and to develop suitable contingency plans.

Intellectual Property

Our intellectual property, including trademarks, patents and licenses, forms a significant part of the Company’s competitive advantage particularly in the Fuel Specialties and Performance Chemicalsfor all of our segments. The Company does not, however, consider its business as a whole to be dependent on any one trademark, patent or license.

The Company has a portfolio of trademarks and patents, both granted and in the application stage, covering products and processes in several jurisdictions. The majority of these patents were developed by the Company and, subject to maintenance obligations including the payment of renewal fees, have at least 10 years life remaining.

The trademark “Innospec and the Innospec device” in Classes 1, 2 and 4 of the “International Classification of Goods and Services for the Purposes of the Registration of Marks” are registered in all jurisdictions in which the Company has a significant market presence. The Company also has trademark registrations for certain product names in all jurisdictions in which it has a significantmarketsignificantmarket presence.

We actively protect our inventions, new technologies, and product developments by filing patent applications and maintaining trade secrets. In addition, we vigorously participate in patent opposition proceedings around the world where necessary to secure a technology base free from infringement of our intellectual property.

Customers

We haveIn 2023, the Company had a significant customer in the Oilfield Services segment which accounted for $265.2 million (13.6%) of our net group sales contracts with customers in some markets using fixed or formula-based prices, as appropriate, to maintain our gross profits.(2022 - $222.2 million and 11.3%).

4


Competition

Competition

Certain markets in which the Company operates are subject to significant competition. The Company competes based on the basis of a number of factors including, but not limited to, product quality and performance, specialized product lines, customer relationships and service, and regulatory expertize.expertise.

Fuel Specialties:Within the Fuel Specialties segment, the Fuelssub-market is generally characterized by a small number of competitors, none of which hold a dominant position. We consider our competitive edge to be our proven technical development capacity, independence from major oil companies and strong long-term customer relationships.

Performance Chemicals:Within the Performance Chemicals segment we operate in the Personal Care, Home Care, Agrochemicalpersonal care, home care, agrochemical, construction, mining and Miningother industrial markets, which are highly fragmented, and the Company experiences substantial competition from a large number of multinational and specialty chemical suppliers in each geographical market. Our competitive position in these markets is based on us supplying a superior, diverse product portfolio which solves particular customer problems or enhances the performance of new or existing products. In a number of specialty chemicals markets, we also supply niche product lines, where we enjoy market-leading positions.

Fuel Specialties: The Fuel Specialties segment is generally characterized by a small number of competitors, none of which hold a dominant position. We consider our competitive edge to be our proven technical development capacity, independence from major oil companies and strong long-term customer relationships. We believe we remain the world’s only producer of tetra ethyl lead (“TEL”) for use in aviation gasoline, which we market as our AvGas product line.

Oilfield Services:Our Oilfield Services segment is very fragmented and although there are a small number of very large competitors, there are also a large number of smaller players focused on specific technologies or regions. Our competitive strength is our proven technology, broad regional coverage and strong customer relationships.

Octane Additives:We believe our Octane Additives segment is the world’s only producer of TEL and accordingly is the only supplier of TEL for use in automotive gasoline. The segment therefore competes with marketers of products and processes that providealternative ways of enhancing octane performance in automotive gasoline.

Research, Development, Testing and Technical Support

Research, product/application development and technical support (“R&D”) provide the basis for the growth of our Performance Chemicals, Fuel Specialties Performance Chemicals and Oilfield Services segments. Accordingly, the Company’s R&D activity has been, and will continue to be, focused on the development of new products and formulations. Our R&D department provides technical support for all of our reporting segments. Expenditures to support R&D services were $31.4$41.7 million, $25.4$38.7 million and $25.3$37.4 million in 2017, 20162023, 2022 and 2015,2021, respectively.

We believe that our proven technical capabilities provide us with a significant competitive advantage. Our Performance Chemicals business has launched significant new mild surfactants, which are well aligned with developing customer needs. In addition, the last five years,business has developed further formulations in emollients, silicones and surfactants for the personal care, home care, agrochemical, construction, mining and other industrial markets. Fuel Specialties segment has developedcontinued to innovate, focused on bringing new detergent,technologies to market which reduce pollution and improve fuel economy, including detergents and cold flow improvers, stabilizers, lubricityimprovers. In Oilfield Services, new technologies have been introduced to improve the hydrocarbon yield from customers’ operations and combustion improver products, in addition to the introduction of many new cost effective fuel additive packages. This proven technical capability has also been instrumental in enabling usprotect assets, including friction modifiers, biocide formulations and additives to produce innovative products including Iselux and Statsafe®.

improve drilling muds.

Health, Safety and Environmental Matters

We are subject to environmental laws in the countries in which we operate and conduct business. Management believes that the Company is in material compliance with applicable environmental laws and has made the necessary provisions for the continued costs of compliance with environmental laws, including where appropriate asset retirement obligations.laws.

5


Our principal site giving rise to environmental remediation liabilitiesasset retirement obligations is the Octane Additivesour Ellesmere Port manufacturing site at Ellesmere Port in the United Kingdom.Kingdom (“U.K.”). There are also asset retirement obligations and environmental remediation liabilities on a much smaller scale in respect of our other manufacturing sites in the U.S. and Europe. At Ellesmere Port there is a continuing asset retirement program related to certain manufacturing units that have been closed.

We recognize environmental remediation liabilities when they are probable and costs can be reasonably estimated, and asset retirement obligations when there is a legal obligation and costs can be reasonably estimated. This involves anticipating the program of work and the associated future expected costs, and so involves the exercise of judgment by management.sites. We regularly review the future expected costs of remediation, and the current estimate is reflected in the Consolidated Balance Sheets and Note 1213 of the Notes to the Consolidated Financial Statements.

The European Union (“E.U.”) legislation known as the Registration, Evaluation and Authorization of Chemical Substances Regulations (“REACH”) requires most of the substances in the Company’s products to be registered with the European Chemicals Agency.Agency (ECHA). Under this legislation the Company has to demonstrate that the substances it uses in its products are safe for use and appropriate for their intended purposes.purposes in the E.U.. During this registration and continual evaluation process, the Company incurs expenseexpenses to test and register substances it manufactures or imports in the E.U..

Following the end of the Brexit transition process, on January 11, 2021 the U.K. government introduced U.K. REACH with the same registration requirements for substances produced in or imported into the U.K. as the E.U. REACH. Furthermore, globally, similar regulatory regimes to the E.U. and U.K. REACH are also entering into force or are being proposed in several other countries. These registration-based regulatory regimes will result in increasing test expenses and registration fees to ensure Innospec products remain compliant with the appropriate regulations and can continue to be sold in these markets.

Environmental, Social & Governance and Corporate Social Responsibility Reporting

As part of our commitment to being open and transparent about our performance, our latest Responsible Business Report, which is our 2022 Report, was independently assured to assess its products. adherence to the globally recognized AA1000 Assurance Standard.

The Company estimates thatResponsible Business Report, along with further information on our sustainability program and performance is available online in the cost“Corporate Social Responsibility” section of complying with REACH will be approximately $2 million over the next three years basedCompany’s website at https://innospecsustainability.com. Such information does not constitute part of, and is not incorporated by reference into this Annual Report on the current regulatory environment.Form 10-K.

Employees and Human Capital Management

Employees

The Company had approximately 19002,400 employees in 2422 countries as at December 31, 2017.2023.

Human capital management is critical to Innospec’s ongoing business success, which requires investing in our people. Our aim is to create a highly engaged and motivated workforce where employees are inspired by leadership, engaged in purpose-driven, meaningful work and have opportunities for growth and development.

An effective approach to human capital management requires that we invest in talent development, culture and employee engagement. We aim to create an environment where our employees are encouraged to make positive contributions and fulfill their potential.

The Company’s Board of Directors (the “Board”) is also actively involved in reviewing and approving executive compensation, selections and succession plans so that we have leadership in place with the requisite skills and experience to deliver results the right way. The Company’s Chief Executive Officer (“CEO”) periodically provides the Board with an assessment of senior executives that have potential as successor for the CEO position, as well as perspectives on potential candidates for other senior management positions.

6


Core Values & Culture

Responsible Growth through Innovation and Customer Service: Financial stability and growth are essential to maintain our goal of making a positive contribution towards a more sustainable future. Generating economic benefits for our employees, stockholders, and local communities, while encouraging ongoing innovation in our product portfolio alongside excellent customer service which will allow our business to be competitive and sustainable.

Caring for People: We strive to create a safe and caring culture where our employees are supported and encouraged to make positive contributions. Our continued success depends on keeping people safe, promoting a healthy lifestyle, protecting human rights, improving education, training and maintaining good relations with our neighbors.

Conserving & Protecting the Environment: We aim to use resources as efficiently as practicable and minimize the impact of our operations on the environment. We look to supply safe, sustainable products, designed to meet the needs of society now and in the future while minimizing their environmental impact.

Leading by Example: We understand that honest, ethical and transparent conduct is vital to our success and reputation. Every employee plays an essential part in complying with local and national laws, rules and regulations. We uphold a high standard of corporate and business integrity across all of our activities.

Employee Engagement

Attracting Talent: We believe our hardworking team of employees is our greatest asset. We employ approximately 2,400 people across 22 countries, and we believe that the skills, commitment and enthusiasm of our employees helps us to deliver long-term growth for investors.

Training: Across our sites, we provide local support and opportunities for the next generation of talent in our industry by offering a range of placements, internships, work experience and apprenticeships. We strive to attract and retain the best talent in a changing and competitive working environment.

As an organization, we are committed to making Innospec a great company to work for and we invest, as appropriate, in the development of our employees to meet this ambition.

Our employees are offered both internal and external training, where appropriate, to support their continued development and to meet the needs of our business. Where relevant, we support our employees’ ongoing professional training and development to encourage their progression within our business.

Pay and Benefits: We offer what we believe are competitive reward and recognition programs, based on both business-wide and individual performance. Our packages have been designed to attract and retain the best employees, reward achievement and encourage our teams to deliver superior performance for our customers and our company.

In addition to our company-wide performance incentive plans, we encourage our employees to share in the long-term success of our company with incentive programs, such as our Global Sharesave Plan. This plan gives employees the opportunity to participate in a savings plan linked to an option to buy shares in Innospec at a discount and, therefore, benefit from any growth in the share price over the savings period. We also provide a range of other benefits in line with the market practice in each location we operate in, including insurance and pension arrangements.

7


Performance Management Framework: We conduct an annual performance management process across the organization. Together with their line managers, employees agree upon annual objectives, and, at the end of the year, review with their line manager their performance against those objectives and their overall performance. The results of each annual performance review affect performance bonus amounts, pay reviews and career advancement decisions.

Senior Leadership Communications and Transparency: We actively seek opportunities for regular engagement and communication by our CEO, CFO and other senior executives with our broader employee population. Communications are through a variety of means including written communications, webcasts and conference calls. For example, we hold a CEO/CFO Call at least once a year, during which the CEO and CFO discuss current issues and developments in the business, including a Q&A session answering questions raised by employees. The CEO/CFO Call is accessible to all employees across the Company. In addition to the CEO/CFO Calls, each financial quarter, following the quarterly financial results announcement, the CEO and CFO provide a written review of the financial results to all employees.

Diversity and Inclusion

Innospec aims to attract and retain the best people by ensuring that employment decisions are based on merit, performance, ability and contribution to the Company. As part of our Global HR Policy, our diversity and equal opportunities policy ensures that current and prospective employees receive equal opportunities irrespective of gender, sexual orientation, race, color, ethnic or national origin, marital status, age, disability, religion or belief.

Health and Safety

Objectives: We prioritize the safety of employees, communities and everyone involved in the manufacture, use or disposal of our products. We set high standards for process and occupational safety, which is managed by our network of Safety, Health and Environment (“SHE”) professionals throughout the business. Our three core objectives being that:

• No one gets hurt

• We do not annoy our neighbors

• We leave only the gentlest footprints on our environment

Leadership: The Company periodically reviews the Corporate SHE structure and organization so that we have the optimum resources and correct approach. We strive to embed SHE in our culture by having leadership that comes from executive management. Our Responsible Care Executive Committee (known as RESPECT) comprises members of the senior leadership team and is led by the CEO. RESPECT is responsible for setting the group’s SHE and Sustainability policies and objectives across the global business. It also monitors ongoing performance in these areas throughout the year. Through this structure, we have established a strong culture of safety within our organization.

Training: Training is an essential part of our health and safety strategy. To minimize the risk of accident or injury, we give our employees the information they need, delivered effectively and at the appropriate time. Our ongoing training programs demonstrate our commitment to targeting zero accidents, making sure that safety is always front of mind and that we continually raise standards.

Every year, employees across our sites take part in a variety of site-specific training courses to enable them to be competent and safe in their roles.

8


Available Information

Our corporate web sitewebsite is www.innospecinc.com.www.innospec.com. We make available, free of charge, on or through this web sitewebsite our annual, quarterly and current reports, and any amendments to those reports, as soon as reasonably practicable after electronically filing such material with, or furnishing it to, the U.S. Securities and Exchange Commission (“SEC”). In addition, the SEC maintains an internet site at www.sec.gov that contains reports, proxy and information statements, and other information that we file electronically with the SEC.

The Company routinely posts important information for investors on itsweb-site website (under Investor Relations). The Company uses this web sitewebsite as a means of disclosing material,non-public information and for complying with its disclosure obligations under SEC Regulation FD (“Fair Disclosure”). Accordingly, investors should monitor the Investor Relations portion of the Company’s web site,website, in addition to following the Company’s press releases, SEC filings, public conference calls, presentations and webcasts.

9


Item 1ARisk Factors

Item 1A Risk Factors

The factors described below represent the principal risks associated with our business.

Global Conditions

TrendsCompetition and market conditions may adversely affect our operating results.

In certain markets, our competitors are larger than us and may have greater access to financial, technological and other resources. As a result, competitors may be better able to adapt to changes in oilconditions in our industries, fluctuations in the costs of raw materials or changes in global economic conditions. Competitors may also be able to introduce new products with enhanced features that may cause a decline in the demand and gas prices affect the level of exploration, development and production activitysales of our products. Consolidation of customers and the demandor competitors, or economic problems of customers in our markets could cause a loss of market share for our services and products, whichplace downward pressure on prices, result in payment delays or non-payment, or declining plant utilization rates. These risks could have a material adverseadversely impact on our business.

Demand for our services and products in our Oilfield Services business is particularly sensitive to the level of exploration, development and production activity of, and the corresponding capital spending by, oil and gas companies. The level of exploration, development and production activity is directly affected by trends in oil and gas prices, which historically have been volatile and are likely to continue to be volatile. Prices for oil and gas are subject to large fluctuations in response to relatively minor changes in the supply of and demand for oil and gas, market uncertainty, and a variety of other economic and political factors that are beyond our control. Even the perception of longer-term lower oil and gas prices by oil and gas companies can similarly reduce or defer major expenditures given the long-term nature of many large-scale development projects. Factors affecting the prices of oil and gas include the level of supply and demand for oil and gas, governmental regulations, including the policies of governments regarding the exploration for and production and development of their oil and gas reserves, weather conditions and natural disasters, worldwide political, military, and economic conditions, the level of oil and gas production bynon-OPEC countries and the available excess production capacity within OPEC, the cost of producing and delivering oil and gas and potential acceleration of the development of alternative fuels and engine technologies. Any prolonged reduction in oil and gas prices will depress the immediate levels of exploration, development, and production activity which could have a material adverse impact on our results of operations, financial position and cash flows.

Continuing adverse global economic conditions could materially affect our current and future businesses.

Global economic factors affecting our business include, but are not limited to, geopolitical instability in some markets, consumer demand for premium personal care and cosmetic products, miles driven by passenger and commercial vehicles, legislation to control fuel quality, impact of alternative propulsion systems, and oil and gas drilling and production rates. The availability, cost and terms of credit have been, and may continue to be, adversely affected by the foregoing factors and these circumstances have produced, and may in the future result in, illiquid markets and wider credit spreads, which may make it difficult or more expensive for us to obtain credit.

The level of inflation and energy costs may result in an adverse impact to the group’s results from employee wages and other costs of operations of our manufacturing sites.

Continuing uncertainties in the U.S. and international markets and economies leading to a decline in business and consumer spending could adversely impact our results of operations, financial position and cash flows.

Domestic or international natural disasters or terrorist attacks may disrupt our operations, decrease the demand for our products or otherwise have an adverse impact on our business.

Chemical related assets, and U.S. corporations such as us, may be at greater risk of future terrorist attacks than other possible targets in the U.S., the U.K. and throughout the world. Extraordinary events such as natural disasters may negatively affect local economies, including those of our customers or suppliers. The occurrence and consequences of such events cannot be predicted, but they can adversely impact economic conditions in general and in our specific markets. The resulting damage from such events could include loss of life, severe injury and property damage or site closure. Any of these matters could adversely impact our results of operations, financial position and cash flows.

While Innospec maintains business continuity plans that are intended to allow it to continue operations or mitigate the effects of events that could disrupt its business, Innospec cannot provide assurances that its plans would fully protect it from all such events. In addition, insurance maintained by Innospec to protect against property damage, loss of business and other related consequences resulting from catastrophic

10


events is subject to coverage limitations, depending on the nature of the risk insured. This insurance may not be sufficient to cover all of Innospec’s damages or damages to others in the event of a catastrophe. In addition, insurance related to these types of risks may not be available now or, if available, may not be available in the future at commercially reasonable rates.

Our business and operations have been, and may in the future be, adversely affected by epidemics, pandemics, outbreaks of disease and other adverse public health developments, including COVID-19.

Epidemics, pandemics, outbreaks of novel diseases and other adverse public health developments in countries and states where we operate may arise at any time. Such developments, including the COVID-19 pandemic, have had, and in the future may have, an adverse effect on our business, financial condition and results of operations. These effects include a potentially negative impact on the availability of our key personnel, labor shortages and increased turnover, temporary closures of our facilities or facilities of our business partners, customers, suppliers, third-party service providers or other vendors, and interruption of domestic and global supply chains, distribution channels and liquidity and capital or financial markets. In particular, restrictions on or disruptions of transportation, port closures or increased border controls or closures, or other impacts on domestic and global supply chains or distribution channels, could increase our costs for raw materials and commodity costs, increase demand for raw materials and commodities from competing purchasers, limit our ability to meet customer demand or otherwise have a material adverse effect on our business, financial condition and results of operations or cash flows.

Precautionary measures that we may take in the future intended to limit the impact of any epidemic, pandemic, disease outbreak or other public health development, may result in additional costs. In addition, such epidemics, pandemics, disease outbreaks or other public health developments may adversely affect economies and financial markets throughout the world, such as the effect that COVID-19 has had on world economies and financial markets, which may affect our ability to obtain additional financing for our businesses and demand for our products and services. The extent to which COVID-19 or other pandemics will impact our business and our financial results in the future will depend on future developments, which are highly uncertain and cannot be predicted. Such developments may include ongoing spread of the virus, disease severity, outbreak duration, extent of any reoccurrence of the COVID-19 or any evolutions or mutations of the virus, and availability, administration and effectiveness of vaccines and development of therapeutic treatments that can restore consumer and business economic confidence.

Business Operations

We face risks related to our foreign operations that may adversely affect our business.

We serve global markets and operate in certain countries with political and economic instability, including the Middle East, Northern Africa, Asia-Pacific, Eastern Europe and South American regions. Our international operations are subject to numerous international business risks including, but not limited to, geopolitical and economic conditions, military actions and war, risk of expropriation, import and export restrictions, trade wars, exchange controls, national and regional labor strikes, high or unexpected taxes, government royalties and restrictions on repatriation of earnings or proceeds from liquidated assets of overseas subsidiaries. Any of these could have a material adverse impact on our results of operations, financial position and cash flows.

11


We are subject to extensive regulation of our international operations that could adversely affect our business and results of operations.

Due to our global operations, we are subject to many laws governing international commercial activity, conduct and relations, including those that prohibit improper payments to government officials, restrict where and with whom we can do business, and limit the products, software

and technology that we can supply to certain countries and customers. These laws include but are not limited to, the U.S. Foreign Corrupt Practices Act and United Kingdom Bribery Act, sanctions and assets control programs administered by the U.S. Department of the Treasury and/or the European Union from time to time, and the U.S. export control laws such as the regulations under the U.S. Export Administration Act, as well as similar laws and regulations in other countries relevant to our business operations. Violations of any of these laws or regulations, which are often complex in their application, may result in criminal or civil penalties that could have a material adverse effect on our results of operations, financial position and cash flows.

We may not be able to consummate, finance or successfully integrate future acquisitions, partnerships or other opportunities into our business, which could hinder our strategy or result in unanticipated expenses and losses.

Part of our strategy is to pursue strategic acquisitions, partnerships and other opportunities to complement and expand our existing business. The success of these transactions depends on our ability to efficiently complete transactions, integrate assets and personnel acquired in these transactions and apply our internal control processes to these acquired businesses. Consummating acquisitions, partnerships or other opportunities and integrating acquisitions involves considerable expense, resources and management time commitments, and our failure to manage these as intended could result in unanticipated expenses and losses. Post-acquisition integration may result in unforeseen difficulties and may deplete significant financial and management resources that could otherwise be available for the ongoing development or expansion of existing operations. Furthermore, we may not realize the benefits of an acquisition in the way we anticipated when we first entered the transaction. Any of these risks could adversely impact our results of operations, financial position and cash flows.

Competition and market conditions may adversely affectOur success depends on our operating results.

In certain markets, our competitors are larger than us and may have greater access to financial, technologicalmanagement team and other resources. As akey personnel, the loss of any of whom could disrupt our business operations.

Our future success will depend in substantial part on the continued services of our senior management. The loss of the services of one or more of our key executive personnel could affect the implementation of our business plan and result competitors may be better ablein reduced profitability. Our future success also depends on the continued ability to adapt to changes in conditions in our industries, fluctuations in the costs of raw materials or changes in global economic conditions. Competitors may alsoattract, develop, retain and motivate highly-qualified technical and support staff. We cannot guarantee that we will be able to introduce new products with enhanced features that may cause a declineretain our key personnel or attract or retain qualified personnel in the demand and sales of our products. Consolidation of customers or competitors, or economic problems of customersfuture. If we are unsuccessful in our markets could cause a loss of market share for our products, place downward pressure on prices, resultefforts in payment delays ornon-payment, or declining plant utilization rates. These risksthis regard, this could adversely impact our results of operations, financial position and cash flows.

Political developmentsAn information technology system failure may adversely affect our businessbusiness.

We rely on information technology systems to transact our business. Like other global companies, we and our third-party service providers have, from time to time, been and will likely in the future be, subject to or targets of unauthorized or fraudulent access, including, but not limited to, physical or electronic break-ins or unauthorized tampering, as well as attempted cyber and other security threats and other computer-related penetrations including by state actors, terrorists or organized crime. Also, like other global companies, we have an increasing challenge of attracting and retaining highly qualified security personnel to assist us in combating these security threats. The frequency and sophistication of such threats continue to increase, with malicious actors frequently changing tactics and techniques. These threats often become further heightened in connection with geopolitical tensions.

On June 23, 2016, the United Kingdom (U.K.) held a referendum in which voters approved an exitThe rapid evolution and increased adoption of artificial intelligence technologies may intensify our cyber security risks. The proliferation of third-party financial data aggregators and emerging technologies, including our use of automation, artificial intelligence and robotics, increase our cyber security risks and exposure. Artificial intelligence capabilities may be used to identify vulnerabilities and craft increasingly sophisticated cyber security attacks. Vulnerabilities may be introduced from the European Union (E.U.), commonly referreduse of artificial intelligence by us, our customers, suppliers and other business partners and third-party providers.

Although we have implemented administrative and technical controls and take protective actions to reduce the risk of cyber incidents and breaches of our information technology, and we endeavor to modify such procedures as “Brexit”. Subsequently,circumstances warrant, such measures may be insufficient to prevent physical and electronic break-ins, cyber-attacks or other security breaches to our computer systems.

12


Our systems, processes, software and network and those of our third-party service providers may be vulnerable to internal or external security breaches, computer viruses, malware or other malicious code or cyber-attacks, catastrophic events, power interruptions, hardware failures, fire, natural disasters, human error, system failures and disruptions, and other events that could have security consequences. An information technology failure or disruption could prevent us from being able to process transactions with our customers, operate our manufacturing facilities, and properly report those transactions in a timely manner. Our information technology costs may increase to ensure the U.K. parliament passed the European Union (Notificationappropriate level of Withdrawal) Act 2017, which conferred power on the U.K. government to give noticecyber security as we continuously adapt to the European Council, under

changing technological environment.

Article 50(2)While we have limited insurance coverage in place that may, subject to policy terms and conditions, cover certain aspects of cyber risks, this insurance coverage is subject to certain limitations and may not be applicable to a particular incident or otherwise be sufficient to cover all of our losses beyond any coverage limitations. Furthermore, a significant or protracted information technology system failure may result in a material adverse effect on our results of operations, financial position and cash flows.

Decline in our AvGas business.

The sales of our AvGas product line for use in aviation fuel are recorded within our Fuel Specialties business. The piston aviation industry has been, and is currently, researching a safe replacement fuel to replace leaded fuel. The U.S. Federal Aviation Administration (“FAA”) program (Piston Aviation Fuels Initiative) has been established to identify a replacement fuel, and candidate fuels are at an early pre-screening stage. In 2022, the Treaty on European Union,FAA created a new team named Eliminate Aviation Gasoline Lead Emissions (“EAGLE”). This is a government-industry partnership that also encompasses fuel producers and distributors, airport operators, communities that support general aviation airports, and environmental experts. The most significant announcement impacting the Company is the stated aim of EAGLE to eliminate lead emissions from general aviation by the U.K.’s intention to withdraw fromend of 2030. There are also regulatory projects underway for the European Union. The U.K. submitted this noticeE.U., which are considering the phase out of leaded fuel for the aviation industry earlier than the FAA timetable.

While we expect that at some point in the future a replacement fuel will be identified, trialed and supplied to the European Council on March 29, 2017. Accordingly,industry, there is no currently available alternative. If a suitable product is identified and the U.K.use of leaded fuel is currently expectedprohibited in piston aviation, the Company’s future operating income and cash flows from operating activities would be adversely impacted.

Failure to withdraw from the European Union on March 29, 2019. The U.K. is currentlyprotect our intellectual property rights could adversely affect our future performance and cash flows.

Failure to maintain or protect our intellectual property rights may result in the processloss of negotiating a withdrawal agreement with the European Union, but if this is not agreed and ratifiedvaluable technologies, or us having to pay other companies for infringing on their intellectual property rights. Measures taken by March 29, 2019 (or such later date asus to protect our intellectual property may be agreed between the U.K. and the European Council), the U.K.challenged, invalidated, circumvented or rendered unenforceable. In addition, international intellectual property laws may be requiredmore restrictive or may offer lower levels of protection than under U.S. law. We may also face patent infringement claims from our competitors which may result in substantial litigation costs, claims for damages or a tarnishing of our reputation even if we are successful in defending against these claims, which may cause our customers to withdraw from the European Union without a withdrawal agreement being in force. It is possible that there will be greater restrictions on imports and exports between the U.K. and E.U. countries and increased regulatory complexities. The announcementswitch to our competitors. Any of Brexit caused significant volatility in global stock markets and currency exchange rate fluctuations that resulted in the strengthening of the U.S. dollar against foreign currencies in which we conduct business.

These political developments maythese events could adversely impact our results of operations, financial position and cash flows.

13


Industry Matters

Trends in oil and gas prices affect the level of exploration, development and production activity of our customers, and the demand for our services and products, which could have a material adverse impact on our business.

Demand for our services and products in our Oilfield Services business is particularly sensitive to the level of exploration, development and production activity of, and the corresponding capital spending by, oil and gas companies. The level of exploration, development and production activity is directly affected by trends in demand for and prices of oil and gas, which historically have been volatile and are likely to continue to be volatile. Prices for oil and gas are subject to large fluctuations in response to relatively minor changes in the supply of and demand for oil and gas, market uncertainty, and a variety of other economic and political factors that are beyond our control. Even the perception of longer-term lower oil and gas prices by oil and gas companies can similarly reduce or defer major expenditures given the long-term nature of many large-scale development projects. Factors affecting the prices of oil and gas include, but are not limited to, the level of supply and demand for oil and gas; governmental regulations, including the policies of governments regarding the exploration for and production and development of their oil and gas reserves; weather conditions and natural disasters; worldwide political, military and economic conditions; the level of oil and gas production by non-OPEC (“Organization of the Petroleum Exporting Countries”) countries and the available excess production capacity within OPEC; the cost of producing and delivering oil and gas; and potential acceleration of the development of alternative power generation, fuels and engine technologies. Any prolonged reduction in oil and gas prices will depress the immediate levels of exploration, development and production activity, which could have a material adverse impact on our results of operations, financial position and cash flows.

We could be adversely affected by technological changes in our industry.

Our ability to maintain or enhance our technological capabilities, develop and market products and applications that meet changing customer requirements, and successfully anticipate or respond to technological changes in a cost effective and timely manner will likely impact our future business success. We compete on a number of fronts including, but not limited to, product quality and performance. In the case of some of our products, our competitors are larger than us and may have greater access to financial, technological and other resources. Technological changes include, but are not limited to, the development of electric and hybrid vehicles, and the subsequent impact on the demand for gasoline and diesel. Our inability to maintain a technological edge, innovate and improve our products could cause a decline in the demand and sales of our products, and adversely impact our results of operations, financial position and cash flows.

Decline in our TEL business

The remaining sales of the Octane Additives business are now concentrated to one remaining refinery customer. When this customer chooses to cease using TEL as an octane enhancer then the Company’s future operating income and cash flows from operating activities will be materially impacted.

The sales of the AvTel product line are recorded within our Fuel Specialties business. The piston aviation industry has been, and is currently, researching a safe replacement fuel to replace leaded fuel. While we expect that at some point in the future a replacement fuel will be identified, trialed and supplied to the industry there is no current known replacement. In addition there is no clear timescale on the legislation of a replacement product. If a suitable product is identified and the use of leaded fuel is prohibited in piston aviation the Company’s future operating income and cash flows from operating activities would be adversely impacted.

Having a small number of significant customers may have a material adverse impact on our results of operations.

Our principal customers are oil and gas exploration and production companies, oil refineries, personal care companies, and other chemical and industrial companies. These industries are characterized by a concentration of a few large participants. The loss of a significant customer, a material reduction in demand by a significant customer or termination ornon-renewal of a significant customer contract could adversely impact our results of operations, financial position and cash flows.

Our United Kingdom defined benefit pension plan could adversely impact our financial condition, results of operations and cash flows.

Movements in the underlying plan asset value and Projected Benefit Obligation (“PBO”) of our United Kingdom defined benefit pension plan are dependent on actual return on investments as well as our assumptions in respect of the discount rate, annual member mortality rates, future return on assets and future inflation. A change in any one of these assumptions could impact the plan asset value, PBO and pension credit recognized in the income statement. If future plan investment returns prove insufficient to meet future obligations, or should future obligations increase due to actuarial factors or changes in pension legislation, then we may be required to make additional cash contributions. These events could adversely impact our results of operations, financial position and cash flows.

Our success depends on our management team and other key personnel, the loss of any of whom could disrupt our business operations.

Our future success will depend in substantial part on the continued services of our senior management. The loss of the services of one or more of our key executive personnel could affect implementation of our business plan and result in reduced profitability. Our future success also depends on the continued ability to attract, develop, retain and motivate highly-qualified technical, sales and support staff. We cannot guarantee that we will be able to retain our key personnel or attract or retain qualified personnel in the future. If we are unsuccessful in our efforts in this regard, this could adversely impact our results of operations, financial position and cash flows.

Continuing adverse global economic conditions could materially affect our current and future businesses.

The ongoing concern about the stability of global markets generally and the strength of counterparties in particular has led many lenders and institutional investors to reduce, or cease to provide, credit to businesses and consumers. These factors have led to a substantial and continuing decrease in spending by businesses and consumers, and a corresponding decrease in global infrastructure spending which could affect our business. Global economic factors affecting our business include, but are not limited to, geopolitical instability in some markets, miles driven by passenger and commercial vehicles, legislation to control fuel quality, impact

of alternative propulsion systems, consumer demand for premium personal care and cosmetic products, and oil and gas drilling and production rates. The availability, cost and terms of credit have been, and may continue to be, adversely affected by the foregoing factors and these circumstances have produced, and may in the future result in, illiquid markets and wider credit spreads, which may make it difficult or more expensive for us to obtain credit. Continuing uncertainties in the U.S. and international markets and economies leading to a decline in business and consumer spending could adversely impact our results of operations, financial position and cash flows.

An information technology system failure may adversely affect our business.

We rely on information technology systems to transact our business. Like other global companies, we have, from time to time, experienced threats to our data and systems. Although we have implemented administrative and technical controls and take protective actions to reduce the risk of cyber incidents and protect our information technology, and we endeavor to modify such procedures as circumstances warrant, such measures may be insufficient to prevent physical and electronicbreak-ins, cyber-attacks or other security breaches to our computer systems. While to date we have not experienced a material cyber security breach, our systems, processes, software and network still may be vulnerable to internal or external security breaches, computer viruses, malware or other malicious code or cyber-attack, catastrophic events, power interruptions, hardware failures, fire, natural disasters, human error, system failures and disruptions, and other events that could have security consequences. Such an information technology failure or disruption could prevent us from being able to process transactions with our customers, operate our manufacturing facilities, and properly report those transactions in a timely manner. A significant, protracted information technology system failure may result in a material adverse effect on our results of operations, financial position and cash flows.

We may have additional tax liabilities.

We are subject to income and other taxes in the U.S. and other jurisdictions. Tax laws are dynamic and subject to change as new laws are passed and new interpretations of the law are issued or applied. Recently, the U.S. has enacted significant tax reform which will impact our tax liabilities. Significant judgment is required in estimating our worldwide provision for income taxes. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. Although we believe our tax estimates are reasonable, any final determination pursuant to tax audits and any related litigation could be materially different to what is reflected in our consolidated financial statements. Should any tax authority disagree with our estimates and determine any additional tax liabilities, including interest and penalties for us, this could adversely impact our results of operations, financial position and cash flows.

Uncertainty in the interpretation and application of the 2017 Tax Cuts and Jobs Act could materially affect our tax obligations and effective tax rate

The 2017 Tax Cuts and Jobs Act (the “Tax Reform Act”) was enacted on December 22, 2017, and significantly affected U.S. tax law by changing how the U.S. imposes income tax on multinational corporations. The U.S. Department of Treasury has authority to issue regulations and interpretative guidance that may impact how we apply the law and impact our results of operations in the period issued and subsequently.

The Tax Reform Act requires complex computations not previously required under U.S. tax law. As such, the application of accounting guidance for such items is currently uncertain. Further, compliance with the Tax Reform Act and the accounting for such provisions requires the accumulation of information not previously required or regularly produced. As a result, we have provided a provisional estimate of the effect of the Tax Reform Act in our financial statements. As additional regulatory guidance is issued, as we perform additional analysis on the application of the law, and as we refine our estimates in calculating the effect, our final analysis may be different from our current provisional amounts, which could adversely impact our results of operations, financial position and cash flows.

We are exposed to fluctuations in foreign currency exchange rates, which may adversely affect our results of operations.

We generate a portion of our revenues and incur some operating costs in currencies other than the U.S. dollar. In addition, the financial position and results of operations of some of our overseas subsidiaries are reported in the relevant local currency and then translated to U.S. dollars at the applicable currency exchange rates for inclusion in our consolidated financial statements. Fluctuations in these currency exchange rates affect the recorded levels of our assets and liabilities, results of operations and cash flows.

The primary exchange rate fluctuation exposures we have are with the European Union euro, British pound sterling and Brazilian real. Exchange rates between these currencies and the U.S. dollar have fluctuated in recent years and may continue to do so. We cannot accurately predict future exchange rate variability among these currencies or relative to the U.S. dollar. While we take steps to manage currency exchange rate exposure, including entering into hedging transactions, we cannot eliminate all exposure to future exchange rate variability. These exchange risks could adversely impact our results of operations, financial position and cash flows.

Sharp and unexpected fluctuations in the cost of our raw materials and energy could adversely affect our profit margins.

We use a variety of raw materials, chemicals and energy in our manufacturing and blending processes. Many of these raw materials are derived from petrochemical-based and vegetable-based feedstocks which can be subject to periods of rapid and significant cost instability. These fluctuations in cost can be caused by political instability in oil producing nations and

elsewhere, weather conditions or other factors influencing global supply and demand of these materials, over which we have little or no control. We use long-term contracts (generally with fixed or formula-based costs) and advance bulk purchases to help ensure availability and continuity of supply, and to manage the risk of cost increases. From time to time, we have entered into hedging arrangements for certain utilities and raw materials, but do not typically enter into hedging arrangements for all raw materials, chemicals or energy costs. If the costs of raw

14


materials, chemicals or energy increase, and we are not able to pass on these cost increases to our customers, then profit margins and cash flows from operating activities would be adversely impacted. If raw material costs increase significantly, then our need for working capital could increase. Any of these risks could adversely impact our results of operations, financial position and cash flows.

A disruption inOur business is subject to the supplyrisk of raw materials or transportation servicesmanufacturing disruptions, the occurrence of which would have a material adverse impact onadversely affect our results of operations.

Although we tryWe are subject to anticipate problemshazards which are common to chemical manufacturing, blending, storage, handling and transportation. These hazards include, but are not limited to, fires, explosions, chemical spills and the release or discharge of toxic or hazardous substances together with suppliesthe more generic risks of raw materialslabor strikes or slowdowns, mechanical failure in scheduled downtime, extreme weather or transportation services by building certain inventoriesinterruptions. These hazards could result in loss of strategic importance, transport operations are exposed to various risks such as extreme weather conditions, natural disasters, technological problems, work stoppages as well as transportation regulations. If the Company experiences transportation problems,life, severe injury, property damage, environmental contamination and temporary or if there are significant changes in the costpermanent manufacturing cessation. Any of these services, the Company may not be able to arrange efficient alternatives and timely means to obtain raw materials or ship finished products, whichfactors could adversely impact our results of operations, financial position and cash flows.

Legal, Regulatory and Tax Matters

A high concentrationWe are subject to extensive regulation of significant stockholdersour international operations that could adversely affect our business and results of operations.

Due to our global operations, we are subject to many laws governing international commercial activity, conduct and relations, including, but not limited to, those that prohibit improper payments to government officials, restrict where and with whom we can do business and limit the products, software and technology that we can supply to certain countries and customers. These laws include, but are not limited to, the U.S. Foreign Corrupt Practices Act and U.K. Bribery Act, sanctions and assets control programs administered by the U.S. Department of the Treasury and/or the E.U. from time to time, and the U.S. export control laws such as the regulations under the U.S. Export Administration Act, as well as similar laws and regulations in other countries relevant to our business operations. Violations of any of these laws or regulations, which are often complex in their application, may result in criminal or civil penalties that could have a material adverse impacteffect on our stock price.results of operations, financial position and cash flows.

Approximately 38% of our common stock is held by four stockholders. A decision by any of these stockholders to sell all or a significant part of its holding, or a sudden or unexpected disposition of our stock,Our U.K. defined benefit pension plan could result in a significant decline in our stock price which could in turn adversely impact our abilityfinancial condition, results of operations and cash flows.

Movements in the underlying plan asset value and Projected Benefit Obligation (“PBO”) of our U.K. defined benefit pension plan (“UK Plan”) are dependent on our assumptions in respect of the discount rate, annual member mortality rates, future return on assets and future inflation. A change in any one of these assumptions could impact the plan asset value, PBO and pension credit recognized in the income statement.

In May 2022, the Trustees of the UK Plan entered into an agreement with Legal and General Assurance Society Limited to access equity marketsacquire an insurance policy that operates as an investment asset, with the intent of matching the remaining uninsured part of the UK Plan’s future cash outflow arising from the accrued pension liabilities of members. Such an arrangement is commonly termed as a “buy-in”. The benefit obligation was not transferred to the insurer, and the Company remains responsible for paying pension benefits. The initial value of the asset associated with this contract was equal to the premium paid to secure the contract and is adjusted each reporting period to reflect the estimated fair value of the premium that would be paid for such a contract at that time. The buy-in reduces the UK Plan’s value at risk in relation to key risks associated with improved longevity, inflation and interest rate movements while improving

15


the security to the UK Plan and its members. The Company consequently benefits from the buy-in as it reduces the UK Plan’s potential reliance on the Company for future cash funding requirements. However, should an unexpected issue arise, there could be consequences which adversely impact our results of operations, financial position and cash flows.

We may have additional tax liabilities.

We are subject to income and other taxes in turnthe U.S., the U.K., and a number of other jurisdictions. Tax laws are dynamic and subject to change as new laws are passed and new interpretations of the law are issued or applied. Significant judgment is required in estimating our worldwide provision for income taxes. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. Although we believe our tax estimates are reasonable, any final determination pursuant to tax audits and any related litigation could be materially different to the amounts reflected in our Consolidated Financial Statements. Should any tax authority disagree with our estimates and determine any additional tax liabilities, including interest and penalties for us, this could adversely impact our results of operations, financial position and cash flows.

In 2021, the Organization for Economic Cooperation and Development (“OECD”) released Pillar Two Global Anti-Base Erosion model rules (“Pillar Two Rules”), designed to ensure large corporations are taxed at a minimum rate of 15% in all countries of operation. Although the U.S. has not yet enacted legislation implementing Pillar Two Rules, other countries where Innospec does business, including the U.K., have enacted legislation implementing Pillar Two Rules which are effective from January 1, 2024. We are continuing to evaluate the Pillar Two Rules and their potential impact on future periods, though we do not expect the Pillar Two Rules to have a material impact on the Company’s effective tax rate.

Failure to protect our intellectual property rights could adversely affect our future performance and cash flows.

Failure to maintain or protect our intellectual property rights may result in the loss of valuable technologies, or us having to pay other companies for infringing on their intellectual property rights. Measures taken by us to protect our intellectual property may be challenged, invalidated, circumvented or rendered unenforceable. We may also face patent infringement claims from our competitors which may result in substantial litigation costs, claims for damages or a tarnishing of our reputation even if we are successful in defending against these claims, which may cause our customers to switch to our competitors. Any of these events could adversely impact our results of operations, financial position and cash flows.

Our products are subject to extensive government scrutiny and regulation.

We are subject to regulation by federal, state, local and foreign government authorities. In some cases, we need government approval of our products, manufacturing processes and facilities before we may sell certain products. Many products are required to be registered with the U.S. Environmental Protection Agency (EPA), with the European Chemicals Agency (ECHA) and with comparable government agencies elsewhere. We are also subject to ongoing reviews of our products, manufacturing processes and facilities by government authorities, and must also produce product data and comply with detailed regulatory requirements.

In order to obtain regulatory approval of certain new products we must, among other things, demonstrate that the product is appropriate and effective for its intended uses, that the product has been appropriately tested for safety and that we are capable of manufacturing the product in accordance with applicable regulations. This approval process can be costly, time consuming, and subject to unanticipated and significant delays. We cannot be sure that necessary approvals will be granted on a timely basis or at all. Any delay in obtaining, or any failure to obtain or maintain, these approvals would adversely affect our ability to introduce new products and to generate income from those products. New or stricter laws and regulations may be introduced that could result in additional compliance costs and prevent or inhibit the development, manufacture, distribution and sale of our products. Such outcomes could adversely impact our results of operations, financial position and cash flows.

Diverse chemical regulatory processes in different countries around the world might create complexity and additional cost. U.K. REACH, which was precipitated by the U.K.’s exit from the E.U., is one such example.

16


Legal proceedings and other claims could impose substantial costs on us.

We are from time to time involved in legal proceedings that result from, and are incidental to, the conduct of our business, including employee and product liability claims. Although we maintain insurance to protect us against a variety of claims, if our insurance coverage is not adequate to cover such claims, then we may be required to pay directly for such liabilities. Such outcomes could adversely impact our results of operations, financial position and cash flows.

Environmental liabilities and compliance costs could have a substantial adverse impact on our results of operations.

We operate a number of manufacturing sites and are subject to extensive federal, state, local and foreign environmental, health and safety laws and regulations, including, but not limited to, those relating to emissions to the air, discharges to land and water, and the generation, handling, treatment and disposal of hazardous waste and other materials on these sites. We operate under numerous environmental permits and licenses, many of which require periodic notification and renewal, which is not automatic. New or stricter laws and regulations could increase our compliance burden or costs and adversely affect our ability to develop, manufacture, blend, market and supply products.

Our operations, and the operations of prior owners of our sites, pose the risk of environmental contamination which may result in fines or criminal sanctions being imposed or require significant amounts in environmental remediation payments.

We anticipate that certain manufacturing sites may cease production over time and on closure, will require safely decommissioning and some environmental remediation. The extent of our obligations will depend on the future use of the sites that are affected and the environmental laws in effect at the time. We currently have madehold a decommissioning and remediationplant closure provision in our consolidated financial statementsConsolidated Financial Statements based on current known obligations, anticipated plans for sites andor existing environmental laws. If there were to be unexpected or unknown contamination at these sites, or future plans for the sites or environmental laws change, then current provisions may prove inadequate, which could adversely impact our results of operations, financial position and cash flows.

The inability of counterparties to meet their contractual obligations could have a substantial adverse impact on our results of operations.

We sell products to oil companies, oil and gas exploration and production companies and chemical companies throughout the world. Credit limits, ongoing credit evaluation and account monitoring procedures are used to minimize bad debt risk. Collateral is not generally required. We have in place a credit facility with a syndicate of banks. From time to time, we use derivatives, including interest rate swaps, commodity swaps and foreign currency forward exchange contracts, in the normal course of business to manage market risks. We enter into derivative instruments with a diversified group of major financial institutions in order to manage the exposure tonon-performance of such instruments.

We remain subject to market and credit risks including the ability of counterparties to meet their contractual obligations and the potentialnon-performance of counterparties to deliver contracted commodities or services at the contracted price. The inability of counterparties to meet their contractual obligations could have an adverse impact on our results of operations, financial position and cash flows.

The provisions of our term loan and revolving credit facility may restrict our ability to incur additional indebtedness or to otherwise expand our business.

Our term loan and revolving credit facility contains restrictive clauses which may limit our activities, and operational and financial flexibility. We may not be able to borrow under the credit facility if an event of default under the terms of the facility occurs. An event of default under the term loan and credit facility includes a material adverse change to our assets, operations or financial condition, and certain other events. The term loan and revolving credit facility also contains a number of restrictions that limit our ability, among other things, and subject to certain limited exceptions, to incur additional indebtedness, pledge our assets as security, guarantee obligations of third parties, make investments, undergo a merger or consolidation, dispose of assets or materially change our line of business.

In addition, the term loan and revolving credit facility requires us to meet certain financial ratios, including ratios based on net debt to EBITDA and net interest expense to EBITDA. Net debt, net interest expense and EBITDA arenon-GAAP measures of liquidity defined in the credit facility. Our ability to meet these financial covenants depends upon the future

successful operating performance of the business. If we fail to comply with financial covenants, we would be in default under the term loan and revolving credit facility and the maturity of our outstanding debt could be accelerated unless we were able to obtain waivers from our lenders. If we were found to be in default under the term loan and revolving credit facility, it could adversely impact our results of operations, financial position and cash flows.

Our business is subject to the risk of manufacturing disruptions, the occurrence of which would adversely affect our results of operations.

We are subject to hazards which are common to chemical manufacturing, blending, storage, handling and transportation. These hazards include fires, explosions, remediation, chemical spills and the release or discharge of toxic or hazardous substances together with the more generic risks of labor strikes or slowdowns, mechanical failure in scheduled downtime, extreme weather or transportation interruptions. These hazards could result in loss of life, severe injury, property damage, environmental contamination and temporary or permanent manufacturing cessation. Any of these factors could adversely impact our results of operations, financial position and cash flows.

Domestic or international natural disasters or terrorist attacks may disrupt our operations, decrease the demand for our products or otherwise have an adverse impact on our business.

Chemical related assets, and U.S. corporations such as us, may be at greater risk of future terrorist attacks than other possible targets in the U.S., the United Kingdom and throughout the world. Extraordinary events such as natural disasters may negatively affect local economies, including those of our customers or suppliers. The occurrence and consequences of such events cannot be predicted, but they can adversely impact economic conditions in general and in our specific markets. The resulting damage from such events could include loss of life, severe injury and property damage or site closure. Any of these matters could adversely impact our results of operations, financial position and cash flows.

While Innospec maintains business continuity plans that are intended to allow it to continue operations or mitigate the effects of events that could disrupt its business, Innospec cannot provide assurances that its plans would fully protect it from all such events. In addition, insurance maintained by Innospec to protect against property damage, loss of business and other related consequences resulting from catastrophic events is subject to coverage limitations, depending on the nature of the risk insured. This insurance may not be sufficient to cover all of Innospec’s damages or damages to others in the event of a catastrophe. In addition, insurance related to these types of risks may not be available now or, if available, may not be available in the future at commercially reasonable rates.

We may be exposed to certain regulatory and financial risks related to climate changechange.

The outcome of new or potential legislation or regulation in the U.S. and other jurisdictions in which we operate may result in new or additional requirements, additional charges to fund energy efficiency activities, fees or restrictions on certain activities. Compliance with these

initiatives may also result in additional costs to us, including, among other things, increased production costs, additional taxes, reduced emission allowances or additional restrictions on production or operations. Any adopted future climate change regulations enacted in the future could also negatively impact our ability to compete with companies situated in areas not subject to such limitations. Even without such regulation, increased public awareness and adverse publicity about potential impacts on climate change emanating from us or our industry could harm us. We may not be able to recover the cost of compliance with new or more stringent laws and regulations, which could adversely affect our business and negatively impact our growth. Furthermore, the potential impacts of climate change and related regulation on our customers are highly uncertain and may adversely affect us.

17


Key Third-Party Relationships

Having a small number of significant customers may have a material adverse impact on our results of operations.

Our principal customers are personal and home care companies, oil refiners, oil and gas exploration and production companies, and other chemical and industrial companies. These industries are characterized by a concentration of a few large participants. The loss of a significant customer, a material reduction in demand by a significant customer or termination or non-renewal of a significant customer contract could adversely impact our results of operations, financial position and cash flows.

A disruption in the supply of raw materials or transportation services would have a material adverse impact on our results of operations.

Although we try to anticipate problems with supplies of raw materials or transportation services by building certain inventories of strategic importance, transport operations are exposed to various risks such as extreme weather conditions, natural disasters, technological problems, work stoppages, geopolitical tensions, pandemics, as well as transportation regulations. If the Company experiences transportation problems, or if there are significant changes in the cost of these services, the Company may not be able to arrange efficient alternatives and timely means to obtain raw materials or ship finished products, which could adversely impact our results of operations, financial position and cash flows.

The inability of counterparties to meet their contractual obligations could have a substantial adverse impact on our results of operations.

Credit limits, ongoing credit evaluation and account monitoring procedures are used to minimize bad debt risk. Collateral is not generally required. We have in place a credit facility with a syndicate of banks. From time to time, we use derivatives, including, but not limited to, interest rate swaps, commodity swaps and foreign currency forward exchange contracts, in the normal course of business to manage market risks. We enter into derivative instruments with a diversified group of major financial institutions in order to manage the exposure to non-performance of such instruments.

We remain subject to market and credit risks including the ability of counterparties to meet their contractual obligations and the potential non-performance of counterparties to deliver contracted commodities or services at the contracted price. The inability of counterparties to meet their contractual obligations could have an adverse impact on our results of operations, financial position and cash flows.

Finance and Investment

We are exposed to fluctuations in foreign currency exchange rates, which may adversely affect our results of operations.

We generate a portion of our revenues and incur some operating costs in currencies other than the U.S. dollar. In addition, the financial position and results of operations of some of our overseas subsidiaries are reported in the relevant local currency and then translated to U.S. dollars at the applicable currency exchange rates for inclusion in our Consolidated Financial Statements. Fluctuations in these currency exchange rates affect the recorded levels of our assets and liabilities, results of operations and cash flows.

The primary exchange rate fluctuation exposures we have are with the E.U. euro, British pound sterling and Brazilian real. Exchange rates between these currencies and the U.S. dollar have fluctuated in recent years and may continue to do so. We cannot accurately predict future exchange rate variability among

18


these currencies or relative to the U.S. dollar. While we take steps to manage currency exchange rate exposure, including entering into hedging transactions, we cannot eliminate all exposure to future exchange rate variability. These exchange risks could adversely impact our results of operations, financial position and cash flows.

A high concentration of significant stockholders may have a material adverse impact on our stock price.

Approximately 45% of our common stock is held by four stockholders. A decision by any of these, or other substantial, stockholders to sell all or a significant part of its holding, or a sudden or unexpected disposition of our stock, could result in a significant decline in our stock price. This could in turn adversely impact our ability to access equity markets, which could adversely impact our results of operations, financial position and cash flows.

Our amended and restated by-laws designate specific Delaware courts as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.

Our amended and restated by-laws (the “By-laws”) provide that, unless we consent in writing to the selection of an alternative forum, the appropriate court within the State of Delaware is the sole and exclusive forum, to the fullest extent provided by law, for the following types of actions or proceedings:

any derivative action or proceeding brought on behalf of the Corporation,
any action asserting a claim of breach of a fiduciary duty owed by any director, officer, other employee or stockholder of the Corporation to the Corporation or the Corporation’s stockholders,
any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law (“DGCL”), our amended and restated certificate of incorporation, the By-laws, or as to which the DGCL confers jurisdiction upon the Court of Chancery of the State of Delaware,
any action asserting a claim governed by the internal affairs doctrine, or
any other internal corporate claim as defined in Section 115 of the DGCL.

This includes, to the extent permitted by the federal securities laws, lawsuits asserting both state law claims and claims under the federal securities laws.

This forum selection provision in the By-laws may limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us. It is also possible that, notwithstanding the forum selection clause included in the By-laws, a court could rule that such a provision is inapplicable or unenforceable.

Application of the choice of forum provision may be limited in some instances by law. Section 27 of the Securities Exchange Act of 1934 (“Exchange Act”) provides for exclusive federal court jurisdiction over Exchange Act claims. Accordingly, to the extent the exclusive forum provision is held to cover a shareholder derivative action asserting claims under the Exchange Act, such claims could not be brought in the Delaware Court of Chancery and would instead be within the jurisdiction of the federal district court for the District of Delaware. Section 22 of the Securities Act of 1933 (“Securities Act”) creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Our stockholders will not be deemed by operation of our choice of forum provision to have waived our compliance with the federal securities laws and the

19


regulations promulgated thereunder. The selection of legal jurisdiction for litigation claims may impact the outcome of legal proceedings which could in turn impact our results of operations, financial position and cash flows.

The provisions of our revolving credit facility may restrict our ability to incur additional indebtedness or to otherwise expand our business.

Our revolving credit facility contains restrictive clauses which may limit our activities as well as operational and financial flexibility. We may not be able to borrow under the revolving credit facility if an event of default under the terms of the facility occurs. An event of default under the credit facility includes a material adverse change to our assets, operations or financial condition, and certain other events. The revolving credit facility also contains a number of restrictions that limit our ability, among other things, and subject to certain limited exceptions, to incur additional indebtedness, pledge our assets as security, guarantee obligations of third parties, make investments, undergo a merger or consolidation, dispose of assets or materially change our line of business.

In addition, the revolving credit facility requires us to meet certain financial ratios, including ratios based on net debt to earnings before income tax, depreciation and amortization (“EBITDA”) and net interest expense to EBITDA. Net debt, net interest expense and EBITDA are non-GAAP measures of liquidity defined in the credit facility. Our ability to meet these financial covenants depends upon the future successful operating performance of the business. If we fail to comply with these financial covenants, we would be in default under the revolving credit facility and the maturity of our outstanding debt could be accelerated unless we were able to obtain waivers from our lenders. If we were found to be in default under the revolving credit facility, it could adversely impact our results of operations, financial position and cash flows.

Item 1BUnresolved Staff Comments

Item 1B Unresolved Staff Comments

None.

Item 1C Cyber Security

Risk Management & Strategy

Innospec has strategically integrated cyber security risk management into its broader risk management framework to promote a company-wide culture of cyber security risk management. This integration ensures that cyber security considerations are an integral part of our decision-making processes at every level. For example, training on cyber security risks was required of all Innospec directors and employees who have access to our information technology resources. Our risk management team works closely with our Information Technology (“IT”) leadership to continuously evaluate and address cyber security risks in alignment with our business objectives and operational needs.

Innospec’s IT leadership team is responsible for assessing, identifying and managing the inherent and residual risks associated with cyber security threats across our IT and Operational Technology landscape. IT leadership periodically reviews the Company’s external threats, portfolio, and external services, and will update its risk register accordingly.

IT leadership will, when required by either executive management or the Board, engage third-party reviews of our overall cyber security compliance using The National Institute of Technology (“NIST”) framework. IT leadership will also periodically engage specialist security contractors to test the

20


Company’s resilience to cyber security threats, conduct penetration testing and vulnerability assessments across its assets and request additional investment where necessary to further improve our cyber security.

Innospec utilizes an external service to provide ongoing analysis of the security related to our critical third-party service providers for IT operations and business IT services. Innospec will use the information provided by this external service as part of its IT vendor selection criteria and for ongoing third-party risk management.

Innospec’s cyber security is underpinned by a third-party specialist that monitors critical systems and end-user devices for cyber-attacks. In the first instance, cyber-attacks are brought to the attention of the IT leadership for evaluation and remediation before further escalation to the CEO and CFO is considered.

Periodically, our systems are subject to targeted attacks which are intended to interrupt our operations or may lead to the loss, misuse or theft of personal information relating to our employees, suppliers and customers or lead to the loss of Company data, confidential information or our intellectual property.

Governance

Innospec’s Board and its committees provide oversight of the Company’s IT, including cyber security, in connection with the Company’s efforts to assess and manage the Company’s risk exposure. Oversight of risk management, including cyber security risk management is an integral part of Board and committee deliberations throughout the year. Since 2019, the Board has retained NCC Group (“NCC”) to perform cyber security reviews. NCC reports its findings directly to the Board. In addition, in early 2020 the Audit Committee retained Deloitte to lead a series of information technology risk evaluations. The evaluation resulted in a three-year audit plan covering Cyber Security, Legacy IT and IT Strategy. The audit plan was approved by the Audit Committee.

Innospec’s Board has delegated responsibility for the management of the Company’s IT to the Company's IT steering committee via the CEO and CFO. The IT steering committee is made up of executive management, business leaders from our reporting segments, the functional heads responsible for our operating systems, IT leadership and is chaired by our Global IT Director. The Company considers that the IT steering committee members have the appropriate qualifications and experience required to enable them to fulfill their responsibilities. The IT steering committee may, as per its agreed terms of reference, escalate any matter it wishes to the Board via either the CEO or CFO.

IT leadership is made up of senior managers with the appropriate qualifications and business experience required for their roles across Innospec’s IT operations. The Company considers that the IT leadership team is sufficiently experienced and qualified in its role of assessing and managing cyber security risks across the business. IT leadership formally reports through the CEO and CFO to the Board.

Innospec’s CEO and CFO are involved with and approve the Company’s strategy for managing the prevention, detection, mitigation and remediation of cyber security incidents as part of its “IT Security Management System” which includes defined escalation and internal communications processes and responsibilities.

IT leadership will, as required, present to the IT steering committee, information regarding any IT risks identified and the mitigation plans to reduce the Company’s residual risks. The IT steering committee will be regularly updated as to the occurrence, mitigation and resolution of cyber security incidents. Any cyber security incident that is considered significant in nature will be shared by IT leadership with the IT steering committee in accordance with the agreed communication and escalation processes. The IT steering

21


committee will assess the incident and make a recommendation to the CEO and CFO as to whether the incident is reportable to the SEC and/or other regulators or stakeholders.

In the last three fiscal years, management has determined there were no cyber security threats that have materially affected Innospec and that the expenses incurred relating to cyber incidents have been immaterial. The Company is not aware of any threats that are reasonably likely to materially affect its business strategy, results of operations or financial condition for the foreseeable future.

IT leadership provides a written report to the Board each quarter and the Global IT Director presents in person at least annually. Those reports and presentations include information on Innospec’s cyber security and the related key performance indicators. IT leadership also provides external threat analysis to the Board when new relevant threats are identified as being exploitable and their potential impact on Innospec.

22


Item 2Properties

Item 2 Properties

General

A summary of the Company’s principal properties is shown in the following table. Each of these properties is owned by the Company except where otherwise noted:

Location

Reporting Segment

Operations

Location

Reporting SegmentOperations

Englewood, Colorado (1)

Fuel Specialties

Corporate Headquarters/

Business Teams/

Sales/Administration

Englewood, Colorado(1)

Newark, Delaware (1)

Fuel Specialties

Research & Development

Herne, Germany

Fuel Specialties

Sales/Manufacturing/Administration/

Research & Development

Vernon, France

Fuel Specialties

Sales/Manufacturing/Administration/

Research & Development

Leuna, Germany

Fuel Specialties

Sales/Manufacturing/Administration/

Research & Development

Ellesmere Port, United Kingdom

Fuel Specialties, Performance Chemicals

European Headquarters/

Business Teams/

Sales/Manufacturing/Administration/

Research & Development/

Fuel Technology Center

Beijing, China (1)

Fuel Specialties and Performance Chemicals

Corporate Headquarters

Business Teams

Sales/Administration

Newark, Delaware

Shanghai, China (1)

Fuel Specialties

Research & Development
Herne, Germany(1)Fuel Specialties and Performance Chemicals

Sales/Manufacturing/Administration

Research & Development

Vernon, FranceFuel Specialties

Sales/Manufacturing/Administration

Research & Development

Moscow, Russia

Singapore, Singapore (1)

Fuel Specialties

Sales/Administration
Leuna, GermanyFuel Specialties and Performance Chemicals

Sales/Manufacturing/AdministrationAsia-Pacific Headquarters/

Research & DevelopmentBusiness Teams/

Sales/Administration

Ellesmere Port, United Kingdom

Milan, Italy (1)

Fuel Specialties and Performance Chemicals

Sales/Administration

Rio de Janeiro, Brazil (1)

Fuel Specialties, Performance Chemicals and Octane Additives

Oilfield Services

European HeadquartersSales/Administration

São Paulo, Brazil

Performance Chemicals

Manufacturing/Administration/

Business Teams

Sales/Manufacturing/Administration

Research & Development

Fuel Technology Center

Beijing, China(1)Fuel Specialties and Performance ChemicalsSales/Administration
Singapore(1)Fuel Specialties and Performance Chemicals

Asia-Pacific Headquarters

Business Teams

Sales/Administration

Milan, Italy(1)Fuel Specialties and Performance ChemicalsSales/Administration
Rio de Janeiro, Brazil(1)Fuel Specialties and Performance ChemicalsSales/Administration

High Point, North Carolina

Performance Chemicals

Manufacturing/AdministrationAdministration/

Research & Development

Salisbury, North Carolina

Performance Chemicals

Manufacturing/AdministrationAdministration/

Research & Development

Chatsworth, California(1)

Performance ChemicalsSales/Manufacturing/Administration

Everberg, Belgium

Chatsworth, California (1)

Performance Chemicals

Sales/Manufacturing/Administration

Saint Mihiel, France

Performance Chemicals

Manufacturing/Administration/Research & Development

Castiglione, Italy

Performance Chemicals

Manufacturing/Administration/Research & Development

Barcelona, Spain (1)

Performance Chemicals

Manufacturing/Administration/Research & Development

23


Location

Reporting Segment

Operations

Oklahoma City, Oklahoma

Oilfield Services

Sales/Manufacturing/Administration

Midland, Texas

Oilfield Services

Sales/Manufacturing/Administration

Pleasanton, Texas

Oilfield Services

Sales/Manufacturing/Administration

Sugar Land, Texas (1)

Oilfield Services

Sales/Administration/Research & Development

Saint Mihiel, France

Performance ChemicalsManufacturing/Administration/Research & Development

Castiglione, ItalyPerformance ChemicalsManufacturing/Administration/Research & Development
Barcelona, Spain(1)Performance ChemicalsManufacturing/Administration/Research & Development
Oklahoma City, OklahomaOilfield ServicesSales/Manufacturing/Administration
Midland, TexasOilfield ServicesSales/Manufacturing/Administration
Pleasanton, TexasOilfield ServicesSales/Manufacturing/Administration

The Woodlands, Houston, Texas(1)

Oilfield Services

Sales/Administration/Research & Development

Williston, North Dakota

Oilfield Services

Sales/Warehouse

Casper, Wyoming(1)

Oilfield ServicesWarehouse

Zug, Switzerland

Casper, Wyoming (1)

Oilfield Services

Octane Additives

Warehouse

Al-Khobar, Kingdom of Saudi Arabia (1)

Oilfield Services

Sales/Warehouse/Administration

(1)

Leased property

(1)
Leased property

Manufacturing Capacity

We believe that our plants and supply agreements are sufficient to meet current sales levels. Operating rates of the plants are generally flexible and varied with product mix and normal sales demand swings. We believe that all of our facilities are maintained to appropriate levels and in sufficient operating condition though there remains an ongoing need for maintenance and capital investment.

Item 3Legal Proceedings

Item 3 Legal Proceedings

Legal matters

While weWe are involved from time to time in claims and legal proceedings that result from, and are incidental to, the conduct of our business including business and commercial litigation, and employee and product liability claims,claims.

As previously reported in the first quarter of 2023, we lodged a civil and criminal legal claim and insurance claim related to a misappropriation of inventory in Brazil and as a consequence we have written-off $7.4 million of our inventory to cost of goods sold in our Consolidated Financial Statements. In the second quarter of 2023, we incurred additional charges of $8.0 million as we exited the Brazilian trading relationship associated with the inventory misappropriation. The costs incurred in the second quarter of 2023 include $5.0 million to cost of goods sold and $3.0 million to selling, general and administration costs. A corresponding asset for the potential legal or insurance recoveries has not been recorded for the resulting financial losses arising from this matter.

In addition, unrelated to the Brazil matter, in the unlikely event there are no material pending legal proceedings to which the Company or any of its subsidiaries is a party, or of which any of their property is subject. It is possible, however, that an adverse resolution of an unexpectedly large number of such individual claims or proceedings with an adverse resolution, this could in the aggregate have a material adverse effect on the results of operations for a particular year or quarter.

Item 4Mine Safety Disclosures

Item 4 Mine Safety Disclosures

Not applicable.

24


PART II

Item 5Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Item 5 Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information and Holders

The Company’s common stock is listed on the NASDAQ under the symbol “IOSP.” As of February 9, 20186, 2024, there were 917653 registered holders of the common stock. The following table shows the closing high and low prices of our common stock for each of the last eight quarters:

   First
Quarter
   Second
Quarter
   Third
Quarter
   Fourth
Quarter
 

2017

        

High

  $73.25   $69.15   $66.10   $72.95 

Low,

  $61.00   $60.40   $54.25   $60.95 

2016

        

High

  $52.32   $50.21   $60.81   $72.75 

Low

  $42.45   $43.14   $45.59   $55.50 

Dividends

The Company declared the following cash dividends for the year ended December 31, 2017:

Date declared

  Stockholders of Record   Date Paid   Amount per share 

November 7, 2017

   November 16, 2017    November 27, 2017   $0.39 

May 9, 2017

   May 22, 2017    May 31, 2017   $0.38 

The Company declared the following cash dividends for the year ended December 31, 2016:

Date declared

  Stockholders of Record   Date Paid   Amount per share 

November 2, 2016

   November 15, 2016    November 24, 2016   $0.34 

May 3, 2016

   May 16, 2016    May 25, 2016   $0.33 

There are no restrictions on our ability to declare dividends and the Company is allowed to repurchase its own common stock as long as we are in compliance with the financial covenants in the Company’s credit facility.

Unregistered Sales of Equity Securities

There were no unregistered sales of equity securities during the fourth quarter of 2017.2023.

Issuer Purchases of Equity Securities

The following table provides information about our repurchases of equity securities in the quarter ended December 31, 2023.

Period

 

Total number
of shares
purchased

 

 

Average price
paid per share

 

 

Total number
of shares
purchased as
part of
publicly
announced
plans or
programs

 

 

Approximate
dollar value
of shares
that may yet
be purchased
under the
plans or
programs

October 1, 2023 through October 31,
   2023

 

 

900

 

 

$

95.95

 

 

 

900

 

 

$43.6 million

November 1, 2023 through November 30,
   2023

 

 

447

 

 

$

100.61

 

 

 

 

 

$43.6 million

Total

 

 

1,347

 

 

$

97.50

 

 

 

900

 

 

$43.6 million

During 2017the quarter ended December 31, 2023, the Company made no repurchasespurchased its common stock as part of our common stock.

As at December 31, 2017, there was $82.5 million still available under thea share repurchase program that was approvedannounced on November 3, 2015February 15, 2022. The repurchase program allows for the repurchase of $90.0up to $50 million of Innospec sharesthe Company’s common stock to be repurchased in the open market over a three year period.three-year period commencing on February 16, 2022.

The company also repurchased its common stock in connection with the exercising of stock options by employees.

The Company has authorized securities for issuance under equity compensation plans. The information contained in the table under the heading “Equity Compensation Plans” in the Proxy Statement is incorporated herein by reference. The current limit for the total amount of shares which can be issued or awarded under the Company’s five stock option plans is 2,640,000.

25


Stock Price Performance Graph

The graph below compares the cumulative total return to stockholders on the common stock of the Corporation, the S&P 500 Index, NASDAQ Compositethe S&P 1500 Specialty Chemicals Index and the Russell 2000 Indexindex since December 31, 2012,2018, assuming a $100 investment and there-investment of any dividends thereafter. Historical stock price performance should not be relied upon as an indication of future stock price performance.

img168268360_0.jpg

Value of $100 Investment made December 31, 2012*2018*

  2012   2013   2014   2015   2016   2017 

 

2018

 

 

2019

 

 

2020

 

 

2021

 

 

2022

 

 

2023

 

Innospec Inc.

  $100.00   $135.46   $126.76   $163.03   $207.64   $216.34 

 

$

100.00

 

 

$

169.14

 

 

$

150.06

 

 

$

151.33

 

 

$

174.45

 

 

$

211.40

 

S&P 500 Index

   100.00    129.60    144.36    143.31    156.98    187.47 

 

 

100.00

 

 

 

131.49

 

 

 

155.68

 

 

 

200.37

 

 

 

164.08

 

 

 

207.21

 

NASDAQ Composite Index

   100.00    138.32    156.85    165.84    178.28    228.63 

S&P 1500 Specialty Chemicals
Index

 

 

100.00

 

 

 

118.29

 

 

 

137.60

 

 

 

175.78

 

 

 

132.06

 

 

 

151.74

 

Russell 2000 Index

  $100.00   $137.00   $141.84   $133.74   $159.78   $180.79 

 

$

100.00

 

 

$

125.52

 

 

$

150.58

 

 

$

172.89

 

 

$

137.56

 

 

$

160.85

 

* Excludes purchase commissions.

Item 6Selected Financial Data

26


Item 6 [Reserved]

FINANCIAL HIGHLIGHTS

27

(in millions, except financial ratios, share and
per share data)

 2017  2016  2015  2014  2013 

Summary of performance:

     

Net sales

 $1,306.8  $883.4  $1,012.3  $960.9  $818.8 

Operating income

  129.7   105.4   156.3   112.5   90.6 

Income before income taxes

  128.1   103.1   152.3   110.9   92.8 

Income taxes

  (66.3  (21.8  (32.8  (26.8  (15.0

Net income

  61.8   81.3   119.5   84.1   77.8 

Net income attributable to Innospec Inc.

  61.8   81.3   119.5   84.1   77.8 

Net cash provided by operating activities

 $82.7  $105.5  $118.2  $106.3  $61.3 

Financial position at year end:

     

Total assets

 $1,410.2  $1,181.4  $1,028.6  $999.9  $794.7 

Long-term debt including finance leases (including current portion)

  224.3   273.3   134.7   140.5   146.2 

Cash, cash equivalents, and short- term investments

  90.2   101.9   141.7   46.3   86.8 

Total equity

 $794.3  $653.8  $605.3  $515.9  $409.4 

Financial ratios:

     

Net income attributable to Innospec Inc. as a percentage of sales

  4.7   9.2   11.8   8.8   9.5 

Effective tax rate as a percentage (1)

  51.8   21.1   21.5   24.2   16.2 

Current ratio(2)

  2.1   2.4   2.2   1.9   2.6 

Share data:

     

Earnings per share attributable to Innospec Inc.

     

– Basic

 $2.56  $3.39  $4.96  $3.45  $3.29 

– Diluted

 $2.52  $3.33  $4.86  $3.38  $3.22 

Dividend paid per share

 $0.77  $0.67  $0.61  $0.55  $0.50 

Shares outstanding (basic, thousands)

     

– At year end

  24,350   24,071   24,101   24,291   24,347 

– Average during year

  24,148   23,998   24,107   24,391   23,651 

Closing stock price

     

– High

 $73.25  $72.75  $58.70  $46.03  $48.71 

– Low

 $54.25  $42.45  $39.47  $35.55  $35.27 

– At year end

 $70.60  $68.50  $54.31  $42.70  $46.22 

(1)The effective tax rate is calculated as income taxes as a percentage of income before income taxes. Incometaxes are impacted in 2017 by the provisional estimates recorded in respect of the Tax Reform Act.

(2)Current ratio is defined as current assets divided by current liabilities.

QUARTERLY SUMMARY

(in millions, except per share data)

  First
Quarter
  Second
Quarter
  Third
Quarter
   Fourth
Quarter
 

2017

      

Net sales

  $294.3  $326.3  $332.4   $353.8 

Gross profit

   90.9   105.1   98.8    108.5 

Operating income

   26.4   34.7   30.2    38.4 

Net income/(loss)(1)

   17.2   26.1   23.3    (4.8

Net cash provided by operating activities

  $(19.9 $(10.9 $35.2   $78.3 

Per common share:

      

Earnings – basic

  $0.71  $1.08  $0.97   $(0.20

– diluted

  $0.70  $1.06  $0.95   $(0.20

2016

      

Net sales

  $212.1  $228.0  $205.5   $237.8 

Gross profit

   76.2   85.5   79.2    91.4 

Operating income

   25.6   28.6   18.9    32.3 

Net income(2)

   18.9   28.9   11.4    22.1 

Net cash provided by operating activities

  $6.7  $50.4  $29.9   $18.5 

Per common share:

      

Earnings – basic

  $0.79  $1.21  $0.48   $0.92 

– diluted

  $0.77  $1.18  $0.47   $0.90 

NOTES

(1)Net income includes the following special items, before tax except for the adjustment of unrecognized tax benefits, during the year ended December 31, 2017:

(in millions)

  First
Quarter
   Second
Quarter
  Third
Quarter
  Fourth
Quarter
 

2017

      

US Tax Cuts and Jobs Act 2017

  $0.0   $0.0  $0.0  $40.6 

Amortization of acquired intangible assets

   5.1    5.0   5.0   5.5 

Adjustment of unrecognized tax benefits

   0.0    0.0   (0.5  0.0 

Loss/(gain) on disposal of subsidiary

   0.0    1.0   0.0   (0.1

Foreign currency exchange losses/(gains)

   1.0    (2.1  (1.8  (3.7

Foreign exchange loss on liquidation of subsidiary

   1.8    0.0   0.0   0.0 

Fair value acquisition accounting

  $1.7   $0.0  $0.0  $0.0 

(2)Net income includes the following special items, before tax except for the adjustment of unrecognized tax benefits, during the year ended December 31, 2016:

(in millions)

  First
Quarter
  Second
Quarter
  Third
Quarter
  Fourth
Quarter
 

2016

     

Adjustment to fair value of contingent consideration

  $(1.6 $(2.4 $(2.3 $(3.1

Amortization of acquired intangible assets

   4.2   4.2   4.3   4.3 

Acquisition-related costs

   0.0   1.0   1.7   1.7 

Adjustment of unrecognized tax benefits

   0.0   (0.4  (1.2  0.0 

Loss on disposal of subsidiary

   1.4   0.0   0.0   0.0 

Settlement of distributor claim

   0.0   0.0   1.0   0.0 

Foreign currency exchange losses/(gains)

  $0.3  $(8.5 $5.0  $2.3 

Item 7Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations

This discussion should be read in conjunction with our consolidated financial statementsConsolidated Financial Statements and the notesNotes thereto.

EXECUTIVE OVERVIEW

In 2017,2023 Innospec delivered strong results. We again benefited from our balanced end-market exposure as the negative impact of customer destocking in Performance Chemicals was offset by significant growth in Oilfield Services, and steady results in Fuel Specialties.

In Performance Chemicals, full year sales grewand operating income declined, but we believe that destocking pressure peaked in linethe third quarter of 2023. This combined with new contract awards contributed to significant sequential improvement in operating income and margins in the second half of 2023. While the economic environment remains a challenge, we expect further improvement in this business in 2024 as activity levels return. In addition, we acquired QGP which we believe will further strengthen our expectations, as we delivered on our strategyPerformance Chemicals segment and add a manufacturing base in South America to growcompliment all of our strategic business units. Sales inend markets.

In Fuel Specialties, after adjusting for the non-recurring Brazil inventory charges in the first half of 2023, full-year operating income grew and Performance Chemicals reflectedoperating margins improved to 18%. Our target for operating margins continues to be 19-21%. Sales growth combined with further margin improvement is a key focus and opportunity for the strength of our product portfolio and research and development pipelineglobal Fuel Specialties team in these markets. Our 2024.

Oilfield Services segment experienced stronghad another excellent full year. Operating income approximately doubled and operating margins improved above our 10% target. While we expect production chemicals activity to remain at moderate levels in 2024, we continue to pursue further sales growth reflecting the increase in customer activity, as the market recovered.

Our Octane Additives segment performance was in line with the final stages of transition to unleaded gasoline in the automotive market. Our Avtel product line, producing TEL for Avgas 100LL for piston engine aircraft, is includedand margin improvement in our Fuel Specialties segment. We anticipate that this product line will decline when an alternative to Avgas 100LL is proven, and a deliverable transition plan is developed.other segments.

During the year, we completed the integration of the business acquired from Huntsman at the end of 2016. From the first quarter of 2018, Performance Chemicals will be reported as a single business in our commentary, and we will no longer report the detailed split between the acquired and heritage businesses.

CRITICAL ACCOUNTING ESTIMATES

Note 2 of the Notes to the Consolidated Financial Statements includes a summary of the significant accounting policies and methods used in the preparation of the consolidated financial statements.Consolidated Financial Statements.

Plant Closure Provisions

Business combinations

The acquisition method of accounting requires that we recognize the assets acquired and liabilities assumed at their acquisition date fair values. Goodwill is measured as the excess of consideration transferred over the acquisition date net fair values of the assets acquired and the liabilities assumed.

The measurement of the fair values of assets acquired and liabilities assumed requires considerable judgment. Although independent appraisals may be used to assist in the determination of the fair values of certain assets and liabilities, those determinations are usually based on significant estimates provided by management, such as forecast revenue or profit. In determining the fair value of intangible assets, an income approach is generally used and may incorporate the use of a discounted cash flow method. In applying the discounted cash flow method, the estimated future cash flows and residual values for each intangible asset are discounted to a present value using a discount rate appropriate to the business being

acquired. These cash flow projections are based on management’s estimates of economic and market conditions including revenue growth rates, operating margins, capital expenditures and working capital requirements.

While we use our best estimates and assumptions as part of the process to value assets acquired and liabilities assumed at the acquisition date and contingent consideration at each balance sheet reporting date, our estimates are inherently uncertain and subject to refinement. During the measurement period, which occurs before finalization of the purchase price allocation, changes in assumptions and estimates based on new information that was not previously available, that result in adjustments to the fair values of assets acquired and liabilities assumed will have a corresponding offset to goodwill. Subsequent adjustments will impact our consolidated statements of income.

Environmental Liabilities

We are subject to environmental laws in the countries in which we conduct business. OurEllesmere Port in the U.K. is our principal site giving rise to environmental remediation liabilities isasset retirement obligations, associated with the Octane Additives manufacturing site at Ellesmere Port in the United Kingdom.production of TEL. There are also asset retirement obligations and environmental remediation liabilities on a much smaller scale in respect of our other manufacturing sites in the U.S. and Europe.sites. At Ellesmere Port there is a continuing asset retirement program related to certain manufacturing units that have been closed.

28


Remediation

Plant closure provisions at December 31, 20172023 amounted to $46.1$61.6 million and relate principally to our Ellesmere Port site in the United Kingdom.U.K.. We recognize environmental remediation liabilities when they are probable and costs can be reasonably estimated, and asset retirement obligations when there is a legal obligationrequirement, including those arising from a Company promise, and the costs can be reasonably estimated. The Company has to anticipate the program of work required and the associated future expected costs, and comply with environmental legislation in the countries in which it operates or has operated in. The Company viewsWe develop these assumptions utilizing the costs of vacating our Ellesmere Port site as contingent upon if and when it vacates the site because there is no present intention to do so.

Pensions

The Company maintains a defined benefit pension plan covering a number of its current and former employees in the United Kingdom. The Company also has other much smaller pension arrangements in the U.S. and overseas, but the obligations under those plans are not material. The United Kingdom plan is closed to future service accrual, but has a large number of deferred and current pensioners.

Movements in the underlying plan asset value and Projected Benefit Obligation (“PBO”) are dependent on actual return on investments as well aslatest information available together with recent costs. While we believe our assumptions for plant closure provisions are reasonable, they are subjective estimates and it is possible that variations in respectany of the discount rate, annual member mortality rates, future return on assets and future inflation. A changeassumptions will result in any one of these assumptions could impact the plan asset value, PBO and pension charge recognized in the income statement. Such changes could adversely impact our results of operations and financial position. For example, a 0.25% change in the discount rate

assumption would change the PBO by approximately $25 million while the net pension credit for 2018 would change by approximately $0.1 million. A 0.25% change in the level of price inflation assumption would change the PBO by approximately $18 million and the net pension credit for 2018 would change by approximately $1.5 million.

Further information is provided in Note 9 of the Notesmaterially different calculations to the Consolidated Financial Statements.liabilities we have reported.

Income Taxes

We are subject to income and other taxes in the U.S., the U.K. and a number of other jurisdictions. Tax laws are dynamic and subject to change as new laws are passed and new interpretations of the law are issued or applied.

The calculation of our tax liabilities involves evaluating uncertainties in the application of accounting principles and complex tax regulations. We recognize liabilities for anticipated tax audit issues based on our estimate of whether, and the extent to which, additional taxes will be required. If we ultimately determine that payment of these amounts is unnecessary, we reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer necessary.

We also recognize tax benefits to the extent that it is more likely than not that our positions will be sustained, based on technical merits of the position, when challenged by the taxing authorities. To the extent that we prevail in matters for which liabilities have been established or are required to pay amounts in excess of the liabilities recorded in our liabilities,Consolidated Financial Statements, our effective tax rate in a given period may be materially affected. An unfavorable tax settlement may require cash payments and result in an increase in our effective tax rate in the year of resolution. A favorable tax settlement may be recognized as a reduction in our effective tax rate in the year of resolution. We report interest and penalties related to uncertain income tax positions as income taxes. For additional information regarding uncertain income tax positions, see Note 11 of the Notes to the Consolidated Financial Statements.

Pensions

The Company maintains a defined benefit pension plan covering certain current and former employees in the United Kingdom (“UK Plan”). The UK Plan is closed to future service accrual but has a large number of deferred and current pensioners. The Company also has other smaller pension arrangements in the U.S. and overseas.

In May 2022, the Trustees of the UK Plan entered into an agreement with Legal and General Assurance Society Limited to acquire an insurance policy that operates as an investment asset, with the intent of matching the remaining uninsured part of the UK Plan’s future cash outflow arising from the accrued pension liabilities of members. Such an arrangement is commonly termed as a “buy-in”. The benefit obligation was not transferred to the insurer, and the Company remains responsible for paying pension benefits. The initial value of the asset associated with this contract was equal to the premium paid to secure the contract and is adjusted each reporting period to reflect the estimated fair value of the premium that would be paid for such a contract at that time. The buy-in reduces the UK Plan’s value at risk in relation to key risks associated with improved longevity, inflation and interest rate movements while improving the security to the UK Plan and its members. The Company consequently benefits from the buy-in as it reduces the UK Plan’s potential reliance on the Company for future cash funding requirements.

29


Movements in the UK Plan’s Projected Benefit Obligation (“PBO”) are dependent on our assumptions in respect of the discount rate, annual member mortality rates, future return on assets and future inflation. A change in any one of these assumptions could impact the plan asset value, PBO and pension charge recognized in the income statement. Such changes could adversely impact our results of operations and financial position. For example, a 0.25% change in the discount rate assumption would change the PBO at December 31, 2023 by approximately $10.8 million and the net pension credit for 2024 would change by approximately $0.6 million. A 0.25% change in the level of price inflation assumption would change the PBO at December 31, 2023 by approximately $6.9 million and the net pension credit for 2024 by approximately $0.3 million.

Further information is provided in Note 10 of the Notes to the Consolidated Financial Statements.

Goodwill

On December 22, 2017, the U.S. Tax Cuts and Jobs Act (the “Tax Reform Act”) was enacted and significantly revises the U.S. corporate income tax regime. The new legislation contains several key tax provisions that affect us, including aone-time mandatory transition tax on accumulated foreign earnings and a reduction in the U.S. corporate income tax rate from 35% to 21% effective January 1, 2018, amongst others.

On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for the tax effects of the Tax Reform Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Reform Act enactment date for companies to complete their accounting under ASC 740,Income Taxes. Until accounting is complete, companies may record provisional estimates. As a result of the Tax Reform Act, we have recorded provisional amounts in relation to the accounting of the transition tax in 2017. We consider the accounting of the transition tax and other items as

further disclosed in Note 10 to be incomplete due to the forthcoming guidance and our ongoing analysis of final data and tax positions which may impact these calculations.

We expect to complete our analysis within the measurement period in accordance with SAB 118.

Goodwill

The Company’s reporting units, the level at which goodwill is assessed for potential impairment, are consistent with the reportable segments. The components in each segment (including products, markets and competitors) have similar economic characteristics and the segments, therefore, reflect the lowest level at which operations and cash flows can be sufficiently distinguished, operationally and for financial reporting purposes, from the rest of the Company.

InitiallyTo test for impairment the Company performs a qualitative step zero assessment to determine whether it is more likely than not (that is, a likelihood of more than 50%) that the fair value of a segment is less than the carrying amount prior to performing thetwo-step quantitative goodwill impairment test. Factors utilized in the qualitative assessment process include macroeconomic conditions; industry and market considerations; cost factors; overall financial performance; and Company specific events.

If atwo-step quantitative test is required, we assess the fair value based on projectedpost-tax cash flows discounted at the Company’s weighted average cost of capital.

At December 31, 2017 we had $361.8 million of goodwill relating to our Fuel Specialties, Performance Chemicals These fair value techniques require management judgment and Oilfield Services segments. Our impairment assessment concluded that there had been no impairment of goodwillestimates including revenue growth rates, projected operating margins, changes in respect of those reporting segments.

working capital and discount rates. We would develop these assumptions by considering recent financial performance and trends and industry growth estimates. While we believe our assumptions for impairment assessments are reasonable, they are subjective judgments, and it is possible that variations in any of the assumptions maywill result in materially different calculations of any potential impairment charges.

Property, PlantAt December 31, 2023 we had $399.3 million of goodwill relating to our Performance Chemicals, Fuel Specialties and Equipment and Other Intangible Assets (Net of Depreciation and Amortization, respectively)

AsOilfield Services segments. Our step zero impairment review at December 31, 2017 we had $196.0 million2023 indicated the fair value of property, planteach segment is, more likely than not, higher than the carrying value, meaning no step one impairment review was required to be performed.

30


RESULTS OF OPERATIONS

The following table provides sales, gross profit and equipmentoperating income by reporting segment:

(in millions)

 

2023

 

 

2022

 

 

2021

 

Net sales:

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

$

561.6

 

 

$

639.7

 

 

$

525.3

 

Fuel Specialties

 

 

695.9

 

 

 

730.2

 

 

 

618.3

 

Oilfield Services

 

 

691.3

 

 

 

593.8

 

 

 

339.8

 

 

 

$

1,948.8

 

 

$

1,963.7

 

 

$

1,483.4

 

Gross profit:

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

$

105.6

 

 

$

150.0

 

 

$

125.2

 

Fuel Specialties

 

 

215.1

 

 

 

221.9

 

 

 

193.2

 

Oilfield Services

 

 

270.4

 

 

 

214.8

 

 

 

116.5

 

 

$

591.1

 

 

$

586.7

 

 

$

434.9

 

Operating income:

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

$

54.5

 

 

$

95.3

 

 

$

70.9

 

Fuel Specialties

 

 

109.7

 

 

 

121.7

 

 

 

104.6

 

Oilfield Services

 

 

78.6

 

 

 

41.7

 

 

 

10.4

 

Corporate costs

 

 

(81.2

)

 

 

(71.4

)

 

 

(55.6

)

Profit on disposal

 

 

 

 

 

 

 

 

1.8

 

Total operating income

 

$

161.6

 

 

$

187.3

 

 

$

132.1

 

Other income/(expense), net

 

$

10.5

 

 

$

(1.6

)

 

$

3.8

 

Interest income/(expense), net

 

 

2.3

 

 

 

(1.1

)

 

 

(1.5

)

Income before income taxes

 

 

174.4

 

 

 

184.6

 

 

 

134.4

 

Income taxes

 

 

(35.3

)

 

 

(51.6

)

 

 

(41.3

)

Net income

 

$

139.1

 

 

$

133.0

 

 

$

93.1

 

31


Results of Operations – Fiscal 2023 compared to Fiscal 2022:

(in millions, except ratios)

 

2023

 

 

2022

 

 

Change

 

 

 

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

$

561.6

 

 

$

639.7

 

 

$

(78.1

)

 

 

-12

%

Fuel Specialties

 

 

695.9

 

 

 

730.2

 

 

 

(34.3

)

 

 

-5

%

Oilfield Services

 

 

691.3

 

 

 

593.8

 

 

 

97.5

 

 

 

16

%

 

 

$

1,948.8

 

 

$

1,963.7

 

 

$

(14.9

)

 

 

-1

%

Gross profit:

 

 

 

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

$

105.6

 

 

$

150.0

 

 

$

(44.4

)

 

 

-30

%

Fuel Specialties

 

 

215.1

 

 

 

221.9

 

 

 

(6.8

)

 

 

-3

%

Oilfield Services

 

 

270.4

 

 

 

214.8

 

 

 

55.6

 

 

 

26

%

 

 

$

591.1

 

 

$

586.7

 

 

$

4.4

 

 

 

1

%

Gross margin (%):

 

 

 

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

 

18.8

 

 

 

23.4

 

 

 

(4.6

)

 

 

 

Fuel Specialties

 

 

30.9

 

 

 

30.4

 

 

 

0.5

 

 

 

 

Oilfield Services

 

 

39.1

 

 

 

36.2

 

 

 

2.9

 

 

 

 

Aggregate

 

 

30.3

 

 

 

29.9

 

 

 

0.4

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

$

(51.1

)

 

$

(54.7

)

 

$

3.6

 

 

 

-7

%

Fuel Specialties

 

 

(105.4

)

 

 

(100.2

)

 

 

(5.2

)

 

 

5

%

Oilfield Services

 

 

(191.8

)

 

 

(173.1

)

 

 

(18.7

)

 

 

11

%

Corporate costs

 

 

(81.2

)

 

 

(71.4

)

 

 

(9.8

)

 

 

14

%

 

 

$

(429.5

)

 

$

(399.4

)

 

$

(30.1

)

 

 

8

%

Financial information with respect to our domestic and $163.3 million of other intangible assets (net of depreciation and amortization, respectively), that are discussedforeign operations is contained in Notes 6 and 8Note 3 of the Notes to the Consolidated Financial Statements, respectively. These long-lived assets relate to all of our reporting segments and are being amortized or depreciated straight-line over periods of up to 17 years in respect of the other intangible assets and up to 25 years in respect of the property, plant and equipment.Statements.

Performance Chemicals

We continually assess the markets and products related to these long-lived assets, as well as their specific carrying values, and have concluded that these carrying values, and amortization and depreciation periods, remain appropriate.

We also test these long-lived assets for any potential impairment when events occur or circumstances change which suggests that impairment may have occurred. These types of events or changes in circumstances could include, but are not limited to:

introduction of new products with enhanced features by our competitors;

loss of, material reduction in purchases by, ornon-renewal of a contract by a significant customer;

prolonged decline in business or consumer spending;

sharp and unexpected rise in raw material, chemical or energy costs; and

new laws or regulations inhibiting the development, manufacture, distribution or sale of our products.

In order to facilitate this testing the Company groups together assets at the lowest possible level for which cash flow information is available. Undiscounted future cash flows expected to result from the asset groups are compared with the carrying value of the assets and, if such cash flows are lower, an impairment loss may be recognized. The amount of the impairment loss is the difference between the fair value and the carrying value of the assets. Fair values are determined usingpost-tax cash flows discounted at the Company’s weighted average cost of capital. If events occur or circumstances change it may cause a reduction in periods over which these long-lived assets are amortized or depreciated, or result in anon-cash impairment of a portion of their carrying value. A reduction in amortization or depreciation periods would have no effect on cash flows.

RESULTS OF OPERATIONS

The following table provides operating income by reporting segment:

(in millions)

      2017          2016          2015     

Net sales:

    

Fuel Specialties

  $523.8  $509.6  $532.8 

Performance Chemicals

   419.5   138.7   155.0 

Oilfield Services

   304.4   191.7   265.0 

Octane Additives

   59.1   43.4   59.5 
  

 

 

  

 

 

  

 

 

 
  $1,306.8  $883.4  $1,012.3 
  

 

 

  

 

 

  

 

 

 

Gross profit:

    

Fuel Specialties

  $188.2  $186.4  $176.0 

Performance Chemicals

   75.8   43.4   42.4 

Oilfield Services

   109.3   76.4   99.1 

Octane Additives

   30.0   26.1   28.5 
  

 

 

  

 

 

  

 

 

 
  $403.3  $332.3  $346.0 
  

 

 

  

 

 

  

 

 

 

Operating income:

    

Fuel Specialties

  $107.1  $110.6  $102.1 

Performance Chemicals

   32.6   16.0   16.3 

Oilfield Services

   9.5   (4.7  9.0 

Octane Additives

   26.7   22.7   24.7 

Pension credit

   4.4   6.7   0.2 

Corporate costs

   (47.9  (53.9  (38.3

Adjustment to fair value of contingent consideration

   0.0   9.4   40.7 

(Loss)/profit on disposal of subsidiary

   (0.9  (1.4  1.6 

Foreign exchange loss on liquidation of subsidiary

   (1.8  0.0   0.0 
  

 

 

  

 

 

  

 

 

 

Total operating income

  $129.7  $105.4  $156.3 
  

 

 

  

 

 

  

 

 

 

Included in net income:

    

Other income/(expense), net

  $6.6  $0.9  $0.0 

Interest expense, net

   (8.2  (3.2  (4.0
  

 

 

  

 

 

  

 

 

 

Income before income taxes

   128.1   103.1   152.3 

Income taxes

   (66.3  (21.8  (32.8
  

 

 

  

 

 

  

 

 

 

Net income

  $61.8  $81.3  $119.5 
  

 

 

  

 

 

  

 

 

 

Results of Operations – Fiscal 2017 compared to Fiscal 2016:

(in millions, except ratios)

  2017  2016  Change    

Net sales:

     

Fuel Specialties

  $523.8  $509.6  $14.2   +3

Performance Chemicals

   419.5   138.7   280.8   n/a 

Oilfield Services

   304.4   191.7   112.7   +59

Octane Additives

   59.1   43.4   15.7   +36
  

 

 

  

 

 

  

 

 

  
  $1,306.8  $883.4  $423.4   +48
  

 

 

  

 

 

  

 

 

  

Gross profit:

     

Fuel Specialties

  $188.2  $186.4  $1.8   +1

Performance Chemicals

   75.8   43.4   32.4   +75

Oilfield Services

   109.3   76.4   32.9   +43

Octane Additives

   30.0   26.1   3.9   +15
  

 

 

  

 

 

  

 

 

  
  $403.3  $332.3  $71.0   +21
  

 

 

  

 

 

  

 

 

  

Gross margin (%):

     

Fuel Specialties

   35.9   36.6   -0.7  

Performance Chemicals

   18.1   31.3   -13.2  

Oilfield Services

   35.9   39.9   -4.0  

Octane Additives

   50.8   60.1   -9.3  

Aggregate

   30.9   37.6   -6.7  

Operating expenses:

     

Fuel Specialties

  $(81.1 $(75.8 $(5.3  +7

Performance Chemicals

   (43.2  (27.4  (15.8  +58

Oilfield Services

   (99.8  (81.1  (18.7  +23

Octane Additives

   (3.3  (3.4  0.1   -3

Pension credit

   4.4   6.7   (2.3  -34

Corporate costs

   (47.9  (53.9  6.0   -11

Adjustment to fair value of contingent consideration

   0.0   9.4   (9.4  n/a 

Loss on disposal of subsidiary

   (0.9  (1.4  0.5   -36

Foreign exchange loss on liquidation of subsidiary

   (1.8  0.0   (1.8  n/a 
  

 

 

  

 

 

  

 

 

  
  $(273.6 $(226.9 $(46.7  +21
  

 

 

  

 

 

  

 

 

  

Fuel Specialties

Net sales:the table below details the components which comprise the year onover year change in net sales spread across the markets in which we operate:

Change (%)

  Americas   EMEA   ASPAC   AvTel   Total 

 

Americas

 

 

EMEA

 

 

ASPAC

 

 

Total

 

Volume

   +11    -10    -1    -16    -3 

 

 

-4

 

 

 

-4

 

 

 

-18

 

 

 

-4

 

Price and product mix

   -6    +11    +6    +7    +5 

 

 

-12

 

 

 

-7

 

 

 

+1

 

 

 

-9

 

Exchange rates

   0    +2    0    0    +1 

 

 

 

 

 

+2

 

 

 

+1

 

 

 

+1

 

  

 

   

 

   

 

   

 

   

 

 

 

 

-16

 

 

 

-9

 

 

 

-16

 

 

 

-12

 

   +5    +3    +5    -9    +3 
  

 

   

 

   

 

   

 

   

 

 

Lower sales volumes for all of our regions were primarily driven by reduced demand for our personal care products resulting from cautious consumer sentiment, together with the impact of destocking by our customers. The Americas and EMEA were impacted by an adverse price and product mix due to a higher proportion of lower priced products being sold. ASPAC benefited from a favorable price and product mix due to a higher proportion of higher priced products being sold.

VolumesGross margin: the year over year decrease of 4.6 percentage points was due to an adverse sales mix from reduced sales of higher margin products and the adverse impact of reduced manufacturing efficiency resulting from lower production volumes.

32


Operating expenses: decreased $3.6 million year over year, due to lower selling expenses including commissions, lower performance-related remuneration accruals and lower acquired intangibles amortization following the end of the expected life of the assets.

Fuel Specialties

Net sales: the table below details the components which comprise the year over year change in net sales spread across the markets in which we operate:

Change (%)

 

Americas

 

 

EMEA

 

 

ASPAC

 

 

AvGas

 

 

Total

 

Volume

 

 

-10

 

 

 

-12

 

 

 

-22

 

 

 

-1

 

 

 

-12

 

Price and product mix

 

 

+8

 

 

 

+4

 

 

 

+10

 

 

 

-6

 

 

 

+6

 

Exchange rates

 

 

 

 

 

+3

 

 

 

 

 

 

 

 

 

+1

 

 

 

-2

 

 

 

-5

 

 

 

-12

 

 

 

-7

 

 

 

-5

 

Sales volumes in all of our regions have decreased year over year, primarily due to a reduction in the Americas weresales of lower margin higher as a result of increased demand following a slower than normal end to 2016.volume products. Price and product mix was favorable in the Americas was adversely impacted by increased sales of lower margin products. Volumes in EMEA and ASPAC decreasedall our regions due to customer reformulation to our new technologies. Price and product mix in EMEA and ASPAC benefited froman increased salesproportion of higher margin products. AvTelproducts being sold. AvGas volumes were lower than the prior year due to variations in the timing and level of demand from customers, together with a favorable price mix. EMEA benefited from favorable exchange rate movements year over year, driven by a strengthening of the European Union euro against the U.S. dollar.

Gross margin: the year on year decrease of 0.7 percentage points was adversely impacted by lower sales of higher margin products compared to a strong prior year, partly offset by the benefit of a stronger European Union euro versus the U.S. dollar towards the end of the year.

Operating expenses:the year on year increase of $5.3 million was driven by $3.4 million higher selling and administrative expenses and $1.9 million higher research and development expenses. Higher performance based personnel-related compensation has increased expenses year on year.

Performance Chemicals

Net sales:the table below details the components which comprise the year on year change in net sales spread across the markets in which we operate:

Change (%)

  Americas   EMEA   ASPAC   Acquisition   Total 

Volume

   +16    +5    +11    0    +13 

Acquisition

   0    0    0    +195    +195 

Price and product mix

   -8    +4    -7    0    -6 

Exchange rates

   0    0    -1    0    0 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   +8    +9    +3    +195    +202 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Excluding the Huntsman acquisition, increased Personal Care demand led to higher volumes in all our markets. Price and product mix in the Americas and ASPAC was adversely affected by pricing pressures in Personal Care, while EMEA benefited from favorable price and product mix in Personal Care. ASPAC was adversely impacted by exchange rate movements’ year over year, driven by a weakening of the British pound sterling against the U.S. dollar. Sales growth from the acquisition of our Huntsman business at the end of 2016 has been excluded from the market analysis above and included as one variance for the segment total.

Gross margin: the year on year decrease of 13.2 percentage points was driven by the dilutive effect of the lower margins for our acquired Huntsman business together with someone-off events for an unplanned plant outage and raw materials purchasing and pricing issues in the second quarter for the acquired business.

Operating expenses:the year on year increase of $15.8 million is due to $17.6 million additional expenses within our acquired Huntsman business, partly offset by a reduction in performance based personnel-related compensation and the favorable impact of a $1.0 millionone-off commercial legal settlement in the prior year.

Oilfield Services

Net sales:the year on year increase of $112.7 million was due to an improvement in customer demand for all our product lines following the rising customer activity as oil prices have recovered. Overall volumes increased by 60 percent year on year, partly offset by an adverse price and product mix due to a higher proportion of 1 percent.sales to lower margin customers.

Gross margin:the year onover year decreaseincrease of 4.00.5 percentage points compared withwas primarily due to a strong prior year, is drivenfavorable sales mix from increased sales of higher margin products, being partly offset by the miximpact of the Brazil inventory misappropriation and the ending of that trading relationship.

Operating expenses: the year over year increase of $5.2 million includes increased research and development expenditure and higher provisions for doubtful debts which are primarily related to the ending of the Brazilian trading relationship, being partly offset by lower performance-related remuneration accruals.

Oilfield Services

Net sales: have increased year over year by $97.5 million, or 16%, with the majority of our customer activity concentrated in the Americas region. We believe that customer demand remains strong despite operating income growth moderating, as expected, through the second half of the 2023.

Gross margin: the year over year increase of 2.9 percentage points was due to a favorable sales mix and the adverse effectbenefit of Hurricane Harvey on raw material prices and availability.improved pricing.

Operating expenses:the year onover year increase of $18.7 million was primarily driven by $15.3 million higher selling and technicalcustomer service costs which are necessary to support expenses required to service the increase in customer demand with certain customers, together with $1.2 million additional research and development expenses and $2.2 million higher administration costs to support the business growth.provisions for doubtful debts, while being partly offset by lower performance-related remuneration accruals.

Other Income Statement Captions

Octane Additives

Net sales:have increased by $15.7 million compared to the prior year, due to the phasing of orders from our one remaining refinery customer.

Gross margin:Corporate costs: the year onover year decreaseincrease of 9.3 percentage points was due to lower volumes of production in the current year leading to higher manufacturing costs per tonne.

Operating expenses:the year on year decrease of $0.1$9.8 million was primarily due to a reductionacquisition related costs, additional environmental remediation provisions, increased spending on our information technology infrastructure and some legal costs related to the Brazil inventory misappropriation, being partly offset by lower performance-related remuneration accruals.

33


Other net income/(expense): for 2023 and 2022, includes the following:

(in millions)

 

2023

 

 

2022

 

 

Change

 

Net pensions credit

 

$

6.9

 

 

$

4.8

 

 

$

2.1

 

Foreign exchange gains/(losses) on translation

 

 

7.6

 

 

 

(7.1

)

 

 

14.7

 

Foreign currency forward contracts gains/(losses)

 

 

(4.0

)

 

 

0.7

 

 

 

(4.7

)

 

$

10.5

 

 

$

(1.6

)

 

$

12.1

 

Interest income/(expense), net: was income of $2.3 million in 2023 primarily due to the provisions for doubtful debts.

Other Income Statement Captions

Pension credit:isnon-cash, and was a $4.4 million net credit in 2017interest earned on the Company's cash balances, compared to a $6.7$1.1 million net creditexpense in 20162022 primarily driven by higher amortization of actuarial losses.

Corporate costs:the year on year decrease of $6.0 million related to $4.4 millionnon-recurring acquisition-related costs in the prior year for our Huntsman business, partly offset by $1.9 million of integration related costs in the current year; together with lower performance based personnel-related compensation and the benefit of the weaker British pound sterling against the U.S. dollar for our Ellesmere Port cost base over the year.

Adjustment to fair value of contingent consideration:in the prior year there was a contingent consideration credit of $9.4 million related to an acquisition in 2014.

Loss on disposal of subsidiary:the loss of $0.9 million relates to an indemnity claim in relation to residual testing in the Aroma Chemicals business which was sold in 2015.

Foreign exchange loss on liquidation of subsidiary:the $1.8 million loss relatesdue to the reclassification of historic foreign exchange translations of net assets from accumulated other comprehensive losses, for our captive insurance companycommitment fee which was liquidated in the first quarter of 2017.

Other net income/(expense):other net income of $6.6 million relatedCompany paid to $7.5 million of gains on translation of net balances denominated innon-functional currencies mainly in our European businesses, partly offset by losses of $0.9 million on foreign currency forward exchange contracts. In the prior year, other net income of $0.9 million primarily related to $4.4 million net gains on foreign currency forward contracts, partly offset by losses of $3.5 million on translation of net assets denominated innon-functional currencies in our European businesses.

Interest expense, net:was $8.2 million in 2017 compared to $3.2 million in 2016, driven by the additional term loan related to the Huntsman acquisition, increased working capital requirements funded by our credit facility and the recent rise in LIBOR impacting ourretain its revolving credit facility borrowing.for the term of the agreement.

Income taxes: The effective tax rate was 51.8%20.2% and 21.1%28.0% in 20172023 and 2016,2022, respectively. The adjusted effective tax rate, once adjusted for the items set out in the following table, was 20.2%23.0% in 20172023 compared with 22.4%27.0% in 2016.2022. The Company believes that this adjusted effective tax rate, anon-GAAP financial measure, provides useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, management uses thisnon-GAAP financial measure internally to evaluate the performance of the Company’s operations and for planning and forecasting in subsequent periods.

(in millions, except ratios)

  2017 2016 

 

2023

 

 

2022

 

Income before income taxes

  $128.1  $103.1 

 

$

174.4

 

 

 

184.6

 

Adjustment to fair value of contingent consideration

   0.0   (9.4

Adjustment to acquisition accounting for inventory fair valuation

   1.7   0.0 

Loss on disposal of subsidiary

   0.9   1.4 

Foreign exchange loss on liquidation of subsidiary

   1.8   0.0 

Adjustment for stock compensation

   4.0   0.0 

 

 

8.0

 

 

 

6.7

 

  

 

  

 

 
  $136.5  $95.1 
  

 

  

 

 

Indemnification asset regarding tax audit

 

 

(0.1

)

 

 

0.1

 

Legacy cost of closed operations

 

 

6.1

 

 

 

3.5

 

Acquisition costs

 

 

3.1

 

 

 

 

Adjusted income before income taxes

 

$

191.5

 

 

 

194.9

 

Income taxes

  $66.3  $21.8 

 

$

35.3

 

 

 

51.6

 

Adjustment of income tax provisions

   0.5   1.6 

 

 

1.4

 

 

 

 

Tax on adjustments to fair value of contingent consideration

   0.0   (3.6

Tax on stock compensation

   3.1   0.0 

 

 

0.4

 

 

 

0.6

 

Tax on adjustment to fair value accounting

   0.3   0.0 

Tax Cuts & Jobs Act 2017 provisional impact

   (40.6  0.0 

(Deduct)/add back other discrete items

   (2.0  1.5 
  

 

  

 

 
  $27.6  $21.3 
  

 

  

 

 

Tax loss / (gain) on distribution

 

 

0.4

 

 

 

 

Tax on legacy cost of closed operations

 

 

1.4

 

 

 

0.7

 

Tax on acquisition costs

 

 

0.7

 

 

 

 

Other discrete items

 

 

4.5

 

 

 

(0.3

)

Adjusted income taxes

 

$

44.1

 

 

 

52.6

 

GAAP effective tax rate

   51.8  21.1

 

 

20.2

%

 

 

28.0

%

  

 

  

 

 

Adjusted effective tax rate

   20.2  22.4

 

 

23.0

%

 

 

27.0

%

  

 

  

 

 

The most significant factor impacting ouradjusted effective tax rate is higher in 2023 than the recognized implicationsGAAP effective tax rate, primarily due to elimination of the Tax Reform Act. As a resultimpact of other discrete items. This mainly represents the Act, we accrued a provisional estimate of the mandatory

transition tax on our accumulated earnings as of December 31, 2017, resulting in an increase to income tax expense of $47.7 million. In addition, our U.S. deferred tax assets and liabilities werere-measured from 35% to 21% at the same date, which resulted in $7.1 million of deferred income tax benefit.

In addition to those mentioned above, the mix of taxable profits in the different geographical jurisdictions in which the Group operates continues to have a significant positive impact on the effective tax rate.

The foreign tax rate differentialbenefit arising from profits being earned in foreign jurisdictions with loweradjustments to the tax rates in 2017 was $17.5 million (2016 – $17.1 million). In 2017, the Company’s income tax expense benefitedcharge for previous years arising from return to a greater degree from a proportion of its overall profits arising in Switzerland than in 2016. This resulted in an $8.2 million benefit in Switzerland (2016 – $7.8 million). In addition, there was an $8.3 million benefitprovision adjustments in relation to the United Kingdom (2016 – $8.4 million), a $0.7 million benefitfederal and state tax returns filed in relationthe U.S. during 2023.

Our adjusted effective tax rate was lower in 2022 than the GAAP effective tax rate primarily due to Germany (2016 – $0.5 million), and a $0.3 million benefit in other jurisdictions (2016 – $0.3 million benefit).the elimination of stock compensation activity.

Foreign income inclusions arise each year from certain types of income earned overseas being taxable under U.S. tax regulations. The Tax Reform Act will substantially change the U.S. taxation of income earned overseas in 2018 and future years. In 2017, income earned overseas and taxable under U.S. regulations includes Subpart F income, principally from foreign based company sales in the United Kingdom, and the associated Section 78 tax gross up, and also from the income earned by certain overseas subsidiaries taxable under the U.S. tax regime. In 2017, Subpart F income and the associated Section 78 gross up resulted in U.S. taxation of $7.1 million (2016 – $5.7 million). Certain overseas subsidiaries taxable under the U.S. tax regime generated taxable income of $2.4 million (2016 – $0.2 million loss).

Foreign tax credits can fully or partially offset these incremental U.S. taxes from

34


foreign income inclusions. The utilization of foreign tax credits varies year on year as this is dependent on a number of variable factors which are difficult to predict and may prevent offset. The GAAP effective tax rate and the adjusted effective tax rate in certain years prevent any offsetboth 2023 and 2022 have been negatively impacted by these items.

As a consequence of the Company having operations outside of the U.S., it is exposed to foreign currency fluctuations. These have had a positive impact on the GAAP effective tax credits. In total, $5.6 million of foreignrate and adjusted effective tax credits were utilized during 2017 to offset the incremental U.S. taxes arising from foreign income inclusionsrate in 2023, and a negative impact in 2022.

As in the prior year, excluding those associated with theone-time mandatory transition level of foreign-derived intangible income benefit that the Company is entitled to has also had a positive impact on the GAAP effective tax inclusion (2016 – $6.1 million), all generated during 2017.rate and the adjusted effective tax rate.

Further details are givenFor additional information regarding the GAAP effective tax rate in 2023 see Note 1011 of the Notes to the Consolidated Financial Statements.

35


Results of Operations – Fiscal 20162022 compared to Fiscal 2015:2021:

(in millions, except ratios)

  2016 2015 Change   

 

2022

 

 

2021

 

 

Change

 

 

 

Net sales:

     

 

 

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

$

639.7

 

 

$

525.3

 

 

$

114.4

 

 

+22%

Fuel Specialties

  $509.6  $532.8  $(23.2  -4

 

 

730.2

 

 

 

618.3

 

 

 

111.9

 

 

+18%

Performance Chemicals

   138.7   155.0   (16.3  -11

Oilfield Services

   191.7   265.0   (73.3  -28

 

 

593.8

 

 

 

339.8

 

 

 

254.0

 

 

+75%

Octane Additives

   43.4   59.5   (16.1  -27
  

 

  

 

  

 

  
  $883.4  $1,012.3  $(128.9  -13
  

 

  

 

  

 

  

 

$

1,963.7

 

 

$

1,483.4

 

 

$

480.3

 

 

+32%

Gross profit:

     

 

 

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

$

150.0

 

 

$

125.2

 

 

$

24.8

 

 

+20%

Fuel Specialties

  $186.4  $176.0  $10.4   +6

 

 

221.9

 

 

 

193.2

 

 

 

28.7

 

 

+15%

Performance Chemicals

   43.4   42.4   1.0   +2

Oilfield Services

   76.4   99.1   (22.7  -23

 

 

214.8

 

 

 

116.5

 

 

 

98.3

 

 

+84%

Octane Additives

   26.1   28.5   (2.4  -8
  

 

  

 

  

 

  
  $332.3  $346.0  $(13.7  -4
  

 

  

 

  

 

  

 

$

586.7

 

 

$

434.9

 

 

$

151.8

 

 

+35%

Gross margin (%):

     

 

 

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

 

23.4

 

 

 

23.8

 

 

 

(0.4

)

 

 

Fuel Specialties

   36.6   33.0   +3.6  

 

 

30.4

 

 

 

31.2

 

 

 

(0.8

)

 

 

Oilfield Services

 

 

36.2

 

 

 

34.3

 

 

 

1.9

 

 

 

Aggregate

 

 

29.9

 

 

 

29.3

 

 

 

0.6

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Performance Chemicals

   31.3   27.4   +3.9  

 

$

(54.7

)

 

$

(54.3

)

 

$

(0.4

)

 

+1%

Fuel Specialties

 

 

(100.2

)

 

 

(88.6

)

 

 

(11.6

)

 

+13%

Oilfield Services

   39.9   37.4   +2.5  

 

 

(173.1

)

 

 

(106.1

)

 

 

(67.0

)

 

+63%

Octane Additives

   60.1   47.9   +12.2  

Aggregate

   37.6   34.2   +3.4  

Corporate costs

 

 

(71.4

)

 

 

(55.6

)

 

 

(15.8

)

 

+28%

Profit on disposal

 

 

 

 

 

1.8

 

 

 

(1.8

)

 

+100%

 

$

(399.4

)

 

$

(302.8

)

 

$

(96.6

)

 

+32%

Operating expenses:

     

Fuel Specialties

  $(75.8 $(73.9 $(1.9  +3

Performance Chemicals

   (27.4  (26.1  (1.3  +5

Oilfield Services

   (81.1  (90.1  9.0   -10

Octane Additives

   (3.4  (3.8  0.4   -11

Pension credit

   6.7   0.2   6.5   n/a 

Corporate costs

   (53.9  (38.3  (15.6  +41

Adjustment to fair value of contingent consideration

   9.4   40.7   (31.3  +77

(Loss)/profit on disposal of subsidiary

   (1.4  1.6   (3.0  n/a 
  

 

  

 

  

 

  
  $(226.9 $(189.7 $(37.2  +20
  

 

  

 

  

 

  

Fuel SpecialtiesFinancial information with respect to our domestic and foreign operations is contained in Note 3 of the Notes to the Consolidated Financial Statements.

Performance Chemicals

Net sales:the table below details the components which comprise the year onover year change in net sales spread across the markets in which we operate:

Change (%)

  Americas   EMEA   ASPAC   AvTel   Total 

 

Americas

 

 

EMEA

 

ASPAC

 

Total

Volume

   -14    +11    +3    +4    0 

 

+20

 

 

-9

 

+7

 

+2

Price and product mix

   -2    -9    -1    +4    -3 

 

+20

 

 

+33

 

+18

 

+28

Exchange rates

   0    -1    0    0    -1 

 

 

 

 

-14

 

-7

 

-8

  

 

   

 

   

 

   

 

   

 

 

 

+40

 

 

+10

 

+18

 

+22

   -16    +1    +2    +8    -4 
  

 

   

 

   

 

   

 

   

 

 

Volumes inHigher sales volumes for the Americas were lower than the prior year due to softer fuel demand, a warmer winter and a change in the refinery crude slates. EMEA and ASPAC volumes increased from the prior yearwere primarily driven by increased demand for high volume low marginour personal care products. Price and product mixLower sales volumes for EMEA were due to reductions in EMEA and ASPAC was adversely impacted by the increaseddemand for our home care products when compared to strong sales of lower margin products together with some pricing pressures. AvTel volumes were higher thanin the prior year due to new customer orders combined withyear. All our regions benefited from a favorable price and product mix from a richer customer mix.due to increased sales of higher priced products together with the impact of increased raw materials pricing being passed on through higher selling prices. EMEA wasand ASPAC were adversely impacted by exchange rate movements year over year, driven bydue to a weakeningstrengthening of the European Union euro andU.S. dollar against the British pound sterling againstand the U.S. dollar.European Union euro.

36


Gross margin: the year onover year increasedecrease of 3.60.4 percentage points was primarily achieveddue to adverse manufacturing variances and higher raw materials costs in the fourth quarter of 2022, being partly offset by a favorable sales mix from reducedincreased sales of lower margin products in the Americas, together with the positive effect of weaker exchange rates versus the U.S. dollar on our cost base in EMEA and ASPAC and the higher margin contribution from additional AvTel volumes.products.

Operating expenses:the year onover year increase of $1.9$0.4 million was primarily driven bydue to higher selling expenses to support our increased sales and higher personnel-related expenses, including higher share-based compensation accruals due to the rise in the Innospec share price in the year together with increasedand higher performance-related remuneration accruals; being partly offset by lower provisions againstfor doubtful debts.

Fuel Specialties

Performance Chemicals

Net sales:the table below details the components which comprise the year onover year change in net sales spread across the markets in which we operate:

Change (%)

  Americas   EMEA   ASPAC   Aroma
Chemicals
   Total 

 

Americas

 

 

EMEA

 

ASPAC

 

AvGas

 

 

Total

 

Volume

   +6    +29    +18    0    +12 

 

+10

 

 

-11

 

+11

 

+4

 

 

 

 

Disposals

   0    0    0    -18    -18 

Price and product mix

   -2    -15    +1    0    -4 

 

+28

 

 

+32

 

+14

 

-7

 

 

+26

 

Exchange rates

   0    -3    -4    0    -1 

 

 

 

 

-17

 

-4

 

 

 

 

-8

 

  

 

   

 

   

 

   

 

   

 

 

 

+38

 

 

+4

 

+21

 

-3

 

 

+18

 

   +4    +11    +15    -18    -11 
  

 

   

 

   

 

   

 

   

 

 

Volumes were higher in all our regions, driven by increased Personal Care volumes.The Americas and ASPAC sales volumes have increased year over year as the global demand for refined fuel products has increased. EMEA experienced pricing pressures in Personal Care which adversely affected the price and product mix. ASPAC benefited from favorable pricing in Personal Care. A weakening of the European Union euro and British pound sterling against the U.S. dollar resulted in an adverse exchange rate variance for EMEA and ASPAC. The disposal of our Aroma Chemicals business in 2015 has been excluded from the market analysis above and included as one variance for the segment total.

Gross margin: thesales volumes were lower year onover year increase of 3.9 percentage points was primarily driven by a greater proportion of sales from our higher margin Personal Care business following the disposal of our lower margin Aroma Chemicals business in the prior year, together with the positive effect of weaker exchange rates versus the U.S. dollar on our cost base in EMEA and ASPAC.

Operating expenses: the year on year increase of $1.3 million is primarily due to a $1.0 million commercial legal settlement with a distributor; together with higher share-based compensation accruals driven by the rise in the Innospec share price in the year and higher performance related compensation; partly offset by a $0.6 million reduction due to the disposal of our Aroma Chemicals business in the prior year.

Oilfield Services

Net sales:the year on year decrease of $73.3 million was primarily due to a reduction for the sales of higher volume lower margin products. Price and product mix was favorable in customer activity especially in well completion, following the decline in oil prices in prior years. Customer activity and confidence has improved in 2016 leadingall our regions due to a 22% growthfavorable sales mix with an increased proportion of sales of higher margin products, together with the impact of increased raw materials pricing being passed on through higher selling prices. AvGas volumes were higher than the prior year due to variations in sales for the fourth quarter compared to the fourth quarter of 2015. Overall volumes declineddemand from customers, being offset by 13 percent year on year, together with an adverse price and product mix with a higher proportion of 15 percent.sales being made to lower margin customers. EMEA and ASPAC were adversely impacted by exchange rate movements year over year, due to a strengthening of the U.S. dollar against the British pound sterling and the European Union euro.

Gross margin:the year onover year decrease of 0.8 percentage points was due to the impact of the time lag for passing higher raw material costs through to selling prices.

Operating expenses: the year over year increase of 2.5$11.6 million was due to higher personnel-related expenses, including higher share-based compensation accruals, higher travel expenses, increased sales promotions and increased provisions for doubtful debts.

Oilfield Services

Net sales: have increased year over year by $254.0 million, or 75%, with the majority of our customer activity being concentrated in the Americas region. Customer demand has increased through each quarter in 2022.

Gross margin: the year over year increase of 1.9 percentage points was primarily due to a favorable sales mix, driven bywhile management are continuing to maintain prices in a higher proportion of sales from our higher margin production business.competitive market.

Operating expenses:the year onover year decreaseincrease of $9.0$67.0 million was driven by higher customer service costs which are necessary to support the increase in demand, together with higher personnel-related expenses, including higher share-based compensation accruals and higher performance-related remuneration accruals, and increased provisions for doubtful debts.

37


Other Income Statement Captions

Corporate costs: the year over year increase of $15.8 million was driven by higher personnel-related expenses, including higher share-based compensation accruals and higher performance-related remuneration accruals, together with increased maintenance expenditure for our cost reduction programs and lower selling and technical support expenses to align with the decline in customer demand.information technology infrastructure.

Octane Additives

Net sales:have decreased by $16.1 million compared toProfit on disposal: in the prior year due to the phasing of orders from our one remaining refinery customer.

Gross margin:the year on year increase of 12.2 percentage pointsthere was primarily due to higher volumes of production in 2016 generating favorable manufacturing variances together with the benefit of a weaker British pound sterling against the U.S. dollar for our Ellesmere Port cost base.

Operating expenses:the year on year decrease of $0.4 million was due to the continuing efficient management of the cost base and the benefit of a weaker British pound sterling against the U.S. dollar for our Ellesmere Port cost base.

Other Income Statement Captions

Pension credit:isnon-cash, and was a $6.7 million net credit in 2016 compared to a $0.2 million net credit in 2015 primarily driven by lower interest cost on the projected benefit obligation.

Corporate costs:the year on year increase of $15.6 million, related to $4.6 million higher amortization and other costs related to the EMEA and ASPAC deployment of our group wide ERP system; $4.4 million acquisition-related professional fees; $3.2 million higher legal, professional and other expenses primarily due to the recovery of legal fees in the prior year

and a $3.4 million increase related to higher personnel-related compensation, including higher accruals for share-based compensation driven by the rise in the Innospec share price in the year.

Adjustment to fair value of contingent consideration:the credit of $9.4 million relates to an adjustment to the carrying value of our liability for contingent consideration of $10.3 million, partly offset by the accretion charge of $0.9 million, both in relation to our acquisition of Independence Oilfield Chemicals LLC (“Independence”). The contingent consideration payable at December 31, 2016 has been calculated based on the actual trading results through the period to October 31, 2016, although the amount to be paid is subject to final agreement with the previous owners.

(Loss)/profit on disposal of subsidiary:the disposal of our Aroma Chemicals business generated a $1.4 million loss on disposal in 2016 compared to a profit on disposal of $1.6$1.8 million, in the prior year. The loss on disposal in 2016which principally related to the finalizationsale of land within our oilfield services business in the assets and liabilities disposed.U.S..

Other net income/(expense):other net income of $0.9 million primarily related to $4.4 million net gains on foreign currency forward contracts, partly offset by losses of $3.5 million on translation of net assets denominated innon-functional currencies in our European businesses. In 2015, other net expense of $0.0 million primarily related to gains of $1.4 million on foreign currency forward exchange contracts, offset by $1.4 million of losses on translation of net assets denominated innon-functional currencies in our European businesses. for 2022 and 2021, includes the following:

(in millions)

 

2022

 

 

2021

 

 

Change

 

Net pensions credit

 

$

4.8

 

 

$

5.4

 

 

$

(0.6

)

Foreign exchange gains/(losses) on translation

 

 

(7.1

)

 

 

(2.6

)

 

 

(4.5

)

Foreign currency forward contracts gains/(losses)

 

 

0.7

 

 

 

1.0

 

 

 

(0.3

)

 

 

$

(1.6

)

 

$

3.8

 

 

$

(5.4

)

Interest expense, net:was $3.2$1.1 million in 20162022 compared to $4.0$1.5 million in 2015, with2021. Interest expense includes a commitment fee to retain the reduction being due to the higher amortization of deferred finance costs in the prior year, lower average net debt in 2016 and lower borrowing costs within our revisedCompany’s revolving credit facility partly offset byfor the rise in LIBOR during 2016.term of the agreement.

Income taxes: the The effective tax rate was 21.1%28.0% and 21.5%30.7% in 20162022 and 2015,2021, respectively. The adjusted effective tax rate, asonce adjusted for changes to the fair value of contingent consideration, adjustments to income tax positions anditems set out in the tax impact of other discrete items,following table, was 22.4%27.0% in 20162022 compared with 20.1%22.7% in 2015.2021. The Company believes that this adjusted effective tax rate, anon-GAAP financial measure, provides useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, management uses thisnon-GAAP financial measure internally to evaluate the performance of the Company’s operations and for planning and forecasting in subsequent periods.

(in millions, except ratios)

  2016  2015 

Income before income taxes

  $103.1  $152.3 

Adjustment to fair value of contingent consideration

   (9.4  (40.7

Adjustment to acquisition accounting for inventory fair valuation

   0.0   3.7 

Loss/(profit) on disposal of subsidiary

   1.4   (1.6
  

 

 

  

 

 

 
  $95.1  $113.7 
  

 

 

  

 

 

 

Income taxes

�� $21.8  $32.8 

Add back adjustment of income tax provisions

   1.6   2.3 

Add back tax on adjustments to fair value of contingent consideration

   (3.6  (15.5

Add back other discrete items

   1.5   3.2 
  

 

 

  

 

 

 
  $21.3  $22.8 
  

 

 

  

 

 

 

GAAP effective tax rate

   21.1  21.5
  

 

 

  

 

 

 

Adjusted effective tax rate

   22.4  20.1
  

 

 

  

 

 

 

(in millions, except ratios)

 

2022

 

 

2021

 

Income before income taxes

 

$

184.6

 

 

 

134.4

 

Adjustment for stock compensation

 

 

6.7

 

 

 

4.4

 

Indemnification asset regarding tax audit

 

 

0.1

 

 

 

0.1

 

Legacy cost of closed operations

 

 

3.5

 

 

 

3.4

 

Acquisition costs

 

 

 

 

 

0.8

 

Adjusted income before income taxes

 

$

194.9

 

 

 

143.1

 

Income taxes

 

$

51.6

 

 

 

41.3

 

Adjustment of income tax provisions

 

 

 

 

 

(0.5

)

Tax on stock compensation

 

 

0.6

 

 

 

1.3

 

Tax loss / (gain) on distribution

 

 

 

 

 

(0.2

)

Change in UK statutory tax rate

 

 

 

 

 

(7.3

)

Tax on legacy cost of closed operations

 

 

0.7

 

 

 

(1.5

)

Tax on acquisition costs

 

 

 

 

 

0.2

 

Other discrete items

 

 

(0.3

)

 

 

(0.8

)

Adjusted income taxes

 

$

52.6

 

 

 

32.5

 

GAAP effective tax rate

 

 

28.0

%

 

 

30.7

%

Adjusted effective tax rate

 

 

27.0

%

 

 

22.7

%

In addition to those mentioned above, the following factors had a significant impact on the Company’s38


The GAAP effective tax rate as compared to the U.S. federal income tax rate of 35%:

(in millions)

  2016  2015 

Foreign tax rate differential

  $(17.1 $(14.5

Foreign income inclusions

   0.5   2.7 

Deferred tax credit from United Kingdom income tax rate reduction on pensions

   (0.6  (1.1

The impact on theand adjusted effective tax rate from profits earned in 2022 were negatively impacted by foreign jurisdictions with lower tax rates varies as the geographical mix of the Company’s profits changes year on year. In 2016, the Company’s income tax expense benefited to a greater degree from a proportion of its overall profits arising in Switzerland than in 2015. This resulted in a $7.8 million benefit in Switzerland (2015 – $7.5 million). In addition, there was an $8.4 million benefit in relation to the United Kingdom (2015 – $6.8 million) and a $0.5 million benefit in relation to Germany (2015 – $0.3 million), and a $0.3 million benefit in other jurisdictions (2015 – $0.1 million reduction).

Foreign income inclusions, net of foreign tax credits, which arise each year from certain types of income earned overseas being taxable under U.S. tax regulations.

As a consequence of the Company having operations outside of the U.S., it is exposed to foreign currency fluctuations. These typesalso had a negative impact on the GAAP effective tax rate and adjusted effective tax rate in 2022.

The adjusted effective tax rate is lower than the GAAP effective tax rate, primarily due to elimination of income include Subpart F income, principally from foreign based company salesstock compensation activity to better reflect the Company’s underlying business performance.

The most significant factor impacting our adjusted effective tax rate in 2021 was elimination of the impact of the increase in the United Kingdom, including the associated Section 78U.K. statutory income tax gross up, and also from the income earned by certain overseas subsidiaries taxable under the U.S. tax regime. In 2016, Subpart F income and the associated Section 78 gross up resulted in U.S. taxation of $5.7 million (2015 – $4.7 million). Certain overseas subsidiaries taxable under the U.S. tax regime incurred losses of $0.2 million (2015 – $0.2 million losses).rate.

Foreign tax credits can fully or partially offset these incremental U.S. taxes from foreign income inclusions. The utilization of foreign tax credits varies year on year as this is

dependent on a number of variable factors which are difficult to predict and may in certain years prevent any offset of foreign tax credits. In total, $6.1 million of foreign tax credits were utilized during 2016 to offset the incremental U.S. taxes arising from foreign income inclusions in the year (2015 – $4.7 million). Of this balance, $0.5 million of foreign tax credit carry forwards from earlier years was utilized (2015 – $2.4 million). As at December 31, 2016, the Company has utilized all foreign tax credit carry forwards from earlier years.

The United Kingdom’s 1% reduction in the corporation tax rate effective from April 2020 from 18% to 17%, enacted in September 2016, resulted in a deferred tax credit of $0.6 million in the fourth quarter of 2016 primarily in relation to the deferred tax position of the United Kingdom defined benefit pension plan.

Further details are given in Note 10 of the Notes to the Consolidated Financial Statements.

LIQUIDITY AND FINANCIAL CONDITION

Working Capital

In 2023 our working capital increased by $47.4 million, while our adjusted working capital decreased by $24.5 million. The difference between these measures is primarily due to the exclusion of the increase in our cash and cash equivalents, together with the movements for income taxes.

The Company believes that adjusted working capital, anon-GAAP financial measure, provides useful information to investors in evaluating the Company’s underlying performance and identifying operating trends. Management uses thisnon-GAAP financial measure internally to allocate resources and evaluate the performance of the Company’s operations. Items excluded from the adjusted working capital calculation are listed in the table below and represent factors which do not fluctuate in line with the day to day working capital needs of the business.

(in millions)

  2017 2016 

 

2023

 

 

2022

 

Total current assets

  $561.5  $441.1 

 

$

885.7

 

 

$

872.6

 

Total current liabilities

   (261.6  (183.1

 

 

(371.5

)

 

 

(405.8

)

  

 

  

 

 

Working capital

   299.9   258.0 

 

 

514.2

 

 

 

466.8

 

Less cash and cash equivalents

   (90.2  (101.9

 

 

(203.7

)

 

 

(147.1

)

Less prepaid income taxes

   (2.8  (4.8

 

 

(2.8

)

 

 

(3.3

)

Less other current assets

   (1.1  0.0 

 

 

(0.6

)

 

 

(0.4

)

Add back current portion of accrued income taxes

   15.8   9.4 

 

 

2.6

 

 

 

18.4

 

Add back current portion of long-term debt

   15.8   10.3 

Add back current portion of finance leases

   2.7   1.6 

Add back current portion of plant closure provisions

   5.2   6.7 

 

 

4.6

 

 

 

5.3

 

Add back current portion of deferred income

   0.1   0.1 
  

 

  

 

 

Add back current portion of operating lease liabilities

 

 

13.6

 

 

 

13.9

 

Add back current portion of unrecognized tax benefits

 

 

1.2

 

 

 

 

Adjusted working capital

  $245.4  $179.4 

 

$

329.1

 

 

$

353.6

 

  

 

  

 

 

During 2017 our working capital increased by $41.9 million, whileThe movements in our adjusted working capital has increased by $66.0 million. The difference is primarily due to the exclusion of cash and cash equivalents and long term debt from the adjusted working capital measure. The Huntsman acquisition accounted for approximately $34.0 million of these movements which

are explained as follows:

included aone-off working capital funding requirement post acquisition, reflecting the structure of the acquisition, which excluded the transfer of trade receivables and payables. The remaining movements are primarily driven by the timing of demand from our customers.

We had a $90.1$25.2 million increase in trade and other accounts receivable primarily related to a $61.9 million increase for the Huntsman acquisition indriven by increased trading activity and timing of sales across our Performance Chemicals segment. The increase in sales in our Fuel Specialties and Oilfield Services segments has also increased receivables balances.reporting segments. Days’ sales outstanding in our Fuel SpecialtiesPerformance Chemicals segment increased from 4660 days to 5162 days; increased in our Performance ChemicalsFuel Specialties segment from 5554 days to 6855 days; and increased from 54 days to 5872 days in our Oilfield Services segment.

39


We had a $36.0$73.0 million decrease in inventories, net of a $1.0 million increase in inventories, which is primarily relatedallowances, as we manage inventory levels necessary to a $23.4 million increase in our Fuel Specialties segment due tosupport future demand, whilst mitigating the timingrisk of demand from customers.potential supply chain disruption for certain key raw materials. Days’ sales in inventory in our Fuel SpecialtiesPerformance Chemicals segment increaseddecreased from 8478 days to 10061 days; decreased in our Performance ChemicalsFuel Specialties segment from 94138 days to 51121 days; and decreased from 7258 days to 6353 days in our Oilfield Services segment.

Prepaid expenses increased $6.9$4.6 million, from $6.2$14.1 million to $13.1$18.7 million driven by a payment in advance of $4.2 million in our South American business, together withprincipally due to the timing of invoices received and the normal expensing of prepaid invoices.

We had a $67.0$18.7 million increasedecrease in accounts payable and accrued liabilities primarily relateddue to a $37.1 million increase for the Huntsman acquisitiontiming of supplier payments. Creditor days (including goods received not invoiced) remained unchanged in our Performance Chemicals segment and a $22.1 million increase for our Oilfield Services segment driven by increased customer activity. Creditor daysat 42 days; decreased in our Fuel Specialties segment increased from 2845 days to 3241 days; in our Performance Chemicals segment increasedand decreased from 3254 days to 50 days; and increased from 32 days to 5153 days in our Oilfield Services segment.

Operating Cash Flows

We generated cash from operating activities of $82.7$207.3 million in 20172023 compared to $105.5$81.7 million in 2016. Year over year cash from operating activities has been adversely impacted by2022. The increase is primarily related to theone-off decrease in our working capital funding requirement of $28.0 million fortogether with the Huntsman acquisition.improvements in our earnings before depreciation and amortization, being partly offset by income tax payments.

Cash

Cash

AtAs at December 31, 20172023 and 2016,2022, we had cash and cash equivalents of $90.2$203.7 million and $101.9$147.1 million, respectively, of which $74.1$59.8 million and $90.2$76.4 million, respectively, were held bynon-U.S. subsidiaries principally in the United Kingdom. U.K..

The Company is$56.6 million increase in cash and cash equivalents in 2023 was driven by the cash inflows from operating activities and lower working capital needs, partly offset by the acquisition payment for a position to control whether or not to repatriate foreign earningsbusiness in Brazil, continued investments in capital projects, payments for income taxes and we currently do not expect to make a repatriation in the foreseeable future. The Tax Reform Act requires, amongst other provisions, aone-time mandatory transition tax on accumulated foreign earnings, for which we have recorded a provisional estimated tax liabilitypayment of our semi-annual dividends.

Debt

As at December 31, 20172023 and 2022, the Company had repaid all of $47.7 million. We intend to payits borrowings under the tax liability over an eight-year payment schedulerevolving credit facility and as prescribed bya result, the Tax Reform Act.

related deferred finance costs of $1.2 million (December 31, 2022 – $0.6 million) are now included within other current and non-current assets at the balance sheet date.

Debt

On December 14, 2016,May 31, 2023, Innospec Inc. and certain subsidiaries of the Company entered into a Third Amendment and RestatementMulticurrency Revolving Facility Agreement with various lenders, which amends and restatesproviding for a $250,000,000 four-year multicurrency revolving loan facility. The Agreement also contains an accordion feature whereby the Company may elect to increase the total available borrowings by an aggregate amount of up to $125,000,000. The termination date of the facility is May 30, 2027, but the Company has an option to request an extension of the facility for a further year. The agreement replaced the Company’s credit facility agreement dated December 14, 2011, as amended and restated on August 28, 2013 and November 6, 2015 (the“Pre-Existing Credit Agreement;” thePre-Existing Credit Agreement, as amended and restated pursuantSeptember 26, 2019. See Note 12 to the Third Amendment and Restatement Agreement, being the “Amended Credit Agreement.”)

The Amended Credit Agreement retains the $200,000,000 revolving credit facility availableNotes to the Company and adds a term loan facility of $110,000,000. Consolidated Financial Statements for additional details.

The termination date of the revolving facility remains November 6, 2020. A repayment for the term loan of $11,000,000 was made on December 29, 2017, to be followed by a $16,500,000 installment due December 28, 2018 and a $22,000,000 installment due December 28, 2019, with the outstanding balance due on November 6, 2020.

The term loan and credit facility contains terms which, if breached, would result in it becoming repayable on demand. It requires, among other matters, compliance with the following financial covenant ratios measured on a quarterly basis: (1) our ratio of net debt to EBITDA must not be greater than 3.0:13.5:1.0 and (2) our ratio of EBITDA to net interest must not be less than 4.0:1.1.0. Management has determined that

40


the Company has not breached these covenants throughout the period to December 31, 2017 and does not expect to breach these covenants for the next 12 months.

The credit facility is secured by a number of fixed and floating charges over certain assets which include key operating sites of the Company and its subsidiaries.

The currentrevolving credit facility contains restrictions which may limit our activities andas well as operational and financial flexibility. We may not be able to borrow if an event of default is outstanding, which includes a material adverse change to our assets, operations or financial condition. The credit facility contains a number of restrictions that limit our ability, among other things, and subject to certain limited exceptions, to incur additional indebtedness, pledge our assets as security, guarantee obligations of third parties, make investments, effect a merger or consolidation, dispose of assets, or materially change our line of business.

At December 31, 2017,2023, we had $121.0 million ofno debt outstanding under the revolving credit facility $99.0 million of debt outstanding on our term loan and $5.9 million ofno obligations under finance leases relating to certain fixed assets within our Fuel Specialties and Oilfield Services segments.

leases.

At December 31, 2017, our maturity profile of long-term debt and finance leases is set out below:

(in millions)

    

2018

  $18.5 

2019

   22.9 

2020

   182.5 

2021

   0.4 
  

 

 

 

Total debt

   224.3 

Current portion of long-term debt and finance leases

   (18.5
  

 

 

 

Long-term debt and finance leases, net of current portion

  $205.8 
  

 

 

 

The fair value of long-term debt approximates to the carrying value, as the discounting to its present value is offset by the interest rate swaps.

Outlook

Our business has performed well in 2017, and this is reflected in our positive results. This is continued evidence that our strategy is working. Delivering new products to customers in our key markets, combined with good customer service has enabled us to meet our expectations, in spite of some very challenging market conditions. The business has continued to generate good cash flows even in the light of the required working capital investments to grow and integrate the acquired business, and our leverage has been further improved.

We continue to have expectations that our Fuel Specialties, Performance Chemicals and Oilfield Services businesses will deliver good performances in 2018.

We expect to continue to focus on the development of new technology, combined with good customer service, in order to maintain our competitive advantage.

We anticipate a decline in revenues from our Octane Additives segment. We have not agreed a new contract with our sole remaining customer and thus have limited visibility for 2018 and beyond.

At December 31, 2017, the Company had cash and cash equivalents of $90.2 million, long-term debt of $218.4 million and finance leases of $5.9 million, giving total debt of $224.3 million, resulting in a net debt position of $134.1 million.

During 2017 the Company did not repurchase any of our common stock under the authorized share repurchase program announced on November 3, 2015.

The Company expects to fund its operations and share repurchase program over at least the next 12 months from a combination of operating cash flows and its revolving credit facility.

Contractual Commitments

The following represents contractual commitments at December 31, 20172023 and the effect of those obligations on future cash flows:

(in millions)

  Total   2018   2019-20   2021-22   Thereafter 

Operating activities

          

Planned funding of pension obligations

  $5.2   $1.0   $2.1   $2.1   $0.0 

Remediation payments

   46.1    5.2    8.5    5.0    27.4 

Operating lease commitments

   20.3    4.3    6.3    3.8    5.9 

Raw material purchase obligations

   19.8    6.4    8.2    3.4    1.8 

Interest payments on debt

   11.5    4.8    6.7    0.0    0.0 

Investing activities

          

Capital commitments

   2.3    2.3    0.0    0.0    0.0 

Financing activities

          

Long-term debt obligations

   218.4    15.7    202.7    0.0    0.0 

Finance leases

   5.9    2.7    2.6    0.6    0.0 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $329.5   $42.4   $237.1   $14.9   $35.1 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(in millions)

 

Total

 

 

2024

 

 

2025-26

 

 

2027-28

 

 

Thereafter

 

Operating activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating lease liabilities

 

 

45.2

 

 

 

13.6

 

 

 

15.3

 

 

 

4.8

 

 

 

11.5

 

Operating lease future commitments

 

 

5.8

 

 

 

0.7

 

 

 

1.6

 

 

 

1.6

 

 

 

1.9

 

Interest payments on debt

 

 

3.8

 

 

 

1.1

 

 

 

2.2

 

 

 

0.5

 

 

 

 

Investing activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital commitments

 

 

33.7

 

 

 

29.5

 

 

 

4.2

 

 

 

 

 

 

 

Internally developed software

 

 

8.9

 

 

 

8.9

 

 

 

 

 

 

 

 

 

 

Total

 

$

97.4

 

 

$

53.8

 

 

$

23.3

 

 

$

6.9

 

 

$

13.4

 

Operating activities

The amounts related to pension obligations refer to the likely levels of funding of our United Kingdom defined benefit pension plan (the “Plan”). The Plan is closed to future service accrual, but has a large number of deferred and current pensioners. The Company expects its annual cash contribution to be $1.0 million in 2018, $2.1 million in2019-20 and $2.1 million in2021-22. It is not considered meaningful to predict amounts beyond 2022 since there are too many uncertainties including future returns on assets, pension increases and inflation which are evaluated when the plan undertakes an actuarial valuation every three years.

Remediation payments represent those cash flows that the Company is currently obligated to pay in respect of environmental remediation of current and former facilities. It does not include any discretionary remediation costs that the Company may choose to incur.

Operating lease commitments relate primarily to right-of-use assets at third-party manufacturing facilities, office space, motor vehicles and various items of computer and office equipment which are expected to be renewed and replaced in the normal course of business.

Raw material purchase obligations relate to certain long-term raw material contracts which stipulate fixed or minimum quantities to be purchased; fixed, minimum or variable cost provisions; and the approximate timing of the transaction. Purchase obligations exclude agreements that are cancelable without penalty.

The estimated payments included inon debt are the table above reflect the variable interest charge on long-term debt obligations. Estimated commitment fees are also included andfor our $250.0 million revolving credit facility. Any interest income ishas been excluded.

Due to the uncertainty regarding the nature of tax audits, particularly those which are not currently underway, it is not meaningful to predict the outcome of obligations related to unrecognized tax benefits. Further disclosure is provided in Note 1011 of the Notes to the Consolidated Financial Statements.

Investing activities

Capital commitments relate to certain capital projects that the Company has committed to undertake.

Financing activities

On December 14, 2016, InnospecInternally developed software relates to the planned completion costs for the implementation of our new Enterprise Resource Planning system for EMEA and certain subsidiariesASPAC, including the acquisition costs for the software as well as the external and internal costs of the Company entered intodevelopment.

41


Outlook

Our business teams delivered a Third Amendment and Restatement Agreementstrong overall 2023 result. Despite our expectation for continued economic headwinds in the coming quarters, we enter 2024 with various lenders which amends and restates the Company’s credit facility agreement dated December 14, 2011, as amended and restated on August 28, 2013 and November 6, 2015 (the“Pre-Existing Credit Agreement” thePre-Existing Credit Agreement, as amended and restated pursuantoptimism. Our growing pipeline of technology-based organic opportunities will continue to the Third Amendment and Restatement Agreement, being the “Amended Credit Agreement.”)

The Amended Credit Agreement retains the $200,000,000 revolving credit facility available to the Company and adds a term loan facility of $110,000,000. The termination date of the revolving facility remains November 6, 2020. A repayment for the term loan of $11,000,000 was made on December 29, 2017, to be followed by a $16,500,000 installment due December 28, 2018 and a $22,000,000 installment due December 28, 2019,advance in parallel with the outstanding balance due on November 6, 2020.integration of our recent acquisition of QGP.

Finance leases relateOver the medium to the financing of certain fixed assetslong-term, we do not expect any change in our Fuel Specialtiescustomers’ drive towards cleaner formulations, lower carbon footprint and Oilfield Services segments.operational efficiency. We plan to continue our investment in R&D to improve our products and technology. We believe our innovative chemistries and highly responsive technical service directly support our customers’ priorities.

Cash generation was excellent in 2023, and our debt-free, net cash position remained at over $200 million after funding the QGP acquisition. Entering 2024 we expect to have significant flexibility and balance sheet strength for further M&A, dividend growth, and organic investment.

Environmental Matters and Plant Closures

Under certain environmental laws the Company is responsible for the environmental remediation of hazardous substances or wastes at currently or formerly owned or operated properties.

As most of our manufacturing operations have been conducted outside the U.S., we expect that liability pertaining to the investigation and environmental remediation of contaminated properties is likely to be determined undernon-U.S. law.

We evaluate costs for environmental remediation, decontamination and demolition projects on a regular basis. Full provision is made for those costs to which we are committed under environmental laws amounting to $46.1$61.6 million at December 31, 2017. Remediation expenditure2023. See Note 13 of the Notes to the Consolidated Financial Statements for further details. Expenditure utilizing these provisions was $2.4$4.9 million, $2.7$4.2 million and $2.6$5.3 million in the years 2017, 20162023, 2022 and 2015,2021, respectively.

42


Item 7AQuantitative and Qualitative Disclosures about Market Risk

Item 7A Quantitative and Qualitative Disclosures about Market Risk

The Company uses floating rate debt to finance its global operations. The Company is subject to business risks inherent innon-U.S. activities, including political and economic uncertainty, import and export limitations, and market risk related to changes in interest rates and foreign currency exchange rates. The political and economic risks are mitigated by the stability of the countries in which the Company’s largest operations are located. Credit limits, ongoing credit evaluation and account monitoring procedures are used to minimize bad debt risk. Collateral is not generally required.

From time to time, the Company uses derivatives, including interest rate swaps, commodity swaps and foreign currency forward exchange contracts, in the normal course of business to manage market risks. The derivatives used in hedging activities are considered risk management tools and are not used for trading purposes. In addition, the Company enters into derivative instruments with a diversified group of major financial institutions in order to manage the exposure tonon-performance of such instruments. The Company’s objective in managing the exposure to changes in interest rates is to limit the impact of such changes on earnings and cash flows and to lower overall borrowing costs. The Company’s objective in managing the exposure to changes in foreign currency exchange rates is to reduce volatility on earnings and cash flows associated with such changes.

The Company offers fixed prices for some long-term sales contracts. As manufacturing and raw material costs are subject to variability the Company may use commodity swaps to hedge the cost of some raw materials thus reducing volatility on earnings and cash flows. The derivatives are considered risk management tools and are not used for trading purposes. The Company’s objective is to manage its exposure to fluctuating costs of raw materials.

Interest Rate Risk

From time to time, the Company uses interest rate swaps to manage interest rate exposure. As at December 31, 2017 theThe Company had cash and cash equivalents of $90.2retains a $250.0 million and long-term debt and finance leases of $224.3 million (including current portion). Long-term debt comprises a $200,000,000 revolving credit facility which is available to the Company and a remaining term loan facility of $99,000,000.draw down as required. The credit facilities carryfacility carries an interest rate based onfor U.S. dollar LIBORdenominated debt of the Secured Overnight Financing Rate ("SOFR") plus a margin of between 1.20%1.25% and 2.45%2.50% which is dependent on the Company’s ratio of net debt to EBITDA. Net debt and EBITDA arenon-GAAP measures of liquidity defined in the credit facility.

At December 31, 2017, $121.02023, $0.0 million was drawn under the revolving credit facility and the term loan facility of $99.0 million was drawn. A repayment for the term loan of $11,000,000 was made on December 29, 2017, to be followed by a $16,500,000 installment due December 28, 2018 and a $22,000,000 installment due December 28, 2019, with the outstanding balance due on November 6, 2020.facility.

The Company has taken out interest rate swaps to hedge interest rate risk on core debt. As at December 31, 2017, interest rate swaps with a notional value of $149,000,000 were in place. Fixed interest rates payable under2023, the interest rate swaps vary from 1.42% to 1.67%. Interest

rate swaps in place to hedge interest rate risk on the term loan have an amortizing profile matching the amortization of the term loan.

The Company has $224.3 million long-termhad no debt andor finance leases (including the current portion) which is partly offset by $90.2and $203.7 million cash and cash equivalents. TheAssuming variable interest payable on long-term debt (excluding the margin) exceeds the interest receivable on positive cash balances. On a gross basis, assuming no additional interestreturns on the cash balances, and after deducting interest rate hedging, a hypothetical absolute changeincrease or decrease of 1% in U.S. base interest rates for aone-year period would impactincrease or decrease net income and cash flows by approximately $0.7$2.0 million before tax. On a net basis, assuming additional interest on the cash balances, a hypothetical absolute change of 1% in U.S. base interest rates for aone-year period would impact net income and cash flows by approximately $0.2 million before tax.

The above does not consider the effect of interest or exchange rate changes on overall activity nor management action to mitigate such changes. As at December 31, 2017, Innospec has interest rate swaps which mitigate a proportion of the risk identified above.

Exchange Rate Risk

The Company generates an element of its revenues and incurs some operating costs in currencies other than the U.S. dollar. The reporting currency of the Company is the U.S. dollar.

The Company evaluates the functional currency of each reporting unit according to the economic environment in which it operates. Several major subsidiaries of the Company operating outside of the U.S.

43


have the U.S. dollar as their functional currency due to the nature of the markets in which they operate. In addition, the financial position and results of operations of some of our overseas subsidiaries are reported in the relevant local currency and then translated to U.S. dollars at the applicable currency exchange rate for inclusion in our consolidated financial statements.Consolidated Financial Statements.

The primary foreign currencies in which we have exchange rate fluctuation exposure are the European Union euro, British pound sterling and Brazilian Real.real. Changes in exchange rates between these foreign currencies and the U.S. dollar will affect the recorded levels of our assets and liabilities, to the extent that such figures reflect the inclusion of foreign assets and liabilities which are translated into U.S. dollars for presentation in our consolidated financial statements,Consolidated Financial Statements, as well as our results of operations.

The Company’s objective in managing the exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency exchange rate changes. Accordingly, the Company enters into various contracts that change in value as foreign currency exchange rates change to protect the U.S. dollar value of its existing foreign currency denominated assets, liabilities, commitments, and cash flows. The Company also uses foreign currency forward exchange contracts to offset a portion of the Company’s exposure to certain foreign currency denominated revenues so that gains and losses on these

contracts offset changes in the U.S. dollar value of the related foreign currency denominated revenues. The objective of the hedging program is to reduce earnings and cash flow volatility related to changes in foreign currency exchange rates.

The trading of our Performance Chemicals, Fuel Specialties Performance Chemicals and Oilfield Services segments is inherently naturally hedged and accordingly changes in exchange rates would not be material to our earnings or financial position. The cost base of our Octane Additives reporting segment and corporate costs, however, are largely denominated in British pound sterling. A 5% strengthening in the U.S. dollar against British pound sterling would increase reported operating income by approximately $2.8$1.8 million for aone-year period excluding the impact of any foreign currency forward exchange contracts.

Where a 5% strengthening of the U.S. dollar has been used as an illustration, a 5% weakening would be expected to have the opposite effect on operating income.

Raw Material Cost Risk

We use a variety of raw materials, chemicals and energy in our manufacturing and blending processes. Many of the raw materials that we use are derived from petrochemical-based and vegetable-based feedstocks which can be subject to periods of rapid and significant cost instability. These fluctuations in cost can be caused by political instability in oil producing nations and elsewhere, or other factors influencing global supply and demand of these materials, over which we have nolittle or littleno control. We use long-term contracts (generally with fixed or formula-based costs) and advance bulk purchases to help ensure availability and continuity of supply, and to manage the risk of cost increases. From time to time we enter into hedging arrangements for certain raw materials, but do not typically enter into hedging arrangements for all raw materials, chemicals or energy costs. Should the costs of raw materials, chemicals or energy increase, and should we not be able to pass on these cost increases to our customers, then operating margins and cash flows from operating activities would be adversely impacted. Should raw material costs increase significantly, then the Company’s need for working capital could similarly increase. Any of these risks could adversely impact our results of operations, financial position and cash flows.

44


Item 8Financial Statements and Supplementary Data

Item 8 Financial Statements and Supplementary Data

Report of IndependentRegisteredIndependent Registered Public Accounting Firm

To the stockholdersBoard of Directors and boardStockholders of directors

Innospec Inc.:

Opinions on the Consolidated Financial Statements and Internal Control Overover Financial Reporting

We have audited the accompanying consolidated balance sheets of Innospec Inc. and its subsidiaries (the “Company”) as of December 31, 20172023 and 2016,2022, and the related consolidated statements of income, comprehensive income, accumulated other comprehensive loss,equity and cash flows and equity for each of the three years in the three-year period ended December 31, 2017, and2023, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company’sCompany's internal control over financial reporting as of December 31, 2017,2023, based on criteria established inInternal Control - Integrated Framework(2013) (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 20172023 and 2016,2022, and the results of its operations and its cash flows for each of the three years in the three-year period ended December 31, 2017,2023 in conformity with U.S.accounting principles generally accepted accounting principles.in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017,2023, based on criteria established inInternal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.COSO.

Basis for OpinionOpinions

The Company’sCompany's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Overover Financial Reporting.Reporting appearing under Item 9A. Our responsibility is to express an opinionopinions on the Company’s consolidated financial statements and an opinion on the Company’sCompany's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”)(PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

45


Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

As described in Management’s Report on Internal Control over Financial Reporting, management has excluded QGP Química Geral S.A. (“QGP”) from its assessment of internal control over financial reporting as of December 31, 2023, because it was acquired by the Company in a purchase business combination during 2023. We have also excluded QGP from our audit of internal control over financial reporting. QGP is a wholly-owned subsidiary whose total assets and total revenues excluded from management’s assessment and our audit of internal control over financial reporting represent less than 2% and less than 1% respectively, of the related consolidated financial statement amounts as of and for the year ended December 31, 2023.

Definition and Limitations of Internal Control Overover Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1)(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2)(ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3)(iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

46


Plant Closure Provisions

As described in Notes 2 and 13 to the consolidated financial statements, at December 31, 2023, the Company has recognized plant closure provisions of $61.6 million, the majority of which relates to asset retirement obligations. The Company recognizes asset retirement obligations when there is an obligation based on a legal requirement, including those arising from Company promises, and the costs can be reasonably estimated. The Company must comply with environmental legislation in the countries in which it operates or has operated in and annually reassesses the program of work required. This includes estimating the credit-adjusted risk free rate and the timing and cost of performing the remediation work. Management receives input from specialists to develop these estimates and assumptions utilizing the latest information available together with experience of recent costs.

The principal considerations for our determination that performing procedures relating to the plant closure provisions is a critical audit matter are: (i) the significant judgment made by management when developing the estimate; (ii) a high degree of auditor judgment and subjectivity in applying procedures relating to the recognition and measurement of the asset retirement obligations; (iii) the audit effort involved the use of professionals with specialized skill and knowledge; and (iv) the significant audit effort in evaluating the significant assumptions related to: the program of work required; and the timing and cost of performing the remediation work.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the recognition and measurement of the plant closure provisions. These procedures also included, among others: (i) testing management’s process to recognize and measure the estimate; (ii) evaluating the appropriateness of the valuation method; (iii) testing the data used in the calculation of the estimate; (iv) evaluating the reasonableness of significant assumptions including the assessment of the program of work required; the timing and cost of performing the remediation work; and the credit-adjusted risk-free rate; and (v) evaluating the scope, competency, and objectivity of management’s specialists based on the work they were engaged to perform. Professionals with specialized skill and knowledge were used to assist in evaluating management’s method and the reasonableness of the significant assumptions in respect of the program of the work required and the timing and cost of performing the remediation work.

/s/ KPMG Audit PlcPricewaterhouseCoopers LLP

Manchester, United Kingdom

February 14, 2024.

We have served as the Company’s auditor since 2011.2019.

47


Manchester, United Kingdom

February 15, 2018

CONSOLIDATED STATEMENTS OF INCOME

(in millions, except share and per share data)

  Years ended December 31 

 

Years ended December 31,

 

  2017 2016 2015 

 

2023

 

 

2022

 

 

2021

 

Net sales

  $1,306.8  $883.4  $1,012.3 

 

$

1,948.8

 

 

$

1,963.7

 

 

$

1,483.4

 

Cost of goods sold

   (903.5  (551.1  (666.3

 

 

(1,357.7

)

 

 

(1,377.0

)

 

 

(1,048.5

)

  

 

  

 

  

 

 

Gross profit

   403.3   332.3   346.0 

 

 

591.1

 

 

 

586.7

 

 

 

434.9

 

  

 

  

 

  

 

 

Operating expenses:

    

 

 

 

 

 

 

 

 

 

Selling, general and administrative

   (239.5  (209.5  (206.7

 

 

(387.8

)

 

 

(360.7

)

 

 

(267.2

)

Research and development

   (31.4  (25.4  (25.3

 

 

(41.7

)

 

 

(38.7

)

 

 

(37.4

)

Adjustment to fair value of contingent consideration

   0.0   9.4   40.7 

(Loss)/profit on disposal of subsidiary

   (0.9  (1.4  1.6 

Foreign exchange loss on liquidation of subsidiary

   (1.8  0.0   0.0 
  

 

  

 

  

 

 

Profit on disposal

 

 

 

 

 

 

 

 

1.8

 

Total operating expenses

   (273.6  (226.9  (189.7

 

 

(429.5

)

 

 

(399.4

)

 

 

(302.8

)

  

 

  

 

  

 

 

Operating income

   129.7   105.4   156.3 

 

 

161.6

 

 

 

187.3

 

 

 

132.1

 

Other income/(expense), net

   6.6   0.9   0.0 

 

 

10.5

 

 

 

(1.6

)

 

 

3.8

 

Interest expense, net

   (8.2  (3.2  (4.0
  

 

  

 

  

 

 

Income before income taxes

   128.1   103.1   152.3 

Income taxes

   (66.3  (21.8  (32.8
  

 

  

 

  

 

 

Interest income/(expense), net

 

 

2.3

 

 

 

(1.1

)

 

 

(1.5

)

Income before income tax expense

 

 

174.4

 

 

 

184.6

 

 

 

134.4

 

Income tax expense

 

 

(35.3

)

 

 

(51.6

)

 

 

(41.3

)

Net income

  $61.8  $81.3  $119.5 

 

$

139.1

 

 

$

133.0

 

 

$

93.1

 

  

 

  

 

  

 

 

Earnings per share:

    

 

 

 

 

 

 

 

 

 

Basic

  $2.56  $3.39  $4.96 

 

$

5.60

 

 

$

5.37

 

 

$

3.78

 

  

 

  

 

  

 

 

Diluted

  $2.52  $3.33  $4.86 

 

$

5.56

 

 

$

5.32

 

 

$

3.75

 

  

 

  

 

  

 

 

Weighted average shares outstanding (in thousands):

    

 

 

 

 

 

 

 

 

 

Basic

   24,148   23,998   24,107 

 

 

24,851

 

 

 

24,787

 

 

 

24,647

 

  

 

  

 

  

 

 

Diluted

   24,486   24,442   24,612 

 

 

25,022

 

 

 

24,982

 

 

 

24,854

 

  

 

  

 

  

 

 

Dividend declared per common share

  $0.77  $0.67  $0.61 
  

 

  

 

  

 

 

The accompanying notes are an integral part of these statements.

48


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions)

Total comprehensive income for the years ended December 31

      2017  2016  2015 

Net income

    $61.8  $81.3  $119.5 

Changes in cumulative translation adjustment, net of tax of $(3.3) million, $1.5 million and $(0.2) million, respectively

     44.0   (20.5  (11.0

Unrealized gains on derivative instruments, net of tax of
$(0.2) million, $(0.1) million and $0.0 million, respectively

     0.9   0.3   0.0 

Amortization of prior service credit, net of tax of $0.2 million, $0.2 million and $0.2 million, respectively

     (0.8  (0.9  (1.0

Amortization of actuarial net losses, net of tax of $(0.9) million, $(0.5) million and $(1.0) million, respectively

     4.1   2.1   4.2 

Actuarial net gains arising during the year, net of tax of $(8.8) million, $(0.8) million and $(0.9) million, respectively

     39.5   3.7   3.2 
    

 

 

  

 

 

  

 

 

 

Total comprehensive income

    $149.5  $66.0  $114.9 
    

 

 

  

 

 

  

 

 

 

CONSOLIDATED STATEMENTS OF ACCUMULATED OTHER COMPREHENSIVE LOSS

(in millions)

 

 

 

Accumulated other comprehensive loss for the years ended
December 31

      2017  2016  2015 

Cumulative translation adjustment

    $(36.5 $(80.5 $(60.0

Unrealized gains on derivative instruments, net of tax of $(0.3) million, $(0.1) million and $0.0 million, respectively

     1.2   0.3   0.0 

Unrecognized actuarial net losses, net of tax of $9.9 million, $19.4 million and $20.5 million, respectively

     (3.2  (46.0  (50.9
  

 

 

   

 

 

  

 

 

  

 

 

 

Accumulated other comprehensive loss

    $(38.5 $(126.2 $(110.9
  

 

 

   

 

 

  

 

 

  

 

 

 

Total comprehensive income for the years ended December 31

 

2023

 

 

2022

 

 

2021

 

Net income

 

$

139.1

 

 

$

133.0

 

 

$

93.1

 

Changes in cumulative translation adjustment (1)

 

 

18.3

 

 

 

(34.7

)

 

 

(22.2

)

Amortization of prior service cost/(credit)

 

 

0.5

 

 

 

0.5

 

 

 

0.3

 

Amortization of actuarial net losses/(gains)

 

 

(2.1

)

 

 

0.5

 

 

 

2.6

 

Actuarial net gains/(losses) arising during the year

 

 

(23.4

)

 

 

(93.9

)

 

 

37.2

 

Other comprehensive income, before tax

 

 

132.4

 

 

 

5.4

 

 

 

111.0

 

Income tax income/(expense) related to other comprehensive income

 

 

3.8

 

 

 

29.3

 

 

 

(7.5

)

Total comprehensive income

 

$

136.2

 

 

$

34.7

 

 

$

103.5

 

(1) Amounts are before tax of $(2.4) million in 2023, $5.5 million in 2022 and $2.0 million in 2021.

The accompanying notes are an integral part of these statements.

49


CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share data)

  At December 31 

 

At December 31

 

  2017 2016 

 

2023

 

 

2022

 

Assets

   

 

 

 

 

 

 

Current assets:

   

 

 

 

 

 

 

Cash and cash equivalents

  $90.2  $101.9 

 

$

203.7

 

 

$

147.1

 

Trade and other accounts receivable (less allowances of $4.1 million and $4.7 million, respectively)

   244.5   154.4 

Inventories (less allowances of $12.6 million and $8.6 million, respectively):

   

Trade and other accounts receivable (less allowances of $10.3 million and
$
7.7 million, respectively)

 

 

359.8

 

 

 

334.6

 

Inventories (less allowances of $28.1 million and $27.1 million, respectively):

 

 

 

 

 

 

Finished goods

   145.9   118.1 

 

 

215.7

 

 

 

259.3

 

Raw materials

   63.9   55.7 

 

 

84.4

 

 

 

113.8

 

  

 

  

 

 

Total inventories

   209.8   173.8 

 

 

300.1

 

 

 

373.1

 

Prepaid expenses

   13.1   6.2 

 

 

18.7

 

 

 

14.1

 

Prepaid income taxes

   2.8   4.8 

 

 

2.8

 

 

 

3.3

 

Other current assets

   1.1   0.0 

 

 

0.6

 

 

 

0.4

 

  

 

  

 

 

Total current assets

   561.5   441.1 

 

 

885.7

 

 

 

872.6

 

Net property, plant and equipment

   196.0   157.4 

 

 

268.3

 

 

 

220.9

 

Operating leases right-of-use assets

 

 

45.1

 

 

 

45.3

 

Goodwill

   361.8   374.8 

 

 

399.3

 

 

 

358.8

 

Other intangible assets

   163.3   144.4 

 

 

57.3

 

 

 

45.0

 

Deferred tax assets

   6.5   14.9 

 

 

10.4

 

 

 

5.9

 

Pension asset

   116.0   48.0 

 

 

35.1

 

 

 

48.1

 

Othernon-current assets

   5.1   0.8 

 

 

6.2

 

 

 

7.1

 

  

 

  

 

 

Total assets

  $1,410.2  $1,181.4 

 

$

1,707.4

 

 

$

1,603.7

 

  

 

  

 

 

Liabilities and Equity

   

 

 

 

 

 

 

Current liabilities:

   

 

 

 

 

 

 

Accounts payable

  $117.9  $59.6 

 

$

163.6

 

 

$

165.3

 

Accrued liabilities

   104.1   95.4 

 

 

185.9

 

 

 

202.9

 

Current portion of long-term debt

   15.8   10.3 

Current portion of finance leases

   2.7   1.6 

Current portion of operating lease liabilities

 

 

13.6

 

 

 

13.9

 

Current portion of plant closure provisions

   5.2   6.7 

 

 

4.6

 

 

 

5.3

 

Current portion of accrued income taxes

   15.8   9.4 

 

 

2.6

 

 

 

18.4

 

Current portion of deferred income

   0.1   0.1 
  

 

  

 

 

Current portion of unrecognized tax benefits

 

 

1.2

 

 

 

 

Total current liabilities

   261.6   183.1 

 

 

371.5

 

 

 

405.8

 

Long-term debt, net of current portion

   202.6   258.5 

Finance leases, net of current portion

   3.2   2.9 

Operating lease liabilities, net of current portion

 

 

31.6

 

 

 

31.4

 

Plant closure provisions, net of current portion

   40.9   32.8 

 

 

57.0

 

 

 

51.9

 

Accrued income taxes, net of current portion

   41.7   0.0 

 

 

11.6

 

 

 

21.0

 

Unrecognized tax benefits, net of current portion

   2.5   2.3 

 

 

13.6

 

 

 

13.4

 

Deferred tax liabilities

   45.0   32.3 

 

 

33.5

 

 

 

26.2

 

Pension liabilities and post-employment benefits

   16.5   14.2 

 

 

13.3

 

 

 

12.2

 

Deferred income, net of current portion

   0.5   0.5 

Acquisition-related contingent deferred consideration

 

 

23.4

 

 

 

 

Othernon-current liabilities

   1.4   1.0 

 

 

2.3

 

 

 

1.4

 

Total liabilities

 

 

557.8

 

 

 

563.3

 

Equity:

   

 

 

 

 

 

 

Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares

   0.3   0.3 

Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500
shares

 

 

0.3

 

 

 

0.3

 

Additionalpaid-in capital

   320.4   315.1 

 

 

361.0

 

 

 

354.1

 

Treasury stock (5,204,181 and 5,483,341 shares at cost, respectively)

   (93.3  (97.5

Treasury stock (4,686,511 and 4,788,966 shares at cost, respectively)

 

 

(94.3

)

 

 

(95.4

)

Retained earnings

   605.0   561.8 

 

 

1,028.2

 

 

 

924.2

 

Accumulated other comprehensive loss

   (38.5  (126.2

 

 

(148.1

)

 

 

(145.2

)

  

 

  

 

 

Total Innospec stockholders’ equity

   793.9   653.5 

 

 

1,147.1

 

 

 

1,038.0

 

Non-controlling interest

   0.4   0.3 

 

 

2.5

 

 

 

2.4

 

  

 

  

 

 

Total equity

   794.3   653.8 

 

 

1,149.6

 

 

 

1,040.4

 

  

 

  

 

 

Total liabilities and equity

  $1,410.2  $1,181.4 

 

$

1,707.4

 

 

$

1,603.7

 

  

 

  

 

 

The accompanying notes are an integral part of these statements.

50


CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)millions)

  Years ended December 31 

 

Years ended December 31,

 

      2017         2016         2015     

 

2023

 

 

2022

 

 

2021

 

Cash Flows from Operating Activities

    

 

 

 

 

 

 

 

 

 

Net income

  $61.8  $81.3  $119.5 

 

$

139.1

 

 

$

133.0

 

 

$

93.1

 

Adjustments to reconcile net income to net cash provided by operating activities:

    

 

 

 

 

 

 

 

 

 

Depreciation and amortization

   50.4   38.1   35.2 

 

 

39.3

 

 

 

40.1

 

 

 

42.7

 

Adjustment to fair value of contingent consideration

   0.0   (9.4  (40.7

Loss/(profit) on disposal of subsidiary

   0.9   1.4   (1.6

Foreign exchange loss on liquidation of subsidiary

   1.8   0.0   0.0 

Deferred taxes

   (6.7  0.9   12.0 

 

 

3.6

 

 

 

(5.5

)

 

 

6.4

 

Cash contributions to defined benefit pension plans

   (1.0  (1.1  (9.0

Non-cash (income)/expense of defined benefit pension plans

   (3.6  (6.2  0.5 

Profit on disposal

 

 

 

 

 

 

 

 

(1.8

)

Non-cash income of defined benefit pension plans

 

 

(3.3

)

 

 

(2.5

)

 

 

(3.5

)

Stock option compensation

   4.1   3.3   3.7 

 

 

8.0

 

 

 

6.7

 

 

 

4.4

 

Changes in assets and liabilities, net of effects of acquired and divested companies:

    

 

 

 

 

 

 

 

 

 

Trade and other accounts receivable

   (83.2  (6.0  13.6 

 

 

(12.6

)

 

 

(55.5

)

 

 

(70.3

)

Inventories

   (30.8  7.7   5.5 

 

 

83.0

 

 

 

(98.5

)

 

 

(62.0

)

Prepaid expenses

   (6.8  0.5   1.8 

 

 

(4.2

)

 

 

4.6

 

 

 

(3.5

)

Accounts payable and accrued liabilities

   48.6   (3.4  (24.5

 

 

(26.9

)

 

 

54.2

 

 

 

90.2

 

Plant closure provisions

 

 

4.0

 

 

 

1.1

 

 

 

(1.4

)

Accrued income taxes

   47.5   (2.0  2.0 

 

 

(25.9

)

 

 

9.4

 

 

 

(3.2

)

Plant closure provisions

   3.8   1.9   4.1 

Unrecognized tax benefits

   (0.5  (1.6  (2.3

 

 

1.4

 

 

 

(2.9

)

 

 

0.3

 

Other assets and liabilities

   (3.6  0.1   (1.6

 

 

1.8

 

 

 

(2.5

)

 

 

1.8

 

  

 

  

 

  

 

 

Net cash provided by operating activities

   82.7   105.5   118.2 

 

 

207.3

 

 

 

81.7

 

 

 

93.2

 

Cash Flows from Investing Activities

    

 

 

 

 

 

 

 

 

 

Capital expenditures

   (23.3  (16.5  (17.6

 

 

(62.1

)

 

 

(39.6

)

 

 

(39.1

)

Proceeds on disposal of property, plant and equipment

 

 

0.1

 

 

 

0.2

 

 

 

2.9

 

Business combinations, net of cash acquired

   2.6   (197.4  0.0 

 

 

(34.7

)

 

 

 

 

 

 

Acquisition of intangible asset

   (4.2  0.0   0.0 

Proceeds from disposal of subsidiary

   0.0   0.0   41.5 

Internally developed software

   (4.7  0.0   (8.6

 

 

(15.1

)

 

 

(2.7

)

 

 

 

Purchase of short-term investments

   0.0   0.0   (6.7

Sale of short-term investments

   0.0   4.8   6.4 
  

 

  

 

  

 

 

Net cash (used in)/provided by investing activities

   (29.6  (209.1  15.0 

Net cash used in investing activities

 

 

(111.8

)

 

 

(42.1

)

 

 

(36.2

)

Cash Flows from Financing Activities

    

 

 

 

 

 

 

 

 

 

Non-controlling interest

   0.0   0.0   0.3 

 

 

 

 

 

1.8

 

 

 

0.1

 

Proceeds from revolving credit facility

   10.0   48.0   6.0 

 

 

 

 

 

 

 

 

 

Repayments of revolving credit facility

   (50.0  (20.0  (12.0

 

 

 

 

 

 

 

 

 

(Payment)/receipt of term loans

   (11.0  110.0   0.0 

Repayment of finance leases and term loans

   (2.5  (1.1  (0.4

Repayment of term loan

 

 

(2.3

)

 

 

 

 

 

 

Repayment of finance leases

 

 

 

 

 

(0.1

)

 

 

(0.6

)

Refinancing costs

   0.0   (1.2  (1.5

 

 

(1.4

)

 

 

 

 

 

 

Payment for acquisition-related contingent consideration

   0.0   (44.0  0.0 

Dividend paid

   (18.6  (15.9  (14.9

 

 

(35.1

)

 

 

(31.7

)

 

 

(28.8

)

Issue of treasury stock

   6.8   2.1   1.0 

 

 

0.9

 

 

 

2.2

 

 

 

10.1

 

Repurchase of common stock

   (1.1  (8.4  (15.3

 

 

(1.1

)

 

 

(5.9

)

 

 

(0.8

)

  

 

  

 

  

 

 

Net cash (used in) /provided by financing activities

   (66.4  69.5   (36.8

Net cash used in financing activities

 

 

(39.0

)

 

 

(33.7

)

 

 

(20.0

)

Effect of foreign currency exchange rate changes on cash

   1.6   (0.9  (1.1

 

 

0.1

 

 

 

(0.6

)

 

 

(0.5

)

  

 

  

 

  

 

 

Net change in cash and cash equivalents

   (11.7  (35.0  95.3 

 

 

56.6

 

 

 

5.3

 

 

 

36.5

 

Cash and cash equivalents at beginning of year

   101.9   136.9   41.6 

 

 

147.1

 

 

 

141.8

 

 

 

105.3

 

  

 

  

 

  

 

 

Cash and cash equivalents at end of year

  $90.2  $101.9  $136.9 

 

$

203.7

 

 

$

147.1

 

 

$

141.8

 

  

 

  

 

  

 

 

Amortization of deferred finance costs of $0.6 million (2016 – $0.4 million, 2015 – $1.2 million) for the year are included in depreciation and amortization in the cash flow statement but in interest expense in the income statement. Cash payments/receipts in respect of income taxes and interest are disclosed in Note 10 and Note 11, respectively, of the Notes to the Consolidated Financial Statements.

We have recast certain prior period amounts to conform to new accounting standards.

The accompanying notes are an integral part of these statements.

51


CONSOLIDATED STATEMENTS OF EQUITY

(in millions)

   Common
Stock
  Additional

Paid-In

Capital
  Treasury

Stock
  Retained

Earnings
  Accumulated
Other

Comprehensive
Loss
  Non-
controlling
Interest
  
Total
Equity
 

Balance at December 31, 2014

 $0.3  $308.8  $(78.7 $391.8  $(106.3 $0.0  $515.9 

Net income

     119.5     119.5 

Dividend paid ($0.61 per share)

     (14.9    (14.9

Changes in cumulative translation adjustment

      (11.0   (11.0

Non-controlling interest

       0.3   0.3 

Business disposal

   (0.4      (0.4

Treasury stockre-issued

   (1.6  2.2      0.6 

Treasury stock repurchased

    (15.3     (15.3

Excess tax benefit from stock-based payment arrangements

   0.5       0.5 

Stock option compensation

   3.7       3.7 

Amortization of prior service credit, net of tax

      (1.0   (1.0

Amortization of actuarial net losses, net of tax

      4.2    4.2 

Actuarial net gains arising during the year, net of tax

      3.2    3.2 
 

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balance at December 31, 2015

 $0.3  $311.0  $(91.8 $496.4  $(110.9 $0.3  $605.3 

Net income

     81.3     81.3 

Dividend paid ($0.67 per share)

     (15.9    (15.9

Changes in cumulative translation adjustment

      (20.5   (20.5

Unrealized gains on derivative instruments, net of tax

      0.3    0.3 

Treasury stockre-issued

   (0.2  2.7      2.5 

Treasury stock repurchased

    (8.4     (8.4

Excess tax benefit from stock-based payment arrangements

   1.0       1.0 

Stock option compensation

   3.3       3.3 

Amortization of prior service credit, net of tax

      (0.9   (0.9

Amortization of actuarial net losses, net of tax

      2.1    2.1 

Actuarial net gains arising during the year, net of tax

      3.7    3.7 
 

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balance at December 31, 2016

 $0.3  $315.1  $(97.5 $561.8  $(126.2 $0.3  $653.8 

Net income

     61.8     61.8 

Dividend paid ($0.77 per share)

     (18.6    (18.6

Changes in cumulative translation adjustment

      44.0    44.0 

Non-controlling interest

       0.1   0.1 

Unrealized gains on derivative instruments, net of tax

      0.9    0.9 

Treasury stockre-issued

   1.1   5.3      6.4 

Treasury stock repurchased

    (1.1     (1.1

Stock option compensation

   4.2       4.2 

Amortization of prior service credit, net of tax

      (0.8   (0.8

Amortization of actuarial net losses, net of tax

      4.1    4.1 

Actuarial net gains arising during the year, net of tax

      39.5    39.5 
 

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balance at December 31, 2017

 $0.3  $320.4  $(93.3 $605.0  $(38.5 $0.4  $794.3 

 

Common
Stock

 

 

Additional
Paid-In
Capital

 

 

Treasury
Stock

 

 

Retained
Earnings

 

 

Accumulated
Other
Comprehensive
Loss

 

 

Non-
controlling
Interest

 

 

Total
Equity

 

Balance at December 31, 2020

 

$

0.3

 

 

$

336.1

 

 

$

(93.3

)

 

$

758.6

 

 

$

(57.3

)

 

$

0.5

 

 

$

944.9

 

Net income

 

 

 

 

 

 

 

 

 

 

 

93.1

 

 

 

 

 

 

 

 

 

93.1

 

Dividend paid ($1.16 per share)

 

 

 

 

 

 

 

 

 

 

 

(28.8

)

 

 

 

 

 

 

 

 

(28.8

)

Changes in cumulative translation
   adjustment, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(20.2

)

 

 

 

 

 

(20.2

)

Share of net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.1

 

 

 

0.1

 

Treasury stock re-issued

 

 

 

 

 

6.2

 

 

 

3.5

 

 

 

 

 

 

 

 

 

 

 

 

9.7

 

Treasury stock repurchased

 

 

 

 

 

 

 

 

(0.8

)

 

 

 

 

 

 

 

 

 

 

 

(0.8

)

Stock option compensation

 

 

 

 

 

4.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.4

 

Amortization of prior service credit,
   net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.2

 

 

 

 

 

 

0.2

 

Amortization of actuarial net losses,
   net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2.2

 

 

 

 

 

 

2.2

 

Actuarial net gains during
   the year, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

28.2

 

 

 

 

 

 

28.2

 

Balance at December 31, 2021

 

$

0.3

 

 

$

346.7

 

 

$

(90.6

)

 

$

822.9

 

 

$

(46.9

)

 

$

0.6

 

 

$

1,033.0

 

Net income

 

 

 

 

 

 

 

 

 

 

 

133.0

 

 

 

 

 

 

 

 

 

133.0

 

Dividend paid ($1.28 per share)

 

 

 

 

 

 

 

 

 

 

 

(31.7

)

 

 

 

 

 

 

 

 

(31.7

)

Changes in cumulative translation
   adjustment, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(29.2

)

 

 

 

 

 

(29.2

)

Non-controlling interest investment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.8

 

 

 

1.8

 

Treasury stock re-issued

 

 

 

 

 

0.7

 

 

 

1.0

 

 

 

 

 

 

 

 

 

 

 

 

1.7

 

Treasury stock repurchased

 

 

 

 

 

 

 

 

(5.8

)

 

 

 

 

 

 

 

 

 

 

 

(5.8

)

Stock option compensation

 

 

 

 

 

6.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6.7

 

Amortization of prior service cost,
   net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.4

 

 

 

 

 

 

0.4

 

Amortization of actuarial net losses,
   net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.4

 

 

 

 

 

 

0.4

 

Actuarial net losses during
   the year, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(69.9

)

 

 

 

 

 

(69.9

)

Balance at December 31 2022

 

$

0.3

 

 

$

354.1

 

 

$

(95.4

)

 

$

924.2

 

 

$

(145.2

)

 

$

2.4

 

 

$

1,040.4

 

Net income

 

 

 

 

 

 

 

 

 

 

 

139.1

 

 

 

 

 

 

 

 

 

139.1

 

Dividend paid ($1.41 per share)

 

 

 

 

 

 

 

 

 

 

 

(35.1

)

 

 

 

 

 

 

 

 

(35.1

)

Changes in cumulative translation
   adjustment, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15.9

 

 

 

 

 

 

15.9

 

Share of net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.1

 

 

 

0.1

 

Treasury stock re-issued

 

 

 

 

 

(1.1

)

 

 

2.2

 

 

 

 

 

 

 

 

 

 

 

 

1.1

 

Treasury stock repurchased

 

 

 

 

 

 

 

 

(1.1

)

 

 

 

 

 

 

 

 

 

 

 

(1.1

)

Stock option compensation

 

 

 

 

 

8.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8.0

 

Amortization of prior service cost,
   net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.4

 

 

 

 

 

 

0.4

 

Amortization of actuarial net gains,
   net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1.7

)

 

 

 

 

 

(1.7

)

Actuarial net losses arising during
   the year, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(17.5

)

 

 

 

 

 

(17.5

)

Balance at December 31 2023

 

$

0.3

 

 

$

361.0

 

 

$

(94.3

)

 

$

1,028.2

 

 

$

(148.1

)

 

$

2.5

 

 

$

1,149.6

 

The accompanying notes are an integral part of these statements.

52


NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Note 1. Nature of Operations

Innospec develops, manufactures, blends, markets and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Our Performance Chemicals business creates innovative technology-based solutions for our customers in the personal care, home care, agrochemical, construction, mining and other industrial markets. Our Fuel Specialties business specializes in manufacturing and supplying fuel additives oilfield chemicals, personal care products and other specialty chemicals. Our products are sold primarily to oil and gas exploration and production companies, oil refineries, personal care and home care companies, formulators of agrochemical and mining preparations and other chemical and industrial companies throughout the world. Our fuel additives helpthat improve fuel efficiency, boost engine performance and reduce harmful emissions. Our Oilfield Services business supplies drilling, completion and production chemicals which make exploration and production more effective, cost-efficient and more environmentally-friendly. Our Performance Chemicals business provides effective technology-based solutions for our customers’ processes or products focused in the Personal Care, Home Care, Agrochemical and Mining markets. Our Octane Additives business manufactures a fuel additive for use in automotive gasoline and provides services in respect of environmental remediation. Our principal reportable segments are Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.environmentally friendly.

Note 2. Accounting Policies

Basis of preparation:The consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America on a going concern basis and include all subsidiaries of the Company where the Company has a controlling financial interest. All significant intercompany accounts and balances have been eliminated upon consolidation. In accordance with GAAP in the United States of America, the results of operations of an acquired or disposed business are included or excluded from the consolidated financial statements from the date of acquisition or disposal.

Use of estimates:The preparation of the consolidated financial statements, in accordance with GAAP in the United States of America, requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.

Revenue recognition: Our revenues are primarily derived from the manufacture and sale of specialty chemicals. We recognize revenue when control of the product is transferred to our customer and for an amount that reflects the consideration we expect to collect from the customer. Control is generally transferred to the customer when title transfers (which may include physical possession by the customer), we have a right to payment from the customer, the customer has accepted the product, and the customer has assumed the risks and rewards of ownership. We have supplier managed inventory arrangements with some of our customers to facilitate on-demand product availability. In some cases, the inventory resides at a customer site, although title has not transferred, we are not entitled to payment, and we have not invoiced for the product. We have evaluated the contract terms under these arrangements and have determined that control transfers when the customer uses the product, at which time revenue is recognized. Our contracts generally include one performance obligation, which is providing specialty chemicals. The performance obligation is satisfied at a point in time when products are shipped, delivered, or consumed by the customer, depending on the underlying contracts.

Cash equivalents:Investment securities with maturitiesWhile some of three monthsour customers have payment terms beyond 30 days, we do not provide extended payment terms of a year or less when purchased are considered to be cash equivalents.

Trade and other accounts receivable:The Company records trade and other accounts receivable at net realizable value and maintains allowances for customers not making required payments. The Company determinesmore, nor do our contracts include a financing component. Some of our contracts include variable consideration in the adequacyform of allowances by periodically evaluating each customer receivable considering our customer’s financial condition, credit history and current economic conditions.

Inventories: Inventories are statedrebates. We record rebates at the lowerpoint of cost (FIFO method) or market value. Cost includes materials, labor and an appropriate proportion of plant overheads. The Company accrues volume discounts where it is probable that the required volume will be attained and the amount can be reasonably estimated. The discounts are recordedsale as a reduction in the cost

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

of materials based on projected purchases over the period of the agreement. Inventories are adjusted for estimated obsolescence and written down to market value based on estimates of future demand and market conditions.

Property, plant and equipment:Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is provided over the estimated useful lives of the assets using the straight-line method and is allocated between cost of goods sold and operating expenses. The cost of additions and improvements are capitalized. Maintenance and repairs are charged to expenses as incurred. When assets are sold or retired the associated cost and accumulated depreciation are removed from the consolidated financial statements and any related gain or loss is included in earnings. The estimated useful lives of the major classes of depreciable assets are as follows:

Buildings

7 to 25 years

Equipment

3 to 10 years

Goodwill and other intangible assets: Goodwill and other intangible assets deemed to have indefinite lives are subject to at least annual impairment assessments. Initiallysales when we perform a qualitative assessment to determine whether it is more likely than not thatcan reasonably estimate the fair value of a segment is less than the carrying amount prior to performing thetwo-step goodwill impairment test. If atwo-step test is required we assess the fair value based on projectedpost-tax cash flows discounted at the Company’s weighted average cost of capital. The annual measurement date for impairment assessment of the goodwill relating to the Fuel Specialties, Performance Chemicals and Oilfield Services segments is December 31 each year. The Company capitalizes software development costs, including licenses, subsequent to the establishment of technological feasibility. Other intangible assets deemed to have finite lives, including software development costs and licenses, are amortized using the straight-line method over their estimated useful lives and tested for any potential impairment when events occur or circumstances change which suggest that an impairment may have occurred.

Deferred finance costs:The costs relating to debt financing are capitalized, offset against long-term debt in the consolidated balance sheets and amortized using the effective interest method over the expected life of the debt financing facility. See Note 11 of the Notes to the Consolidated Financial Statements.

Impairment of long-lived assets: The Company reviews the carrying value of its long-lived assets, including buildings and equipment, whenever changes in circumstances suggest that the carrying values may be impaired. In order to facilitate this test the Company groups together assets at the lowest possible level for which cash flow information is available. Undiscounted future cash flows expected to result from the asset groups are compared with the carrying value of the asset groups and if they are lower an impairment loss may be recognized. The amount of the impairment loss is the difference between the fair value and

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

the carrying value of the asset groups. Fair values are determined usingpost-tax cash flows discounted at the Company’s weighted average cost of capital.

Derivative instruments:From time to time,the Company uses various derivative instruments including forward currency contracts, options, interest rate swaps and commodity swaps to manage certain exposures. These instruments are entered into under the Company’s corporate risk management policy to minimize exposure and are not for speculative trading purposes.rebate. The Company recognizes all derivatives as either current ornon-current assets or liabilities in the consolidated balance sheet and measures those instruments at fair value. Changes in the fair value of derivatives that are not designated as hedges, or do not meet the requirements for hedge accounting, are recognized in earnings. Derivatives which are designated as hedges are tested for effectiveness on a quarterly basis, and marked to market. The ineffective portion of the derivative’s change in value is recognized in earnings. The effective portion is recognized in other comprehensive income until the hedged item is recognized in earnings.

Environmental compliance and remediation: Environmental compliance costs include ongoing maintenance, monitoring and similar costs. We recognize environmental liabilities when they are probable and the costs can be reasonably estimated, and asset retirement obligations when there is a legal obligation and the costs can be reasonably estimated. Such accruals are adjusted as further information develops or circumstances change. Costs of future obligations are discounted to their present values using the Company’s historic credit-adjusted risk-free rate.

Revenue recognition: The Company supplies products to customers from its various manufacturing sites and in some instances from containers held on customer sites, under a variety of standard shipping terms and conditions. In each case revenue is recognized when legal title, which is defined and generally accepted in the standard terms and conditions, and the risk of loss transfers between the Company and the customer. Provisions for sales discounts and rebates to customersestimates are based upon the terms of sales contracts and are recorded in the same period as the related sales as a deduction from revenue. The Company accounts for an estimate of the provision required for sales discounts and rebates based on the terms of each agreementour best judgment at the time of revenue recognition.sale, which includes anticipated as well as historical performance.

53


Taxes assessed by a governmental authority which are concurrent with sales to our customers, including sales, use, value-added, and revenue-related excise taxes, are collected by us from the customer and are not included in net sales, but are reflected in accrued liabilities until remitted to the appropriate governmental authority. When we are responsible for shipping and handling costs after title has transferred, we account for those as fulfilment costs and include them in cost of goods sold.

Components of net sales:All amounts billed to customers relating to shipping and handling are classified as net sales. Shipping and handling costs incurred by the Company are classified as cost of goods sold.

Components of cost of goods sold:Cost of goods sold is comprised of raw material costs including inbound freight, duty andnon-recoverable taxes, inbound handling costs associated with the receipt of raw materials, packaging materials, manufacturing costs including labor costs, maintenance and utility costs, plant and engineering overheads, amortization expense for certain other intangible assets, warehousing and outbound shipping costs and handling costs. Inventory losses and provisions and the costs of customer claims are also recognized in the cost of goods line item.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Components of selling, general and administrative expenses:Selling expenses comprise the costs of the direct sales force, and the sales management and customer service departments required to support them. It also comprises commission charges, the costs of sales conferences and trade shows, the cost of advertising and promotions, amortization expense for certain other intangible assets, and the cost of bad and doubtful debts. General and administrative expenses comprise the cost of support functions including accounting, human resources, information technology and the cost of group functions including corporate management, finance, tax, treasury, investor relations and legal departments. Provision of management’s best estimate of legal and settlement costs for litigation in which the Company is involved is accounted for in the administrative expense line item.

Research and development expenses:Research, development and testing costs are expensed to the income statement as incurred.

Earnings per share: Basic earnings per share is based on the weighted average number of common shares outstanding during the period. Diluted earnings per share includes the effect of options that are dilutive and outstanding during the period.

Foreign currencies:The Company’s policy is that foreign exchange differences arising on the translation of the balance sheets of entities that have functional currencies other than the U.S. dollar are taken to a separate equity reserve, the cumulative translation adjustment. In entities where the U.S. dollar is the functional currency no gains or losses on translation occur, and gains or losses on monetary assets relating to currencies other than the U.S. dollar are taken to the income statement in other income/(expense), net. Gains and losses on intercompany foreign currency loans which are long-term in nature, which the Company does not intend to settle in the foreseeable future, are also recorded in accumulated other comprehensive loss. Other foreign exchange gains or losses are also included in other income, net in the income statement.

Stock-basedShare-based compensation plans: The Company accounts for employee stock options and stock equivalent units under the fair value method. Stock options are fair valued at the grant date and the fair value is recognized straight-line over the vesting period of the option. Stock equivalent units are fair valued at each balance sheet date and the fair value is spread over the remaining vesting period of the unit.

Business combinations: The acquisition method of accounting requires that we recognize the assets acquired and liabilities assumed at their acquisition date fair values. Goodwill is measured as the excess

54


of consideration transferred over the acquisition date net fair values of the assets acquired and the liabilities assumed.

The determination of the fair values of certain assets and liabilities are usually based on significant estimates provided by management, such as forecast revenue or profit. In determining the fair value of intangible assets, an income approach is generally used and may incorporate the use of a discounted cash flow method. In applying the discounted cash flow method, the estimated future cash flows and residual values for each intangible asset are discounted to a present value using a discount rate appropriate to the business being acquired. These cash flow projections are based on management’s estimates of economic and market conditions including revenue growth rates, operating margins, capital expenditures and working capital requirements.

Cash equivalents: Investment securities with maturities of three months or less when purchased are considered to be cash equivalents.

Trade and other accounts receivable: The Company records trade and other accounts receivable at net realizable value and maintains allowances for customers not making required payments. The Company determines the adequacy of allowances by periodically evaluating each customer receivable considering our customer’s financial condition, credit history and current economic conditions.

The Company is exposed to credit losses primarily through sales of products. The Company’s expected loss allowance methodology for trade and other accounts receivable is developed using historical collection experience, current and future economic and market conditions and a review of the current status of customers’ receivables. Due to the short-term nature of such receivables, the estimate of accounts receivable amounts that may not be collected is based on aging of the accounts receivable balances and the financial condition of customers. Additionally, a further allowance is included to account for the Company’s historic track record of credit losses, for balances which are not aged sufficiently to be considered under the aging based approach.

Inventories: Inventories are stated at the lower of cost (FIFO method) or market value. Cost includes materials, labor and an appropriate proportion of plant overheads. The Company accrues volume discounts where it is probable that the required volume will be attained and the amount can be reasonably estimated. The discounts are recorded as a reduction in the cost of materials based on projected purchases over the period of the agreement. Inventories are adjusted for estimated obsolescence and written down to market value based on estimates of future demand and market conditions.

Property, plant and equipment: Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is provided over the estimated useful lives of the assets using the straight-line method and is allocated between cost of goods sold and operating expenses. The cost of additions and improvements are capitalized. Maintenance and repairs are charged to expenses as incurred. When assets are sold or retired the associated cost and accumulated depreciation are removed from the consolidated financial statements and any related gain or loss is included in earnings. The estimated useful lives of the major classes of depreciable assets are as follows:

Buildings

7 to 25 years

Equipment

3 to 10 years

 

Goodwill: Goodwill is deemed to have an indefinite life and is subject to at least annual impairment assessments at the reporting unit level. The Company considers that its reporting units are consistent with its reportable segments. The components in each segment (including products, markets and competitors)

55


have similar economic characteristics and the segments, therefore, reflect the lowest level at which operations and cash flows can be sufficiently distinguished, operationally and for financial reporting purposes, from the rest of the Company.

Initially we perform a qualitative assessment to determine whether it is more likely than not (that is, a likelihood of more than 50%) that the fair value of a reportable segment is less than the carrying amount prior to performing a quantitative goodwill impairment test. The annual measurement date for impairment assessment of the goodwill relating to the Performance Chemicals, Fuel Specialties and Oilfield Services segments is December 31 each year. Factors utilized in the qualitative assessment process include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and Company specific events.

If a quantitative test is required, we assess the fair value based on projected post-tax cash flows discounted at the Company’s weighted average cost of capital. These fair value techniques require management judgment and estimates including revenue growth rates, projected operating margins, changes in working capital and discount rates. We would develop these assumptions by considering recent financial performance and industry growth estimates.

Other intangible assets: Other intangible assets are deemed to have finite lives and are amortized using the straight-line method over their estimated useful lives. The Company capitalizes software development costs as intangible assets, including licenses, subsequent to the establishment of technological feasibility. These assets are tested for potential impairment when events occur or circumstances change, which suggest an impairment may have occurred.

In order to facilitate testing for potential impairment the Company groups together assets at the lowest possible level for which cash flow information is available. Undiscounted future cash flows expected to result from the asset groups are compared with the carrying value of the assets and, if such cash flows are lower, an impairment loss may be recognized. The amount of the impairment loss is the difference between the fair value and the carrying value of the assets. Fair values are determined using post-tax cash flows discounted at the Company’s weighted average cost of capital. If events occur or circumstances change it may cause a reduction in the periods over which the assets are amortized or result in a non-cash impairment of their carrying value. A reduction in the amortization periods would have no impact on cash flows.

The estimated useful lives of the major classes of assets are as follows:

Technology

10 to 17 years

Customer lists

10 to 15 years

Brand names

5 to 10 years

Product rights

9 to 10 years

Internally developed software

3 to 10 years

Marketing related

11 years

Leases:We determine if an arrangement is a lease at inception. The present value of the future lease payments for operating leases is included in operating lease right-of-use (“ROU”) assets, and operating lease liabilities (current and non-current) on our consolidated balance sheet at the reporting date. The carrying value of assets under finance leases is included in property, plant and equipment and finance lease liabilities (current and non-current) on our consolidated balance sheet at the reporting date.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of future lease payments over the remaining lease term. Very few of our leases have renewal options or early

56


termination break clauses, but where they do, we have assessed the term of the lease based on any options being exercised only if they are reasonably certain. As most of our leases do not provide an implicit interest rate, we use our incremental borrowing rate based on the information available at point of recognition in determining the present value of future payments.

The operating lease ROU asset excludes lease incentives and initial direct costs incurred. Lease expense for lease payments is recognized on a straight-line basis over the lease term unless payments are variable per the agreement. We do not separate related non-lease components from lease components. Where we have lease payments linked to an index or inflationary rate, this rate has been used to value the asset and liability at the inception of the lease. If the payments are not linked to a specific index or inflationary rate, but can vary during the term of the agreement, they have been included at their actual value for each future period. In some circumstances the future expected payments may be dependent on other factors, for example production volumes, in which case we have used the minimum future expected payments to value the asset.

We do not recognize a ROU asset or operating lease liability for short-term leases (with a length of one year or less), and any associated cost is recognized, as incurred, through the income statement.

Deferred finance costs: The costs relating to debt financing are capitalized and amortized using the effective interest method over the expected life of the debt financing facility. The amortization charge is included in interest expense in the income statement.

Impairment of long-lived assets: The Company reviews the carrying value of its long-lived assets, including buildings and equipment, whenever changes in circumstances suggest that the carrying values may be impaired. In order to facilitate this test, the Company groups together assets at the lowest possible level for which cash flow information is available. Undiscounted future cash flows expected to result from the asset groups are compared with the carrying value of the asset groups and if they are lower an impairment loss may be recognized. The amount of the impairment loss is the difference between the fair value and the carrying value of the asset groups. Fair values are determined using post-tax cash flows discounted at the Company’s weighted average cost of capital.

Derivative instruments: From time to time,the Company uses various derivative instruments including forward currency contracts, options, interest rate swaps and commodity swaps to manage certain exposures. These instruments are entered into under the Company’s corporate risk management policy to minimize exposure and are not for speculative trading purposes. The Company recognizes all derivatives as either current or non-current assets or liabilities in the consolidated balance sheet and measures those instruments at fair value. Changes in the fair value of derivatives that are not designated as hedges, or do not meet the requirements for hedge accounting, are recognized in earnings. Derivatives which are designated as hedges are tested for effectiveness on a quarterly basis and marked to market. The ineffective portion of the derivative’s change in value is recognized in earnings. The effective portion is recognized in other comprehensive income until the hedged item is recognized in earnings.

Plant closure provisions: This includes both environmental compliance and remediation costs. Environmental compliance costs include ongoing maintenance, monitoring and similar costs and extend to environmental liabilities that result from other-than-normal operation of long-lived assets, for example pollution. Remediation costs relate to asset retirement obligations at our current and former manufacturing sites following retirement of the long-lived assets, linked to their normal operation. We recognize environmental remediation liabilities when they are probable and the costs can be reasonably estimated, and asset retirement obligations when there is an obligation based on a legal requirement, including those

57


arising from a Company promise, and the costs can be reasonably estimated. The vast majority of our plant closure provision relates to our Ellesmere Port site in the United Kingdom.

The Company must comply with environmental legislation in the countries in which it operates or has operated in and annually reassesses the program of work required. This includes estimating the credit-adjusted risk-free rate and the timing and cost of performing the remediation work. Management receives input from specialists to develop these estimates and assumptions utilizing the latest information available together with experience of recent costs. While we believe our assumptions for the liabilities are reasonable, they are subjective estimates and it is possible that variations in any of the assumptions will result in materially different calculations to the liabilities we have reported. Costs of future obligations are discounted to their present values using the Company’s credit-adjusted risk-free rate.

Pension plans and other post-employment benefits:The Company recognizes the funded status of defined benefit post-retirement plans on the consolidated balance sheets and changes in the funded status in comprehensive income. The measurement date of the plan’s funded status is the same as the Company’s fiscalyear-end. The service costs are recognized as employees render the services necessary to earn the post-employment benefits. Prior service costs and credits and actuarial gains and losses are amortized over the average remaining life expectancy of the inactive participants using the corridor method.

The insurance contracts are adjusted each reporting period to reflect the estimated fair value of the premium that would be paid for such contracts at that time.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)In May 2022, the Trustees of the United Kingdom defined benefit pension plan (“UK Plan”) entered into an agreement with Legal and General Assurance Society Limited to acquire an insurance policy that operates as an investment asset, with the intent of matching the remaining uninsured part of the UK Plan’s future cash outflow arising from the accrued pension liabilities of members. Such an arrangement is commonly termed as a “buy-in”. The benefit obligation was not transferred to the insurer, and the Company remains responsible for paying pension benefits. The initial value of the asset associated with this contract was equal to the premium paid to secure the contract and is adjusted each reporting period to reflect the estimated fair value of the premium that would be paid for such a contract at that time. The buy-in reduces the UK Plan’s value at risk in relation to key risks associated with improved longevity, inflation and interest rate movements while improving the security to the UK Plan and its members. The Company consequently benefits from the buy-in as it reduces the UK Plan’s potential reliance on the Company for future cash funding requirements.

Movements in the Projected Benefit Obligation (“PBO”) are dependent on our assumptions in respect of the discount rate, annual member mortality rates, future return on assets and future inflation.

Income taxes:The Company provides for income taxes by recognizing deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement carrying amounts and the relevant tax bases of the assets and liabilities. Then theThe Company then evaluates the need for a valuation allowance to reduce deferred tax assets to the amount more likely than not to be realized. The effect on deferred taxes of a change in tax rates is recognized in the period that includes the enactment date. The Company recognizes the tax benefit from a tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50 percent50% likelihood of being realized upon settlement. Changes in recognition or measurement are reflected in the period in which the change injudgment occurs. The Company recognizes accrued interest and penalties associated with unrecognized tax benefits as part of income taxes in our consolidated statements of income.income.

58


Note 3. Segment Reporting and Geographical Area Data

The Performance Chemicals, Fuel Specialties Performance Chemicals and Oilfield Services segments operate in markets where we actively seek growth opportunities although their ultimate customers are different. The Octane Additives

Our Performance Chemicals segment is expected to declineprovides effective technology-based solutions for our customers’ processes or products focused in the near future as our one remaining refinery customer transitions to unleaded fuel.personal care, home care, agrochemical, construction, mining and other industrial markets.

Our Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemicals products used as additives to a wide range of fuels.

Our Performance Chemicals segment provides effective technology-based solutions for our customers’ processes or products focused in the Personal Care, Home Care, Agrochemical and Mining markets.

Our Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations, chemical solutions for fracturing, drilling, stimulation and stimulationcompletion operations, and products for oil and gas production and transport which aid flow assurance and maintain asset integrity.

Our Octane AdditivesIn 2023, the Company had a significant customer in the Oilfield Services segment which we believe is the world’s only producer of tetra ethyl lead (“TEL”), comprises sales of TELaccounted for use in automotive gasoline and provides services in respect of environmental remediation.

There are no significant customers with sales greater than 10%$265.2 million (13.6%) of our net group sales in the last three financial years.

(2022 - $222.2 million and 11.3%).

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The Company evaluates the performance of its segments based on operating income. The following table analyzes sales and other financial information by the Company’s reportable segments:

(in millions)

  2017   2016   2015 

 

2023

 

 

2022

 

 

2021

 

Net Sales:

      

 

 

 

 

 

 

 

 

 

Personal Care

 

$

352.7

 

 

$

393.3

 

 

$

296.1

 

Home Care

 

 

86.8

 

 

 

94.2

 

 

 

93.0

 

Other

 

 

122.1

 

 

 

152.2

 

 

 

136.2

 

Performance Chemicals

 

 

561.6

 

 

 

639.7

 

 

 

525.3

 

Refinery and Performance

  $397.0   $388.9   $408.0 

 

 

540.6

 

 

 

552.6

 

 

 

445.3

 

Other

   126.8    120.7    124.8 

 

 

155.3

 

 

 

177.6

 

 

 

173.0

 

Fuel Specialties

 

 

695.9

 

 

 

730.2

 

 

 

618.3

 

Oilfield Services

 

 

691.3

 

 

 

593.8

 

 

 

339.8

 

  

 

   

 

   

 

 

 

$

1,948.8

 

 

$

1,963.7

 

 

$

1,483.4

 

Operating income/(expense):

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

$

54.5

 

 

$

95.3

 

 

$

70.9

 

Fuel Specialties

   523.8    509.6    532.8 

 

 

109.7

 

 

 

121.7

 

 

 

104.6

 

Oilfield Services

 

 

78.6

 

 

 

41.7

 

 

 

10.4

 

Corporate costs

 

 

(81.2

)

 

 

(71.4

)

 

 

(55.6

)

Profit on disposal

 

 

 

 

 

 

 

 

1.8

 

Total operating income

 

$

161.6

 

 

$

187.3

 

 

$

132.1

 

Identifiable assets at year-end:

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

$

580.1

 

 

$

610.4

 

 

$

469.5

 

Fuel Specialties

 

 

529.2

 

 

 

500.6

 

 

 

571.3

 

Oilfield Services

 

 

310.8

 

 

 

297.8

 

 

 

230.8

 

Corporate

 

 

287.3

 

 

 

194.9

 

 

 

299.3

 

  

 

   

 

  ��

 

 

 

$

1,707.4

 

 

$

1,603.7

 

 

$

1,570.9

 

Personal Care

   200.0    126.8    119.6 

Home Care

   121.1    2.0    0.0 

Fragrances

   0.0    0.0    23.0 

Other

   98.4    9.9    12.4 
  

 

   

 

   

 

 

Performance Chemicals

   419.5    138.7    155.0 
  

 

   

 

   

 

 

Oilfield Services

   304.4    191.7    265.0 

Octane Additives

   59.1    43.4    59.5 
  

 

   

 

   

 

 
  $1,306.8   $883.4   $1,012.3 
  

 

   

 

   

 

 

59


NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(in millions)

  2017  2016  2015 

Gross profit:

    

Fuel Specialties

  $188.2  $186.4  $176.0 

Performance Chemicals

   75.8   43.4   42.4 

Oilfield Services

   109.3   76.4   99.1 

Octane Additives

   30.0   26.1   28.5 
  

 

 

  

 

 

  

 

 

 
  $403.3  $332.3  $346.0 
  

 

 

  

 

 

  

 

 

 

Operating income/(expense):

    

Fuel Specialties

  $107.1  $110.6  $102.1 

Performance Chemicals

   32.6   16.0   16.3 

Oilfield Services

   9.5   (4.7  9.0 

Octane Additives

   26.7   22.7   24.7 

Pension credit

   4.4   6.7   0.2 

Corporate costs

   (47.9  (53.9  (38.3

Adjustment to fair value of contingent consideration

   0.0   9.4   40.7 

(Loss)/profit on disposal of subsidiary

   (0.9  (1.4  1.6 

Foreign exchange loss on liquidation of subsidiary

   (1.8  0.0   0.0 
  

 

 

  

 

 

  

 

 

 

Total operating income

  $129.7  $105.4  $156.3 
  

 

 

  

 

 

  

 

 

 

Identifiable assets at year end:

    

Fuel Specialties

  $437.0  $397.2  $408.9 

Performance Chemicals

   480.8   340.0   120.2 

Oilfield Services

   256.6   240.0   240.9 

Octane Additives

   41.7   38.1   28.7 

Corporate

   194.1   166.1   229.9 
  

 

 

  

 

 

  

 

 

 
  $1,410.2  $1,181.4  $1,028.6 
  

 

 

  

 

 

  

 

 

 

The pension credit relates to the United Kingdom defined benefit pension plan which is closed to future service accrual. The charges related to our other much smaller pension arrangements in the U.S. and overseas are included in the segment and income statement captions consistent with the related employees’ costs.

The Company includes within the corporate costs line item the costs of:

managing the Groupgroup as a company with securities listed on the NASDAQ and registered with the SEC;

the President/CEO’s office, group finance, group human resources, group legal and compliance counsel, and investor relations;

running the corporate offices in the U.S. and Europe;

the corporate development function since they do not relate to the current trading activities of our other reporting segments; and

the corporate share of the information technology, product technology, safety, health, environment, accounting and human resources departments.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following tables analyze sales and other financial information by location:

(in millions)

  2017 2016 2015 

 

2023

 

 

2022

 

 

2021

 

Net sales by source:

    

 

 

 

 

 

 

 

 

 

United States & North America

  $615.7  $474.4  $571.9 

 

$

1,272.8

 

 

$

1,244.9

 

 

$

821.6

 

United Kingdom

   730.9   428.2   445.2 

Rest of Europe

   143.4   118.5   133.3 

Europe

 

 

958.9

 

 

 

1,049.4

 

 

 

927.5

 

Rest of World

   39.2   31.1   22.1 

 

 

51.0

 

 

 

67.7

 

 

 

66.4

 

Sales between areas

   (222.4  (168.8  (160.2

 

 

(333.9

)

 

 

(398.3

)

 

 

(332.1

)

  

 

  

 

  

 

 

 

$

1,948.8

 

 

$

1,963.7

 

 

$

1,483.4

 

  $1,306.8  $883.4  $1,012.3 
  

 

  

 

  

 

 

Income before income taxes:

    

 

 

 

 

 

 

 

 

 

United States & North America

  $11.5  $16.8  $52.7 

 

$

107.8

 

 

$

109.1

 

 

$

54.6

 

United Kingdom

   51.9   42.6   60.6 

Rest of Europe

   63.1   39.2   42.0 

Europe

 

 

81.7

 

 

 

68.4

 

 

 

72.5

 

Rest of World

   1.6   4.5   (3.0

 

 

(15.1

)

 

 

7.1

 

 

 

7.3

 

  

 

  

 

  

 

 

 

$

174.4

 

 

$

184.6

 

 

$

134.4

 

  $128.1  $103.1  $152.3 
  

 

  

 

  

 

 

Long-lived assets at year end:

    

Long-lived assets at year-end:

 

 

 

 

 

 

 

 

 

United States & North America

  $149.7  $155.3  $185.8 

 

$

156.4

 

 

$

147.0

 

 

$

137.3

 

United Kingdom

   45.7   45.9   49.3 

Rest of Europe

   163.5   207.5   10.6 

Europe

 

 

193.9

 

 

 

163.0

 

 

 

167.4

 

Rest of World

   0.3   0.5   0.4 

 

 

17.3

 

 

 

0.2

 

 

 

0.2

 

  

 

  

 

  

 

 

 

$

367.6

 

 

$

310.2

 

 

$

304.9

 

  $359.2  $409.2  $246.1 
  

 

  

 

  

 

 

Identifiable assets at year end:

    

Identifiable assets at year-end:

 

 

 

 

 

 

 

 

 

United States & North America

  $452.2  $377.3  $410.9 

 

$

630.2

 

 

$

570.9

 

 

$

464.9

 

United Kingdom

   258.4   257.6   303.4 

Rest of Europe

   317.5   156.0   30.9 

Europe

 

 

605.9

 

 

 

626.3

 

 

 

698.4

 

Rest of World

   20.3   15.7   16.0 

 

 

72.0

 

 

 

47.7

 

 

 

43.3

 

Goodwill

   361.8   374.8   267.4 

 

 

399.3

 

 

 

358.8

 

 

 

364.3

 

  

 

  

 

  

 

 

 

$

1,707.4

 

 

$

1,603.7

 

 

$

1,570.9

 

  $1,410.2  $1,181.4  $1,028.6 
  

 

  

 

  

 

 

Sales by geographical area are reported by source, being where the transactions originated. Intercompany sales are priced using an appropriate pricing methodology and are eliminated in the consolidated financial statements.

Identifiable assets are those directly associated with the operations of the geographical area.

Goodwill has not been allocated by geographical location on the grounds that it would be impracticable to do so.

60


NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Note 4.    Acquisition of European Differentiated Surfactants business

On December 30, 2016, the Company acquired the European Differentiated Surfactants business (“Huntsman”) from Huntsman Investments (Netherlands) B.V.. We purchased the business for a total consideration of $200.2 million. We acquired the business in order to continue our strategy of building our presence in the Personal Care and Home Care markets which form part of our Performance Chemicals segment.

During the year we have reviewed the fair values of assets acquired and liabilities assumed based on information becoming available after our previous filing, resulting in a $23.1 million increase in assets acquired and a corresponding decrease in goodwill in relation to the recognition of customer relationships offset by an increase in deferred taxation liabilities. The final working capital adjustments of $2.6 million were agreed in the third quarter of 2017.

Huntsman, and the associated goodwill, are included within our Performance Chemicals segment for management and reporting purposes. There is currently no goodwill amortizable for tax purposes.

Note 5.4. Earnings per Share

Basic earnings per share is based on the weighted average number of common shares outstanding during the period. Diluted earnings per share includes the effect of options that are dilutive and outstanding during the period. Per share amounts are computed as follows:

 

  2017   2016   2015 

 

2023

 

 

2022

 

 

2021

 

Numerator (in millions):

      

 

 

 

 

 

 

 

 

 

Net income available to common stockholders

  $61.8   $81.3   $119.5 

 

$

139.1

 

 

$

133.0

 

 

$

93.1

 

  

 

   

 

   

 

 

Denominator (in thousands):

      

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

   24,148    23,998    24,107 

 

 

24,851

 

 

 

24,787

 

 

 

24,647

 

Dilutive effect of stock options and awards

   338    444    505 

 

 

171

 

 

 

195

 

 

 

207

 

  

 

   

 

   

 

 

Denominator for diluted earnings per share

   24,486    24,442    24,612 

 

 

25,022

 

 

 

24,982

 

 

 

24,854

 

  

 

   

 

   

 

 

Net income per share, basic:

  $2.56   $3.39   $4.96 

 

$

5.60

 

 

$

5.37

 

 

$

3.78

 

  

 

   

 

   

 

 

Net income per share, diluted:

  $2.52   $3.33   $4.86 

 

$

5.56

 

 

$

5.32

 

 

$

3.75

 

  

 

   

 

   

 

 

In 2017, 20162023, 2022 and 20152021 the average number of anti-dilutive options excluded from the calculation of diluted earnings per share were 9,422, 020,334, 79,145 and 018,378 respectively.

Note 5. Acquisition of QGP Química Geral

On December 8, 2023, the Company acquired QGP Química Geral (“QGP”). The Company purchased the business for a total consideration of $58.0 million, net of cash acquired, and subject to working capital adjustments. A portion of the consideration is deferred and payable in cash by December 7, 2026, and contingent on the financial performance of QGP for the 12 months ended June 30, 2026. The fair value of this deferred, contingent consideration at December 31, 2023 is $23.4 million. This deferred, contingent consideration will be updated at each balance sheet date based on latest available information.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)We acquired the business to further strengthen our Performance Chemicals segment and add a manufacturing base in South America to compliment all of our end markets.

The revenue and earnings for QGP included in the consolidated income statement of the Company since the acquisition date, are immaterial to the group's results and financial position, due to the proximity of the acquisition to the reporting date.

The following table summarizes the calculations of the total purchase price and the estimated allocation of the purchase price to the provisional assets acquired and liabilities assumed for the business:

(in millions)

 

QGP

 

Goodwill

 

$

37.4

 

Other intangible assets

 

 

7.3

 

Deferred tax on other intangible assets

 

 

(2.5

)

Net property, plant and equipment

 

 

9.6

 

Other net assets acquired

 

 

6.2

 

Purchase price, net of cash acquired

 

$

58.0

 

The measurement periods for the valuation of assets acquired and liabilities assumed ends as soon as information on the facts and circumstances that existed as of the acquisition dates becomes available but

61


does not exceed twelve months. We have reviewed the acquired intangibles associated with the acquisition and concluded that the main identifiable asset is in relation to customer lists. Based on current information available to management, we do not expect there to be any other material intangible assets other than goodwill. We have engaged a third-party to assess the fair value of the intangible assets and acquired fixed assets. This assessment has not been finalized due to the proximity of the acquisition to the filing date. Accordingly, a provisional amount based on previous acquisitions and management’s best current estimate has been included for customer lists with the remaining purchase price above the book value of fixed assets and other net assets acquired being allocated to goodwill at this stage. We have provisionally estimated the expected useful life of the other intangible assets to be 10 years. We have not completed our alignment of accounting policies or fair value review on the other net assets acquired at this stage, but any potential adjustments would not have a material impact on the reported figures.

QGP, and the associated goodwill, are included within our Performance Chemicals segment for management and reporting purposes. There is currently no goodwill amortizable for tax purposes.

Supplemental unaudited pro forma information

For illustrative purposes only pro forma information of the enlarged group is provided below but is not necessarily indicative of what the financial position or results of operations would have been had the QGP acquisition been completed as part of the Company from January 1, 2021. In addition, the unaudited pro forma financial information is not indicative of, nor does it purport to project, the future financial position of operating results of the enlarged group.

(in millions, except per share data)

 

2023

 

 

2022

 

 

2021

 

Net sales

 

$

2,001.7

 

 

$

2,017.9

 

 

$

1,527.9

 

Net income

 

$

145.1

 

 

$

140.7

 

 

$

98.2

 

Earnings per share – basic

 

$

5.84

 

 

$

5.68

 

 

$

3.99

 

                              – diluted

 

$

5.80

 

 

$

5.63

 

 

$

3.95

 

Adjustments to the unaudited pro forma financial information includes amortization in respect of the acquired other intangible assets, and the acquisition-related costs incurred in respect of the transaction.

Note 6. Property, Plant and Equipment

Property, plant and equipment consists of the following:

(in millions)

  2017 2016 

 

2023

 

 

2022

 

Land

  $17.7  $7.2 

 

$

22.8

 

 

$

20.6

 

Buildings

   44.0   37.8 

 

 

81.9

 

 

 

68.7

 

Equipment

   249.4   192.6 

 

 

418.1

 

 

 

377.5

 

Work in progress

   16.1   14.2 

 

 

69.5

 

 

 

45.7

 

  

 

  

 

 
   327.2   251.8 

Less accumulated depreciation

   (131.2  (94.4
  

 

  

 

 
  $196.0  $157.4 
  

 

  

 

 

Total gross cost

 

 

592.3

 

 

 

512.5

 

Less accumulated depreciation and impairment

 

 

(324.0

)

 

 

(291.6

)

Total net book value

 

$

268.3

 

 

$

220.9

 

Following the Huntsman acquisition, we have recognized $2.8 million of asset retirement obligations as an increase in the value of the tangible assets acquired, which will be depreciated over the remaining useful economic life of those assets.

Of the total net book value of equipment at December 31, 2017 $6.22023, $0.0 million (2016 – $4.4 million) are in respect of assets held under finance leases.leases (2022 – $0.0 million).

62


Depreciation charges were $21.4$27.9 million, $13.5$25.7 million and $13.0$26.3 million in 2017, 20162023, 2022 and 2015,2021, respectively.

The estimated additional cost to complete work in progress is $2.3 million (2016 – $9.5 million).

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Note 7. GoodwillLeases

We have operating and finance leases for toll manufacturing facilities, warehouse storage, land, buildings, plant and equipment. Our leases have remaining lease terms of up to 22 years, some of which include options to terminate the leases within 1 year.

The components of lease expense were as follows:

(in millions)

 

Twelve Months
Ended December 31

 

 

Twelve Months
Ended December 31

 

 

Twelve Months
Ended December 31

 

 

2023

 

 

2022

 

 

2021

 

Finance lease cost:

 

 

 

 

 

 

 

 

 

   Amortization of right-of-use assets

 

$

 

 

$

 

 

$

0.5

 

   Interest on lease liabilities

 

 

 

 

 

 

 

 

 

Total finance lease cost

 

 

 

 

 

 

 

 

0.5

 

Operating lease cost

 

 

17.9

 

 

 

15.6

 

 

 

13.8

 

Short-term lease cost

 

 

8.1

 

 

 

7.2

 

 

 

3.8

 

Variable lease cost

 

 

 

 

 

0.3

 

 

 

0.3

 

Total lease cost

 

$

26.0

 

 

$

23.1

 

 

$

18.4

 

Supplemental cash flow information related to leases is as follows:

(in millions)

 

Twelve Months
Ended December 31

 

 

Twelve Months
Ended December 31

 

 

Twelve Months
Ended December 31

 

 

2023

 

 

2022

 

 

2021

 

Cash paid for amounts included in the
   measurement of lease liabilities:

 

 

 

 

 

 

 

 

 

Operating cash flows from operating leases

 

$

26.1

 

 

$

23.1

 

 

$

18.1

 

Operating cash flows from finance leases

 

 

 

 

 

0.1

 

 

 

0.5

 

Right-of-use assets obtained in exchange for new
   lease obligations:

 

 

 

 

 

 

 

 

 

Operating leases

 

$

7.8

 

 

$

14.9

 

 

$

5.2

 

63


Supplemental balance sheet information related to leases is as follows:

(in millions except lease term and discount rate)

 

December 31,
2023

 

 

December 31,
2022

 

Operating leases:

 

 

 

 

 

 

Operating lease right-of-use assets

 

$

45.1

 

 

$

45.3

 

Current portion of operating lease liabilities

 

$

13.6

 

 

$

13.9

 

Operating lease liabilities, net of current portion

 

 

31.6

 

 

 

31.4

 

Total operating lease liabilities

 

$

45.2

 

 

$

45.3

 

Weighted average remaining lease term:

 

 

 

 

 

 

Operating leases

 

6.2 years

 

 

5.5 years

 

Weighted average discount rate:

 

 

 

 

 

 

Operating leases

 

 

3.5

%

 

 

2.6

%

Maturities of lease liabilities were as follows as at December 31, 2023:

(in millions)

 

Operating
Leases

 

Within one year

 

$

14.0

 

Year two

 

 

10.0

 

Year three

 

 

7.3

 

Year four

 

 

3.3

 

Year five

 

 

3.0

 

Thereafter

 

 

12.6

 

Total lease payments

 

 

50.2

 

Less imputed interest

 

 

(5.0

)

Total

 

$

45.2

 

As of December 31, 2023, additional operating and finance leases that have not yet commenced are $5.8 million.

Future lease payment for all non-cancellable operating and finance leases as of December 31, 2022 were as follows:

(in millions)

 

Operating
Leases

 

Within one year

 

$

14.3

 

Year two

 

 

8.9

 

Year three

 

 

6.4

 

Year four

 

 

5.2

 

Year five

 

 

1.5

 

Thereafter

 

 

13.5

 

Total lease payments

 

 

49.8

 

Less imputed interest

 

 

(4.5

)

Total

 

$

45.3

 

As of December 31, 2022, additional operating and finance leases that have not yet commenced are $2.7 million.

64


Note 8. Goodwill

The following table analyzes goodwill movement for 20172023 and 2016.2022.

(in millions)

  Fuel
Specialties
   Performance
Chemicals
 Oilfield
Services
   Octane
Additives
 Total 

 

Performance
Chemicals

 

 

Fuel
Specialties

 

 

Oilfield
Services

 

 

Total

 

At December 31, 2015

        

Gross cost(1)

  $207.9   $22.2  $37.3   $236.5  $503.9 

At December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

Gross cost

 

$

111.9

 

 

$

207.6

 

 

$

44.8

 

 

$

364.3

 

Accumulated impairment losses

   0.0    0.0   0.0    (236.5  (236.5

 

 

 

 

 

 

 

 

 

 

 

 

  

 

   

 

  

 

   

 

  

 

 

Net book amount

  $207.9   $22.2  $37.3   $0.0  $267.4 

 

$

111.9

 

 

$

207.6

 

 

$

44.8

 

 

$

364.3

 

  

 

   

 

  

 

   

 

  

 

 

Exchange effect

 

 

(5.4

)

 

 

(0.1

)

 

 

 

 

 

(5.5

)

At December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Gross cost

 

$

106.5

 

 

$

207.5

 

 

$

44.8

 

 

$

358.8

 

Accumulated impairment losses

 

 

 

 

 

 

 

 

 

 

 

 

Net book amount

 

$

106.5

 

 

$

207.5

 

 

$

44.8

 

 

$

358.8

 

Additions

   0.0    107.4   0.0    0.0   107.4 

 

 

37.4

 

 

 

 

 

 

 

 

 

37.4

 

At December 31, 2016

        

Gross cost(1)

  $207.9   $129.6  $37.3   $236.5  $611.3 

Exchange effect

 

 

3.0

 

 

 

0.1

 

 

 

 

 

 

3.1

 

At December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Gross cost

 

$

146.9

 

 

$

207.6

 

 

$

44.8

 

 

$

399.3

 

Accumulated impairment losses

   0.0    0.0   0.0    (236.5  (236.5

 

 

 

 

 

 

 

 

 

 

 

 

  

 

   

 

  

 

   

 

  

 

 

Net book amount

  $207.9   $129.6  $37.3   $0.0  $374.8 

 

$

146.9

 

 

$

207.6

 

 

$

44.8

 

 

$

399.3

 

  

 

   

 

  

 

   

 

  

 

 

Exchange effect

   0.0    10.2   0.0    0.0   10.2 

Measurement period adjustment

   0.0    (23.1  0.0    0.0   (23.1

At December 31, 2017

        

Gross cost(1)

  $207.9   $116.6  $37.3   $236.5  $598.3 

Accumulated impairment losses

   0.0    0.0   0.0    (236.5  (236.5
  

 

   

 

  

 

   

 

  

 

 

Net book amount

  $207.9   $116.6  $37.3   $0.0  $361.8 
  

 

   

 

  

 

   

 

  

 

 

(1)Gross cost is net of $8.7 million, $0.3 million and $289.5 million of historical accumulated amortization in respect of the Fuel Specialties, Performance Chemicals and Octane Additives reporting segments, respectively.

During the year we have reviewed the fair values of assets acquired and liabilities assumed for our Huntsman acquisition within our Performance Chemicals segment, based on information becoming available after our previous filing, resulting in a $23.1 million increase in assets acquired and a corresponding decrease in goodwill.

The Company’s reporting units, the level at which goodwill is tested for impairment, are consistent with the reportable segments: Performance Chemicals, Fuel Specialties and Oilfield Services.

On December 8, 2023, the Company acquired QGP. This resulted in additional goodwill of $37.4 million recognized within our Performance Chemicals Oilfield Services and Octane Additives. segment. See Note 5 of the Notes to the Consolidated Financial Statements for further details.

The components in each segment (including products, markets and competitors) have similar economic characteristics and the segments, therefore, reflect the lowest level at which operations and cash flows can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the Company.

The Company assesses goodwill for impairment on at least an annual basis, initially based on a qualitative assessment to determine whether it is more likely than not that the fair value of a segment is less than the carrying amount. If a potential impairment is identified, then atwo-stepan impairment test is followed.

performed.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The Company performed its annual impairment assessment in respect of goodwill as at December 31, 2017, 20162023, 2022 and 2015.2021. Our impairment assessment concluded that there had been no impairment of goodwill in respect of those reporting units.

We believe that where appropriate the assumptions used in our impairment assessments are reasonable, but that they are judgmental, and variations in any of the assumptions may result in materially different calculations of any potential impairment charges.

65


Note 8.9. Other Intangible Assets

OtherThe following table analyzes other intangible assets comprise the following:movement for 2023 and 2022.

(in millions)

  2017   2016 

Gross cost:

    

– Product rights

  $34.0   $34.0 

– Brand names

   8.9    8.9 

– Technology

   55.1    55.1 

– Customer and distributor relationships

   127.5    85.1 

– Patents

   2.9    2.9 

Non-compete agreements

   4.1    4.1 

– Marketing related

   22.1    22.1 

– Internally developed software

   41.2    36.4 
  

 

 

   

 

 

 
   295.8    248.6 
  

 

 

   

 

 

 

(in millions)

 

2023

 

 

2022

 

Gross cost at January 1

 

$

291.1

 

 

$

295.2

 

Additions

 

 

22.4

 

 

 

2.7

 

Written down in the year

 

 

 

 

 

(4.1

)

Exchange effect

 

 

1.6

 

 

 

(2.7

)

Gross cost at December 31

 

 

315.1

 

 

 

291.1

 

Accumulated amortization at January 1

 

 

(246.1

)

 

 

(237.7

)

Amortization expense

 

 

(10.6

)

 

 

(14.0

)

Written down in the year

 

 

 

 

 

4.1

 

Exchange effect

 

 

(1.1

)

 

 

1.5

 

Accumulated amortization at December 31

 

 

(257.8

)

 

 

(246.1

)

Net book amount at December 31

 

$

57.3

 

 

$

45.0

 

Accumulated amortization:

    

– Product rights

   (16.4   (12.6

– Brand names

   (4.4   (3.2

– Technology

   (15.7   (12.3

– Customer and distributor relationships

   (43.2   (32.5

– Patents

   (2.9   (2.9

Non-compete agreements

   (4.1   (3.4

– Marketing related

   (22.1   (21.2

– Internally developed software

   (23.7   (16.1
  

 

 

   

 

 

 
   (132.5   (104.2
  

 

 

   

 

 

 
  $163.3   $144.4 
  

 

 

   

 

 

 

Product rights

Following the acquisition of Chemsil on August 30, 2013, the Company recognized an intangible asset of $34.0 million in respect of Chemsil’s product rights portfolio. This asset has an expected life of 9 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

An amortization expense of $3.8 million was recognized in 2017 (2016 – $3.8 million) in selling, general and administrative expenses.

Brand names

Following the acquisition of Independence on October 27, 2014, the Company recognized an intangible asset of $6.0 million in respect of Independence’s brand name. This asset has an expected life of 10 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

Following the acquisition of Bachman on November 4, 2013, the Company recognized an intangible asset of $2.9 million in respect of Bachman’s brand names. This asset has an expected life of 5 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

An amortization expense of $1.2 million was recognized in 2017 (2016 – $1.2 million) in selling, general and administrative expenses.

Technology

Following the acquisition of Independence on October 27, 2014, the Company recognized an intangible asset of $26.0 million in respect of Independence’s product formulations. This asset has an expected life of 15 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

Following the acquisition of Bachman on November 4, 2013, the Company recognized an intangible asset of $8.5 million in respect of Bachman’s core chemistryknow-how of oilfield chemicals. This asset has an expected life of 15 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

Following the acquisition of Strata on December 24, 2012, the Company recognized an intangible asset of $18.3 million in respect of technologicalknow-how of the mixing and manufacturing process, patents which protect the technology and the associated product branding. This asset has an expected life of 16.5 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

An amortization expense of $3.4 million was recognized in 2017 (2016 – $3.4 million) in cost of goods sold.

Customer and distributor relationships

On August 9, 2017, the Company acquired an intangible asset from Huntsman Holland B.V. for $4.2 million in respect of long-term customer and distributor relationships in ASPAC and America. This asset has a weighted average expected life of 10 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

On March 31, 2017 the Company recognized an intangible asset of $33.5 million in respect of long-term customer relationships relating to the Huntsman acquisition on December 30, 2016. This asset has a weighted average expected life of 10 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

Following the acquisition of Independence on October 27, 2014, the Company recognized an intangible asset of $29.2 million in respect of Independence’s long-term customer relationships. This asset has a weighted average expected life of 10 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

Following the acquisition of Bachman on November 4, 2013, the Company recognized an intangible asset of $14.5 million in respect of Bachman’s long-term customer relationships. This asset has a weighted average expected life of 14.5 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

Following the acquisition of Strata on December 24, 2012, the Company recognized an intangible asset of $28.2 million in respect of long-term customer relationships. This asset has an expected life of 11.5 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

Following the acquisition of Finetex (now merged into Innospec Active Chemicals LLC) in January 2005, the Company recognized an intangible asset of $4.2 million in relation to customer lists acquired. This asset has an expected life of 13 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

An amortization expense of $10.7 million was recognized in 2017 (2016 – $6.8 million) in selling, general and administrative expenses.

Non-compete agreements

Following the acquisition of Independence on October 27, 2014, the Company recognized an intangible asset of $2.6 million in respect of anon-compete agreement. This asset has an expected life of 3 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

Following the acquisition of Strata on December 24, 2012, the Company recognized an intangible asset of $1.5 million in respect of anon-compete agreement. This asset had an expected life of 2 years and is now fully amortized.

An amortization expense of $0.7 million was recognized in 2017 (2016 – $0.9 million) in selling, general and administrative expenses.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Marketing related

An intangible asset of $28.4 million was recognized in the second quarter of 2007 in respect of Ethyl Corporation foregoing their entitlement effective April 1, 2007 to a share of the future income stream under the sales and marketing agreements to market and sell TEL. In 2008, contract provisions no longer deemed necessary of $6.3 million were offset against the intangible asset. The amount attributed to the Octane Additives reporting segment was amortized straight-line to December 31, 2013 and the amount attributed to the Fuel Specialties reporting segment was amortized straight-line to December 31, 2017.

An amortization expense of $0.9 million was recognized in 2017 (2016 – $0.9 million) in cost of goods sold.

Internally developed software

In September 2017 we completed the implementation of our new information system platform for our acquired Huntsman businesses. At December 31, 2017 we had capitalized $4.4 million (2016 – $0.0 million) in relation to this internally developed software. This asset has an expected life of 5 years and is being amortized on a straight-line basis over this period. No residual value is anticipated.

In August 2017 we completed the implementation of our existing information system platform at two of our reporting entities in the United States for a cost of $0.3 million. At December 31, 2017 we had capitalized $36.7 million (2016 – $36.4 million) in relation to the phased deployment of this internally developed software to the majority of entities in the group which began in 2013. This asset has an expected life of 5 years from the point in time each deployment is completed and is being amortized on a straight-line basis over these periods. No residual value is anticipated.

An amortization expense of $7.6 million was recognized in 2017 (2016 – $7.3 million) in selling, general and administrative expenses.

Amortization expense

The aggregate of other intangible asset amortization expense was $28.3$10.6 million, $24.2$14.0 million and $21.0$16.0 million in 2017, 20162023, 2022 and 2015, respectively,2021, respectively. Excluding the impact of which $4.3foreign exchange translation on the balance sheet, $2.3 million, $4.3$2.3 million and $4.4$2.3 million of amortization, respectively, was recognized in cost of goods sold, and the remainder was recognized in selling, general and administrative expenses.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)In 2023, we capitalized $15.1 million (2022 - $2.7 million) in relation to our internally developed software for a new Enterprise Resource Planning (“ERP”) system covering our EMEA and ASPAC regions. The expenses capitalized include the acquisition costs for the software as well as the external and internal costs of the development. The additional completion costs are currently expected to be approximately $8.9 million. A timescale and plan for the further implementation of the new ERP system into our other regions has not yet been fully determined at this time.

In 2023, we capitalized $7.3 million in relation to the acquisition of QGP. See Note 5 of the Notes to the Consolidated Financial Statements for further details.

Other intangible assets at December 31, 2023 were:

(in millions)

 

Gross
carrying
amount

 

 

Accumulated
amortization

 

Product rights

 

$

34.0

 

 

$

(34.0

)

Brand names

 

 

8.9

 

 

 

(8.4

)

Technology

 

 

55.1

 

 

 

(42.3

)

Customer relationships

 

 

131.6

 

 

 

(105.4

)

Internally developed software

 

 

60.5

 

 

 

(42.7

)

Other

 

 

25.0

 

 

 

(25.0

)

 

 

$

315.1

 

 

$

(257.8

)

66


Other intangible assets at December 31, 2022 were:

(in millions)

 

Gross
carrying
amount

 

 

Accumulated
amortization

 

Product rights

 

$

34.0

 

 

$

(34.0

)

Brand names

 

 

8.9

 

 

 

(7.8

)

Technology

 

 

55.1

 

 

 

(40.0

)

Customer relationships

 

 

122.9

 

 

 

(96.9

)

Internally developed software

 

 

45.2

 

 

 

(42.4

)

Other

 

 

25.0

 

 

 

(25.0

)

 

 

$

291.1

 

 

$

(246.1

)

Future amortization expense is estimated to be as follows for the next five years:

(in millions)

    

2018

  $25.8 

2019

  $22.5 

2020

  $22.2 

2021

  $19.0 

2022

  $17.4 

(in millions)

 

 

 

2024

 

$

11.8

 

2025

 

$

10.2

 

2026

 

$

10.0

 

2027

 

$

6.5

 

2028

 

$

6.1

 

Note 9.10. Pension and Post-employmentPost-Employment Benefits

United Kingdom plan

The Company maintains a defined benefit pension plan (the “Plan”) covering a number of itscertain current and former employees in the United Kingdom although it does also have other much smaller pension arrangements in the U.S. and overseas.(the “UK Plan”). The UK Plan is closed to future service accrual butand has a large number of deferred and current pensioners. The Projected Benefit Obligation (“PBO”) is based on final salary and years of credited service reduced by social security benefits according to a plan formula. Normal retirement age is 65 but provisions are made for early retirement.

In May 2022, the Trustees of the UK Plan entered into an agreement with Legal and General Assurance Society Limited to acquire an insurance policy that operates as an investment asset, with the intent of matching the remaining uninsured part of the UK Plan’s future cash outflow arising from the accrued pension liabilities of members. Such an arrangement is commonly termed as a “buy-in”. The Plan’s assets are invested by several investment management companies in funds holding United Kingdom and overseas equities, United Kingdom and overseas fixed interest securities, index linked securities, property unit trusts and cash or cash equivalents. The trustees’ investment policy is to seek to achieve specified objectives through investing in a suitable mixture of real and monetary assets. The trustees recognize that the returns on real assets, while expected to be greater over the long-term than those on monetary assets, are likely to be more volatile. A mixture across asset classes should nevertheless provide the level of returns required by the Plan to meet its liabilities at an acceptable level of risk for the trustees and an acceptable level of costbenefit obligation was not transferred to the Company.insurer, and the Company remains responsible for paying pension benefits. The initial value of the asset associated with this contract was equal to the premium paid to secure the contract and is adjusted each reporting period to reflect the estimated fair value of the premium that would be paid for such a contract at that time. The buy-in reduces the UK Plan’s value at risk in relation to key risks associated with improved longevity, inflation and interest rate movements while improving the security to the UK Plan and its members. The Company consequently benefits from the buy-in as it reduces the UK Plan’s potential reliance on the Company for future cash funding requirements.

In 2017,2023, the Company contributed $1.0$0.0 million (2022 – $0.0 million) in cash to the UK Plan in accordance with an agreement with the trustees. For the year ending December 31, 2024, there are no plans to make cash contributions to the UK Plan.

67


The service cost shown in the table below has been recognized in selling, general and administrative expenses within corporate costs and the other items recognized within other income, net.

(in millions)

 

2023

 

 

2022

 

 

2021

 

Service cost

 

$

3.4

 

 

$

2.2

 

 

$

1.6

 

Interest cost on PBO

 

 

19.6

 

 

 

10.1

 

 

 

7.6

 

Expected return on plan assets

 

 

(25.2

)

 

 

(16.0

)

 

 

(15.5

)

Amortization of prior service cost/(credit)

 

 

0.5

 

 

 

0.5

 

 

 

0.3

 

Amortization of actuarial net losses

 

 

(1.6

)

 

 

 

 

 

1.6

 

Settlement event

 

 

 

 

 

 

 

 

(0.3

)

Net periodic benefit

 

$

(3.3

)

 

$

(3.2

)

 

$

(4.7

)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Plan assumptions at December 31, (%):

 

2023

 

 

2022

 

 

2021

 

Discount rate

 

 

4.59

 

 

 

4.91

 

 

 

1.84

 

Inflation rate

 

 

2.70

 

 

 

2.85

 

 

 

3.55

 

Rate of return on plan assets – overall on bid-value

 

 

4.25

 

 

 

4.00

 

 

 

2.30

 

Plan asset allocation by category (%):

 

2023

 

 

2022

 

 

2021

 

Debt securities and insurance contracts

 

 

96

 

 

 

96

 

 

 

82

 

Equity securities and real estate

 

 

 

 

 

 

 

 

5

 

Cash

 

 

4

 

 

 

4

 

 

 

13

 

 

 

100

 

 

 

100

 

 

 

100

 

(in millions)

  2017  2016  2015 

Plan net pension (credit)/charge:

    

Service cost

  $0.9  $1.0  $1.5 

Interest cost on PBO

   15.2   20.7   27.7 

Expected return on plan assets

   (24.5  (29.9  (33.4

Amortization of prior service credit

   (1.0  (1.1  (1.2

Amortization of actuarial net losses

   5.0   2.6   5.2 
  

 

 

  

 

 

  

 

 

 
  $(4.4 $(6.7 $(0.2
  

 

 

  

 

 

  

 

 

 

Plan assumptions at December 31, (%):

    

Discount rate

   2.56   2.48   3.69 

Inflation rate

   2.20   2.25   2.15 

Rate of return on plan assets – overall onbid-value

   2.75   3.20   4.20 

Plan asset allocation by category (%):

    

Equity securities

   38   25   34 

Debt securities

   53   66   62 

Cash

   9   9   4 
  

 

 

  

 

 

  

 

 

 
   100   100   100 
  

 

 

  

 

 

  

 

 

 

Following the buy-in, the UK Plan does not need to follow an investment strategy. The discount rate used represents the annualized yield based on a cash flow matched methodology with reference to an AA corporate bond spot curve and having regard to the duration of the UK Plan’s liabilities.

The inflation rate is derived using a similar cash flow matched methodology as used for the discount rate but having regard to the difference between yields on fixed interest and index linked United Kingdom government gilts.

A 0.25%0.25% change in the discount rate assumption would change the PBO at December 31, 2023 by approximately $25$10.8 million and the net pension credit for 20172023 would change by approximately $0.1$0.6 million.

A 0.25%0.25% change in the level of price inflation assumption would change the PBO at December 31, 2023 by approximately $18$6.9 million and the net pension credit for 20172023 by approximately $1.5$0.3 million.

68


Movements in PBO and fair value of UK Plan assets are as follows:

(in millions)

 

2023

 

 

2022

 

Change in PBO:

 

 

 

 

 

 

Opening balance

 

$

404.0

 

 

$

679.1

 

Interest cost

 

 

19.6

 

 

 

10.1

 

Service cost

 

 

3.5

 

 

 

2.2

 

Benefits paid

 

 

(35.6

)

 

 

(45.6

)

Plan amendments

 

 

 

 

 

0.4

 

Actuarial losses/(gains)

 

 

10.1

 

 

 

(174.2

)

Exchange effect

 

 

22.5

 

 

 

(68.0

)

Closing balance

 

$

424.1

 

 

$

404.0

 

Fair value of plan assets:

 

 

 

 

 

 

Opening balance

 

$

452.1

 

 

$

838.9

 

Benefits paid

 

 

(35.6

)

 

 

(45.6

)

Actual return on assets

 

 

17.9

 

 

 

(258.7

)

Exchange effect

 

 

24.8

 

 

 

(82.5

)

Closing balance

 

$

459.2

 

 

$

452.1

 

Net pension asset

 

$

35.1

 

 

$

48.1

 

Due to the UK Plan being closed to future accrual the PBO is equal to the Accumulated Benefit Obligation.

The current investment strategy of theUK Plan is to obtain an asset allocation ofholds approximately 85% debt securities and 15% equity securities in order to achieve a more predictable return on assets. As at December 31, 2017, approximately 30%1% (December 31, 2016202237%1%) of the UK Plan’s assets were held in index-tracking funds with one investment management company. Approximately 10% (December 31, 2016 – 18%) of the Plan’s assets were invested in United Kingdomdebt securities issued by non-U.S. governments and government gilts.agencies. No more than 5%5% of the UK Plan’s assets were invested in any one individual company’s investment funds.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Debt securities

MovementsIn the prior year, fixed income securities are valued based on quotations received from independent pricing services or from dealers who make markets in PBOsuch securities and fair value of Plan assets are classified as follows:

(in millions)

  2017  2016 

Change in PBO:

   

Opening balance

  $710.2  $739.7 

Interest cost

   15.2   20.7 

Service cost

   0.9   1.0 

Benefits paid

   (37.8  (39.7

Actuarial losses/(gains)

   (32.7  119.8 

Exchange effect

   65.6   (131.3
  

 

 

  

 

 

 

Closing balance

  $721.4  $710.2 
  

 

 

  

 

 

 

Fair value of plan assets:

   

Opening balance

  $758.2  $795.2 

Actual benefits paid

   (37.8  (39.7

Actual contributions by employer

   1.0   1.1 

Actual return on assets

   43.0   142.2 

Exchange effect

   73.0   (140.6
  

 

 

  

 

 

 

Closing balance

  $837.4  $758.2 
  

 

 

  

 

 

 

The accumulated benefit obligation for the Plan was $721.4 million and $710.2 million at December 31, 2017 and 2016, respectively.

For the vast majority of assets, a market approach is adopted to assess the fair value of the assets,Level 1. Corporate debt securities are classified as Level 2 in line with the inputs beingindustry standard.

Equity backed securities

In the quoted market prices for the actual securities held in the relevant fund.

Equity securities

Commonprior year, common and preferred stock for which market prices are readily available at the measurement date are valued at the last reported sale price or official closing price on the primary market or exchange on which they are actively traded and are classified in Level 1.

Fixed income securities

Fixed income securities are valued based on quotations received from independent pricing services or from dealers who make markets in such securities andtraded. Other financial derivatives are classified as Level 1.2 and certain investments that are measured at fair value using the net asset value per share (or its equivalent) have not been categorized with a hierarchy.

Other asset backed securities

Insurance contracts

The Company has invested in insurance contracts, known asbuy-in contracts. The value of the insurance contract iscontracts are based on significant unobservable inputs including plan participant medical data, in addition to observable inputs which include expected return on assets and

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

estimated value premium. Therefore, we have classified the contracts as Level 3 investments. Fair value estimates are provided by the external parties and are subsequently reviewed and approved by management.

69


The fair values of pension assets by level of input were as follows:

(in millions)

 Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
  Significant
Other
Observable
Inputs
(Level 2)
  Significant
Unobservable
Inputs
(Level 3)
  Total 

At December 31, 2017

    

Fixed income securities:

    

Debt securities issued bynon-U.S. governments and government agencies

 $86.0  $  $  $86.0 

Corporate debt securities

  194.5   232.3    426.8 

Other asset-backed securities

    

Equity securities:

    

Equity securities held for proprietary investment purposes

  0.1     0.1 

Real estate

  34.4     34.4 

Insurance contracts

    162.8   162.8 

Investments measured at net asset value(1)

     52.3 
 

 

 

  

 

 

  

 

 

  

 

 

 

Total assets at fair value

  315.0   232.3   162.8   762.4 

Cash

  75.0     75.0 
 

 

 

  

 

 

  

 

 

  

 

 

 

Total plan assets

 $390.0  $232.3  $162.8  $837.4 
 

 

 

  

 

 

  

 

 

  

 

 

 

At December 31, 2016

    

Fixed income securities:

    

Debt securities issued by U.S. government and government agencies

 $0.2  $  $  $0.2 

Debt securities issued bynon-U.S. governments and government agencies

  139.3     139.3 

Corporate debt securities

  180.8     180.8 

Other asset-backed securities

    

Equity securities:

    

Equity securities held for proprietary investment purposes

  84.2     84.2 

Real estate

  57.1     57.1 

Insurance contracts

    152.9   152.9 

Investments measured at net asset value(1)

     51.7 

Other assets

   26.2    26.2 
 

 

 

  

 

 

  

 

 

  

 

 

 

Total assets at fair value

  461.6   26.2   152.9   692.4 

Cash

  65.8     65.8 
 

 

 

  

 

 

  

 

 

  

 

 

 

Total plan assets

 $527.4  $26.2  $152.9  $758.2 
 

 

 

  

 

 

  

 

 

  

 

 

 

(in millions)

 

Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

 

Total

 

At December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities issued by non-U.S.
   governments and government agencies

 

$

4.7

 

 

 

 

 

 

 

 

$

4.7

 

Corporate debt securities

 

 

 

 

 

 

 

 

 

 

 

 

Equity backed securities:

 

 

 

 

 

 

 

 

 

 

 

 

Other financial derivatives

 

 

 

 

 

 

 

 

 

 

 

 

Other asset backed securities:

 

 

 

 

 

 

 

 

 

 

 

 

Insurance contracts

 

 

 

 

 

 

 

 

438.7

 

 

 

438.7

 

Real estate

 

 

 

 

 

 

 

 

 

 

 

 

Total assets at fair value

 

 

4.7

 

 

 

 

 

 

438.7

 

 

 

443.4

 

Cash

 

 

15.8

 

 

 

 

 

 

 

 

 

15.8

 

Total plan assets

 

$

20.5

 

 

$

 

 

$

438.7

 

 

$

459.2

 

At December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities issued by non-U.S.
   governments and government agencies

 

$

4.3

 

 

 

 

 

 

 

 

$

4.3

 

Corporate debt securities

 

 

 

 

 

 

 

 

 

 

 

 

Equity backed securities:

 

 

 

 

 

 

 

 

 

 

 

 

Other financial derivatives

 

 

 

 

 

 

 

 

 

 

 

 

Other asset backed securities:

 

 

 

 

 

 

 

 

 

 

 

 

Insurance contracts

 

 

 

 

 

 

 

 

431.8

 

 

 

431.8

 

Real estate

 

 

 

 

 

 

 

 

 

 

 

 

Total assets at fair value

 

 

4.3

 

 

 

 

 

 

431.8

 

 

 

436.1

 

Cash

 

 

16.0

 

 

 

 

 

 

 

 

 

16.0

 

Total plan assets

 

$

20.3

 

 

$

 

 

$

431.8

 

 

$

452.1

 

(1)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) have not been categorized in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statement of financial position.
(1)
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) have not been categorized in the fair value table with a hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statement of financial position.

70


NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The reconciliation of the fair value of the UK Plan assets measured using significant unobservable inputs was as follows:

(in millions)

  Other
Assets
 

 

Other
Assets

 

Balance at December 31, 2015

  $171.9 

Balance at December 31, 2021

 

$

162.2

 

Realized/unrealized gains/(losses):

  

 

 

 

Relating to assets still held at the reporting date

   16.8 

 

 

(206.6

)

Relating to assets sold during the period

   0.0 

Purchases, issuances and settlements

   (6.7

 

 

502.8

 

Exchange effect

   (29.1

 

 

(26.6

)

  

 

 

Balance at December 31, 2016

   152.9 
  

 

 

Balance at December 31, 2022

 

$

431.8

 

Realized/unrealized gains/(losses):

  

 

 

 

Relating to assets still held at the reporting date

   2.8 

 

 

16.9

 

Relating to assets sold during the period

   0.0 

Purchases, issuances and settlements

   (7.4

 

 

(33.7

)

Exchange effect

   14.5 

 

 

23.7

 

  

 

 

Balance at December 31, 2017

  $162.8 
  

 

 

Balance at December 31, 2023

 

$

438.7

 

The projected net service costperiodic benefit for the year ending December 31, 20182024 is $1.2 million and will be recognized in selling, general and administrative expenses. The following will be recognized in other income and expense:as follows:

(in millions)

    

 

 

 

Service cost

 

$

3.3

 

Interest cost on PBO

  $15.1 

 

 

18.5

 

Expected return on plan assets

   (22.4

 

 

(25.7

)

Amortization of prior service credit

   (1.1

 

 

0.5

 

Amortization of actuarial net losses

   2.0 

 

 

 

  

 

 
  $(6.4
  

 

 

Net periodic benefit

 

$

(3.4

)

In total, there will be a net pension credit of $5.2 million to the Innospec’s net income for the year ending December 31, 2018.

The following benefit payments are expected to be made:

(in millions)

    

2018

  $37.9 

2019

  $38.7 

2020

  $38.4 

2021

  $37.9 

2022

  $37.5 

2023-2027

  $181.7 

(in millions)

 

 

 

2024

 

$

34.9

 

2025

 

$

34.8

 

2026

 

$

34.3

 

2027

 

$

34.0

 

2028

 

$

33.5

 

2029-2033

 

$

161.6

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

German plan

The Company also maintains an unfunded defined benefit pension plan covering a number of itscertain current and former employees in Germany (the “German plan”)., which is reported within our Fuel Specialties segment. The German plan is closed to new entrants and has no assets.

71


The service cost shown in the table below has been recognized in selling, general and administrative expenses within corporate costs and the other items recognized within other income, net.

(in millions)

  2017   2016   2015 

Plan net pension charge:

      

Service cost

  $0.2   $0.2   $0.2 

Interest cost on PBO

   0.2    0.2    0.2 

Amortization of actuarial net loss

   0.4    0.2    0.3 
  

 

 

   

 

 

   

 

 

 
  $0.8   $0.6   $0.7 
  

 

 

   

 

 

   

 

 

 

Plan assumptions at December 31, (%):

      

Discount rate

   1.70    1.80    2.40 

Inflation rate

   1.75    1.75    1.75 

Rate of increase in compensation levels

   2.75    2.75    2.75 

(in millions)

 

2023

 

 

2022

 

 

2021

 

Service cost

 

$

0.1

 

 

$

0.1

 

 

$

0.1

 

Interest cost on PBO

 

 

0.3

 

 

 

0.1

 

 

 

0.1

 

Amortization of actuarial net loss/(gain)

 

 

(0.5

)

 

 

0.5

 

 

 

1.0

 

Net periodic cost/(benefit)

 

$

(0.1

)

 

$

0.7

 

 

$

1.2

 

Plan assumptions at December 31, (%):

Discount rate

 

 

3.70

 

 

 

3.70

 

 

 

0.90

 

Inflation rate

 

 

2.25

 

 

 

2.25

 

 

 

2.00

 

Rate of increase in compensation levels

 

 

2.75

 

 

 

2.75

 

 

 

2.75

 

Movements in PBO of the German plan are as follows:

(in millions)

  2017 2016 

 

2023

 

 

2022

 

Change in PBO:

   

 

 

 

 

 

 

Opening balance

  $10.1  $9.2 

 

$

8.2

 

 

$

13.2

 

Service cost

   0.2   0.2 

 

 

0.1

 

 

 

0.1

 

Interest cost

   0.2   0.2 

 

 

0.3

 

 

 

0.1

 

Benefits paid

   (0.2  (0.2

 

 

(0.3

)

 

 

(0.3

)

Actuarial losses/(gains)

   0.2   1.0 

 

 

0.6

 

 

 

(4.0

)

Exchange effect

   1.3   (0.3

 

 

0.2

 

 

 

(0.9

)

  

 

  

 

 

Closing balance

  $11.8  $10.1 

 

$

9.1

 

 

$

8.2

 

  

 

  

 

 

The amountOther plans

As at December 31, 2023, we have post-employment obligations in our Performance Chemicals European businesses with a liability of unrecognized$4.2 million (December 31, 2022 – $4.1 million). For the year ended December 31, 2023, we have recognized an actuarial net lossesgain of $0.3 million in other comprehensive loss in respect ofrelation to the German plan is $2.6 million, net of tax of $0.8 million.Performance Chemicals pension in France (December 31, 2022 – $0.3 million).

Other plans

Company contributions to defined contribution schemes during 20172023 were $7.9$12.9 million (2016(2022$7.9$11.0 million).

As at December 31, 2017,, across all of our Performance Chemicals segment has post-employment obligations in its European businesses with a liability of $4.7 million (December 31, 2016 – $4.1 million).reporting segments.

72


NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Note 10.11. Income Taxes

A roll-forward of unrecognized tax benefits is as follows:

(in millions)

  2017  2016  2015 

Opening balance at January 1

  $2.2  $3.6  $5.7 

Reductions for tax positions of prior periods

   0.0   (0.6  0.0 

Additions for tax positions of prior periods

   0.5   0.0   0.3 

Additions for current year tax positions

   0.0   0.0   1.2 

Reductions due to lapsed statute of limitations

   (0.5  (0.8  (3.6
  

 

 

  

 

 

  

 

 

 

Closing balance at 31 December

  $2.2  $2.2  $3.6 
  

 

 

  

 

 

  

 

 

 

We recognizeand associated accrued interest and penalties associated with unrecognized tax benefitsis as part of income taxes in our consolidated statements of income. Related to the unrecognized tax benefits noted above, we accrued net interest and penalties of $0.2 million during 2017, a net reduction in interest and penalties of $0.2 million in 2016 and a net reduction in interest and penalties of $0.2 million in 2015. Total accrued interest and penalties at December 31, 2017 on all remaining unrecognized tax benefits amounted to $0.3 million (December 31, 2016 - $0.1 million).follows:

(in millions)

 

Unrecognized
Tax Benefits

 

 

Interest
and
Penalties

 

 

Total

 

Opening balance at January 1, 2021

 

$

13.6

 

 

$

2.4

 

 

$

16.0

 

Reductions for tax positions of prior periods

 

 

(1.3

)

 

 

 

 

 

(1.3

)

Additions for tax positions of prior periods

 

 

0.9

 

 

 

0.7

 

 

 

1.6

 

Closing balance at December 31, 2021

 

 

13.2

 

 

 

3.1

 

 

 

16.3

 

Current

 

 

 

 

 

 

 

 

 

Non-current

 

$

13.2

 

 

$

3.1

 

 

$

16.3

 

Opening balance at January 1, 2022

 

$

13.2

 

 

$

3.1

 

 

$

16.3

 

Reductions for tax positions of prior periods

 

 

(3.1

)

 

 

 

 

 

(3.1

)

Additions for tax positions of prior periods

 

 

0.1

 

 

 

0.1

 

 

 

0.2

 

Closing balance at December 31, 2022

 

 

10.2

 

 

 

3.2

 

 

 

13.4

 

Current

 

 

 

 

 

 

 

 

 

Non-current

 

$

10.2

 

 

$

3.2

 

 

$

13.4

 

Opening balance at January 1, 2023

 

$

10.2

 

 

$

3.2

 

 

$

13.4

 

Reductions for tax positions of prior periods

 

 

 

 

 

 

 

 

 

Additions for tax positions of prior periods

 

 

0.3

 

 

 

1.1

 

 

 

1.4

 

Closing balance at December 31, 2023

 

 

10.5

 

 

 

4.3

 

 

 

14.8

 

Current

 

 

(1.0

)

 

 

(0.2

)

 

 

(1.2

)

Non-current

 

$

9.5

 

 

$

4.1

 

 

$

13.6

 

All of the $2.5$14.8 million of unrecognized tax benefits and interest and penalties, would impact our effective tax rate if recognized.

In 2021 a non-U.S. subsidiary, Innospec Limited, entered into a review by the U.K. tax authorities under the U.K.’s Profit Diversion Compliance Facility (“PDCF”) in relation to the period 2017 to 2020 inclusive. The Company or one of its subsidiaries files income tax returns with the U.S. federal government, and various state and foreign jurisdictions. As previously disclosed, one of the Company’s U.S. subsidiaries was subject to a state tax examination in respect of 2012 through to 2014 inclusive. The examination was completed in the fourth quarter of 2017 at no additional cost to the Company.

The Company and its U.S. subsidiaries are currently subject to a federal income tax examination in respect of 2015. The Company currently anticipates that adjustments, if any, arising out of this tax audit would not result in a material change to the Company’s financial position as at December 31, 2017.

As previously disclosed, tax audits have been opened by the Italian tax authorities in respect of Innospec Performance Chemicals Italia Srl, acquired as part of the Huntsman business in respect of the period 2011 to 2013 inclusive. As a consequence of information received in the fourth quarter of 2017, the Company believeshas determined that additional tax of approximately $0.5 million, together with associatedand interest of $0.2totaling $1.2 million may arise as a result of the 2011 audit. Thereongoing review. During 2023 the Company recorded an additional interest accrual of $0.1 million and a $0.1 million increase due to foreign exchange movements. The Company believes that it is insufficient evidence to conclude onreasonably possible that there will be a decrease of $1.2 million unrecognized tax benefits within the positioncoming year in relation to 2012 or 2013 atthis item resulting from effective settlement of the current time.outstanding tax positions with the U.K. tax authorities.

A non-U.S. subsidiary, Innospec Performance Chemicals Italia Srl, is subject to an ongoing tax audit in relation to the period 2011 to 2014 inclusive. The Company has determined that additional tax, interest and penalties totaling $3.4 million may arise as a consequence of the tax audit. This includes additional interest accrued of $0.1 million and $0.1 million for foreign exchange movements recorded during 2023. As any additional tax arising as a consequence of the tax audit would be reimbursed by the previous owner under the terms of the sale and purchase agreement, the Company has recorded an unrecognized tax benefit of $0.7 million in the quarter,

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

together with an indemnification asset of the same amount is recorded in the financial statements to reflect this arrangement.

In 2018 the factCompany recorded an unrecognized tax benefit in relation to a potential adjustment that could arise as a consequence of the final liability wouldTax Cuts and Jobs Act of 2017 (“Tax Act”), but for which retrospective adjustment to the filed 2017 U.S. federal income tax returns was not permissible. The Company has

73


determined that additional tax, interest and penalties totaling $10.2 million may arise in relation to this item. This includes an increase in the unrecognized tax benefit of $0.1 million and additional interest accrued of $0.9 million recorded during 2023. The Company believes that it is reasonably possible that there will be reimbursed bya decrease of $10.2 million unrecognized tax benefits within the previous owner.coming year in relation to this item due to a lapse of the statute of limitations.

TheAs of December 31, 2023, the Company and its U.S. subsidiaries remain open to examination by the IRS for certain elements of 2017 year and for years 2014 onwards.2020 onwards under the statute of limitations. The Company’s subsidiaries in foreign tax jurisdictions are open to examination including France (2014Brazil (2019 onwards), Germany (2015(2019 onwards), Switzerland (2015 onwards) and the United Kingdom (2016U.K. (2017 onwards).

The sources of income before income taxes were as follows:

(in millions)

  2017   2016   2015 

 

2023

 

 

2022

 

 

2021

 

Domestic

  $3.1   $16.8   $52.7 

 

$

95.2

 

 

$

106.3

 

 

$

53.2

 

Foreign

   125.0    86.3    99.6 

 

 

79.2

 

 

 

78.3

 

 

 

81.2

 

  

 

   

 

   

 

 

 

$

174.4

 

 

$

184.6

 

 

$

134.4

 

  $128.1   $103.1   $152.3 
  

 

   

 

   

 

 

The components of income tax expense are summarized as follows:

(in millions)

  2017   2016   2015 

 

2023

 

 

2022

 

 

2021

 

Current:

      

 

 

 

 

 

 

 

 

 

Federal

  $51.2   $4.4   $5.2 

 

$

12.4

 

 

$

27.0

 

 

$

12.4

 

State and local

   0.9    1.1    1.3 

 

 

0.2

 

 

 

6.5

 

 

 

2.6

 

Foreign

   21.0    15.3    14.3 

 

 

18.6

 

 

 

23.1

 

 

 

19.4

 

  

 

   

 

   

 

 

 

 

31.2

 

 

 

56.6

 

 

 

34.4

 

   73.1    20.8    20.8 
  

 

   

 

   

 

 

Deferred:

      

 

 

 

 

 

 

 

 

 

Federal

   (8.1   (0.7   12.8 

 

 

5.2

 

 

 

(3.7

)

 

 

(1.9

)

State and local

   0.7    (0.3   0.5 

 

 

0.3

 

 

 

(0.7

)

 

 

(0.3

)

Foreign

   0.6    2.0    (1.3

 

 

(1.4

)

 

 

(0.6

)

 

 

9.1

 

  

 

   

 

   

 

 

 

 

4.1

 

 

 

(5.0

)

 

 

6.9

 

   (6.8   1.0    12.0 

 

$

35.3

 

 

$

51.6

 

 

$

41.3

 

  

 

   

 

   

 

 
  $66.3   $21.8   $32.8 
  

 

   

 

   

 

 

Cash payments for income taxes were $24.2$54.3 million, $23.1$50.0 million and $22.5$36.8 million during 2017, 20162023, 2022 and 2015,2021, respectively.

74


NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The effective tax rate varies from the U.S. federal statutory rate because of the factors indicated below:

(in percent)

  2017 2016 2015 

 

2023

 

 

2022

 

 

2021

 

Statutory rate

   35.0  35.0  35.0

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

Foreign income inclusions

   2.1   1.0   1.8 

 

 

2.1

 

 

 

3.3

 

 

 

1.7

 

Foreign tax rate differential

   (13.7  (16.6  (9.6

 

 

0.9

 

 

 

0.9

 

 

 

1.0

 

Tax charge/(credit) from previous years

   1.1   (0.7  (0.5

 

 

(2.6

)

 

 

0.2

 

 

 

0.6

 

Net credit from unrecognized tax benefits

   (0.4  (1.6  (1.5

Net charge/(credit) from unrecognized tax benefits

 

 

0.7

 

 

 

(1.4

)

 

 

0.4

 

Foreign currency transactions

   (0.9  2.4   (1.9

 

 

(1.4

)

 

 

3.5

 

 

 

0.1

 

United Kingdom income tax rate reduction

   0.0   (0.6  (0.7

Effect of U.S. tax law change

   31.7   0.0   0.0 

Tax on unremitted earnings

 

 

1.4

 

 

 

0.3

 

 

 

0.1

 

Change in U.K. statutory tax rate

 

 

 

 

 

 

 

 

5.4

 

State and local taxes

 

 

1.0

 

 

 

2.2

 

 

 

1.3

 

U.S. incentive for foreign derived intangible income

 

 

(2.8

)

 

 

(2.7

)

 

 

(1.5

)

Innovation incentives

 

 

(1.3

)

 

 

(0.8

)

 

 

(1.1

)

Non-deductible officer compensation

 

 

1.0

 

 

 

1.4

 

 

 

0.2

 

Tax on closure of legacy operations

 

 

 

 

 

 

 

 

1.6

 

Other items and adjustments, net

   (3.1  2.2   (1.1

 

 

0.2

 

 

 

0.1

 

 

 

(0.1

)

  

 

  

 

  

 

 

 

 

20.2

%

 

 

28.0

%

 

 

30.7

%

   51.8  21.1  21.5
  

 

  

 

  

 

 

The most significant factor impacting our effective tax rate is the recognized implications of the Tax Reform Act. U.S. GAAP requires that the impact of tax legislation is recognized in the period in which the law was enacted. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for the tax effects of the Tax Reform Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Reform Act enactment date for companies to complete their accounting under ASC 740,Income Taxes. Until accounting is complete, companies may record provisional estimates.

As a result of the Tax Reform Act, we accrued a provisional estimate of the mandatory transition tax on our accumulated earnings as of December 31, 2017, resulting in an increase to income tax expense of $47.7 million. In addition, our U.S. deferred tax assets and liabilities were re-measured using a tax rate reduced from 35% to 21% at the same date, which resulted in $7.1 million of deferred income tax benefit.

On account of the complexity of the new Global Intangible Low-Taxed Income (“GILTI”) tax rules, the company continues to evaluate this provision of the Tax Reform Act and the application of ASC 740,Income Taxes. Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current period expense when incurred (the “period cost method”) or factoring such amounts into the Company’s recognition and measurement of its deferred taxes (the “deferred method”). The Company has not yet made any adjustments related to potential GILTI tax in its financial statements and has not yet made an accounting policy decision in respect of GILTI.

We consider the accounting of the transition tax, GILTI provisions and other items to be incomplete due to the forthcoming guidance and our ongoing analysis of final data and tax positions which may impact these calculations.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

We expect to complete our analysis within the measurement period in accordance with SAB 118.

The mix of taxable profits generated in the different geographical jurisdictions in which the Group operates continues to have a significant positive impact on the effective rate.

Foreign income inclusions arise each year from certain types of income earned overseas being taxable under the U.S. tax regulations. These types of income include Subpart F income, principally from foreign based company sales in the United Kingdom, including the associated Section 78 tax gross up, and also from the income earned by certain overseas subsidiaries taxable under the U.S. tax regime. Foreign income inclusions have a negative impact on the effective tax rate.

Foreign tax credits can fully or partially offset these incremental U.S. taxes from foreign income inclusions. The utilization of foreign tax credits varies year on year as this is dependent on a number of variable factors which are difficult to predict and may in certain years prevent any offset of foreign tax credits.offset. The effective tax rate is favorablynegatively impacted by the generationnet impact of foreign inclusions post foreign tax credits againstcredit usage in 2023.

As a consequence of the Company having operations outside of the U.S., it is also exposed to foreign currency fluctuations. These have had a positive impact on the effective tax rate in 2023.

As in the prior year, the level of foreign-derived intangible income inclusionsbenefit that the Company is entitled to has had a positive impact on the effective tax rate. There was also a benefit arising from adjustments to the tax charge for previous years, primarily arising from return to provision adjustments in 2017.relation to the federal and state tax returns filed in the U.S. during 2023.

Other items do not have a materialsignificant impact on the effective tax rate.rate in either 2023 or 2022.

75


NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Details of deferred tax assets and liabilities are analyzed as follows:

(in millions)

  2017   2016 

 

2023

 

 

2022

 

Deferred tax assets:

    

 

 

 

 

 

 

Stock compensation

  $4.3   $5.5 

 

$

3.7

 

 

$

3.7

 

Net operating loss carry forwards

   15.9    18.2 

 

 

9.2

 

 

 

10.9

 

Other intangible assets

   4.8    3.7 

 

 

8.7

 

 

 

10.5

 

Accretion expense

   3.3    5.1 

 

 

3.2

 

 

 

3.2

 

Restructuring provision

 

 

1.6

 

 

 

1.7

 

Employee related liabilities

 

 

7.3

 

 

 

8.1

 

Foreign tax credits

 

 

1.7

 

 

 

0.8

 

Operating lease liabilities

 

 

12.6

 

 

 

11.8

 

Inventory provisions

 

 

6.5

 

 

 

6.6

 

Research and experimental expenditure

 

 

5.3

 

 

 

2.7

 

Other

   4.5    9.5 

 

 

5.3

 

 

 

4.8

 

  

 

   

 

 

Subtotal

   32.8    42.0 

 

 

65.1

 

 

 

64.8

 

Less valuation allowance

   0.0    0.0 

 

 

(0.1

)

 

 

(0.7

)

  

 

   

 

 

Total net deferred tax assets

  $32.8   $42.0 

 

$

65.0

 

 

$

64.1

 

  

 

   

 

 

Deferred tax liabilities:

    

 

 

 

 

 

 

Property, plant and equipment

  $(16.7  $(13.0

 

$

(24.8

)

 

$

(22.5

)

Intangible assets including goodwill

   (27.0   (38.0

 

 

(31.2

)

 

 

(30.3

)

Pension asset

   (18.3   (8.2

 

 

(7.6

)

 

 

(10.9

)

Investment impairment recapture

   (3.5   0.0 

Customer relationships

   (5.8   0.0 

 

 

(5.1

)

 

 

(3.4

)

Unremitted overseas earnings

 

 

(4.4

)

 

 

(1.9

)

Right-of-use assets

 

 

(12.5

)

 

 

(11.8

)

Other

   0.0    (0.2

 

 

(2.5

)

 

 

(3.6

)

  

 

   

 

 

Total deferred tax liabilities

  $(71.3  $(59.4

 

$

(88.1

)

 

$

(84.4

)

  

 

   

 

 

Net deferred tax liability

  $(38.5  $(17.4

 

$

(23.1

)

 

$

(20.3

)

  

 

   

 

 

Deferred tax assets

  $6.5   $14.9 

 

$

10.4

 

 

$

5.9

 

Deferred tax liabilities

   (45.0   (32.3

 

 

(33.5

)

 

 

(26.2

)

  

 

   

 

 

 

$

(23.1

)

 

$

(20.3

)

  $(38.5  $(17.4
  

 

   

 

 

The Tax Reform Act reducesCompany assesses the U.S. statutory corporate tax rate from 35%available positive and negative evidence to 21%, effective January 1, 2018, which resulted inestimate whether sufficient future taxable income will be generated to permit use of the re-measurement of our U.S.existing deferred tax positions asassets. Available evidence considered in determining the use of December 31, 2017. Consequently, we have recorded a decrease to our net deferred tax liability of $7.1 million, with a corresponding net adjustment to deferred tax benefit of $7.1 million for the year ended December 31, 2017.

The Company evaluates deferred tax assets includes, but is not limited to, determine whethercumulative losses arising in recent accounting periods, the Company’s estimate of future taxable income and any applicable tax-planning strategies. Based on such evidence, if it is more likely than not that they will be realized. Deferred tax assets are reviewed each period on a tax jurisdiction by tax jurisdiction basis to analyze whether there is sufficient positivesome portion or negative evidence to support realizability. As a resultall of the Company’s assessment of itssuch deferred tax assets at December 31, 2017, the Company considers it more likely thanwill not that it will recover the full benefit of its deferred tax assets and no valuation allowance is required.

Should it be determined in the future that it is no longer more likely than not that these assets will be realized, a valuation allowance would be required, andis recorded to reduce the Company’s operating

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

results would be adversely affected duringdeferred tax assets. On the period in which suchbasis of this evaluation, as of December 31, 2023, a determination would be made.

Gross net operating loss carry forwardsvaluation allowance of $75.2$0.1 million result in ahas been recorded to recognize only the portion of the deferred tax asset of $15.9 million.that is more likely than not to be realized. The net operating loss carry forwards arose in the U.S. and in fiveamount of the Company’s foreign subsidiaries. Net operating lossdeferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carry forwardsforward period are reduced or increased or if other evidence becomes available.

As of $27.1December 31, 2023, the Company has approximately $0.3 million arose from state and federal tax losses in prior and current periods in certain of the Company’s U.S. subsidiaries. It is expected that sufficient taxable profits will be generated in the U.S. against which the federal net operating loss carry forwards of $16.6 million can be relieved prior to their expiration in the period 2035 to 2037, and thetax-effected state net operating loss carry forwardscarryforwards, net of $10.5 millionfederal benefit. Some of these loss carryforwards will begin to expire in 2036 if not utilized, while other can be relieved before their expiration in the period 2022 to 2037.carried forward indefinitely. The Company utilized all remaining federal

76


net operating loss carry forwards incarryforwards during 2023. The Company also has approximately $8.9 million of tax-effected foreign net operating loss carryforwards, net of valuation allowance, across five of the Company’s foreign subsidiaries, totaling $48.1 million arose in prior and current periods and it is expected that sufficient taxable profits will be generated against which these net operating loss carry forwards can be relieved. These losses canalso be carried forward indefinitely without expiration.indefinitely.

The Company is in a position to control whether or not to repatriate foreign earnings and we currently do not expect to make a repatriation in the foreseeable future. No additional income taxes have been provided for on any remaining undistributed foreign earnings not subject to the transition tax, or any additional outside basis difference inherent in these entities, as the earnings continue to be indefinitely reinvested in foreign operations. Determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings not subject to the transition tax and additional outside basis difference in these entities (i.e. basis difference in excess of that subject to the one-time transition tax) is not practicable at this time.

Note 11.12. Long-Term Debt

As at December 31, 2023 and 2022, the Company has not drawn down on its revolving credit facility.

Long-term debt consists of the following:

(in millions)

  2017   2016 

Revolving credit facility

  $121.0   $161.0 

Term loan

   99.0    110.0 

Deferred finance costs

   (1.6   (2.2
  

 

 

   

 

 

 
   218.4    268.8 

Less current portion

   (15.8   (10.3
  

 

 

   

 

 

 
  $202.6   $258.5 
  

 

 

   

 

 

 

On December 14, 2016,May 31, 2023, Innospec Inc. and certain subsidiaries of the Company (together with the Company, the “Borrowers”) entered into a Third Amendment and RestatementMulticurrency Revolving Facility Agreement with various lenders (the “Agreement”) which amends and restatesreplaces the Company’s credit facility agreement dated December 14, 2011, as amended and restated on August 28, 2013 and November 6, 2015 (the “Pre-Existing Credit Agreement” the Pre-Existing CreditSeptember 26, 2019. The Agreement as amended and restated pursuant to the Third Amendment and Restatement Agreement, being the “Amended Credit Agreement.”)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The Amended Credit Agreement retains the $200,000,000provides for a $250,000,000four-year multicurrency revolving creditloan facility available to the Borrowers (the “Facility”). The Agreement also contains an accordion feature whereby the Company and adds a term loan facilitymay elect to increase the total available borrowings by an aggregate amount of $110,000,000.up to $125,000,000. The termination date of the revolving facility remains November 6, 2020. A repaymentFacility is May 30, 2027, but the Company has an option to request an extension of the Facility for a further year. As a consequence, the term loanCompany has capitalized $1.4 million of $11,000,000 was made on December 29, 2017,costs relating to be followed by a $16,500,000 installment due December 28, 2018 and a $22,000,000 installment due December 28, 2019, with the outstanding balance due on November 6, 2020.

The Company capitalized refinancing costs of $1.2 million in 2016,new Agreement which are beingto be amortized over the expected lifeperiod to May 30, 2027. In addition, the Company has written-off $0.6 million of capitalized costs relating to the previous agreement.

The deferred finance costs of $1.2 million (December 31, 2022 – $0.6 million) related to the arrangement of the credit facility, as shown here:are included within other current and non-current assets at the balance sheet dates.

(in millions)

  2017   2016 

 

2023

 

 

2022

 

Gross cost at January 1

  $2.7   $1.5 

 

$

1.8

 

 

$

1.8

 

Written off

 

 

(1.8

)

 

 

 

Capitalized in the year

   0.0    1.2 

 

 

1.4

 

 

 

 

  

 

   

 

 

 

 

1.4

 

 

 

1.8

 

  $2.7   $2.7 
  

 

   

 

 

Accumulated amortization at January 1

  $(0.5  $(0.1

 

$

(1.2

)

 

$

(0.8

)

Written off

 

 

1.4

 

 

 

 

Amortization in the year

   (0.6   (0.4

 

 

(0.4

)

 

 

(0.4

)

  

 

   

 

 

 

$

(0.2

)

 

$

(1.2

)

  $(1.1  $(0.5
  

 

   

 

 

Net book value at December 31

  $1.6   $2.2 

 

$

1.2

 

 

$

0.6

 

  

 

   

 

 

Amortization expense was $0.6$0.4 million, $0.4$0.4 million and $1.2$0.3 million in 2017, 20162023, 2022 and 2015,2021, respectively. The charge is included in interest expense, see Note 2 of the Notes to the Consolidated Financial Statements.

The obligations of the Company under the credit facilitiesfacility are secured obligations and guaranteed by certain subsidiaries of the Company. Amounts available under the revolving facility may be borrowed in U.S. dollars, Euros, British pounds and other freely convertible currencies.

The Company’s credit facilities containfacility contains restrictive clauses which may constrain our activities and limit our operational and financial flexibility. The facility obliges the lenders to comply with a request for utilization of finance unless there is an event of default outstanding. Events of default are defined in the credit facility and include a material adverse change to our assets, operations or financial condition. The facility contains a number of restrictions that limit our ability, amongstamong other things, and subject to certain limited exceptions, to incur additional indebtedness, pledge our assets as security, guarantee obligations of third parties, make investments, undergo a merger or consolidation, dispose of assets, or materially change our line of business.

77


In addition, the credit facilities containfacility contains terms which, if breached, would result in it becoming repayable on demand. It requires, among other matters, compliance with the following financial covenant ratios measured on a quarterly basis: (1) the ratio of net debt to EBITDA shall not be greater than 3.0:3.5:1 and (2) the ratio of EBITDA to net interest shall not be less than

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

4.0:1. Management has determined that the Company has not breached these covenants throughout the period to December 31, 20172023 and does not expect to breach these covenants for the next 12 months. The credit facility is secured by a number of fixed and floating charges over certain assets which include key operating sites of the Company and its subsidiaries.

The weighted average rate of interest on borrowings was 2.59%0.00% at December 31, 20172023 and 1.72%0.00% at December 31, 2016.2022. Payments of interest on long-term debt were $7.2$0.0 million, $2.6$0.0 million and $2.3$0.0 million in 2017, 20162023, 2022 and 2015,2021, respectively.

The net cash outflows in respect of refinancing costs were $0.0$1.4 million, $1.2$0.0 million and $1.5$0.0 million in 2017, 20162023, 2022 and 2015,2021, respectively.

Note 12.13. Plant Closure Provisions

The Company has continuing plans to remediate manufacturing facilities at sites around the world as and when those operations are expected to cease or we are required to decommission the sites according to local laws and regulations. The liability for estimated plant closure costs includes costs for environmental remediation liabilities and asset retirement obligations.

The principal site giving rise to environmental remediation liabilitiesasset retirement obligations is the manufacturing site at Ellesmere Port in the United Kingdom, which management believes is the last ongoing manufacturer of TEL.Kingdom. There are also asset retirement obligations and environmental remediation liabilities on a much smaller scale in respect of our other manufacturing sites in the U.S. and Europe. The liability for estimated closure costs of Innospec’s manufacturing facilities includes costs for decontamination and environmental remediation activities (“remediation”) when demand for TEL diminishes.sites.

Movements in the provisions are summarized as follows:

(in millions)

  2017 2016 2015 

 

2023

 

 

2022

 

 

2021

 

Total at January 1

  $39.5  $37.7  $34.1 

 

$

57.2

 

 

$

56.5

 

 

$

58.5

 

Charge for the period

   5.9   4.7   6.8 

 

 

8.9

 

 

 

5.3

 

 

 

3.9

 

Measurement period adjustment

   2.8   0.0   0.0 

Utilized in the period

   (2.4  (2.7  (2.6

 

 

(4.9

)

 

 

(4.2

)

 

 

(5.3

)

Disposal in the period

   0.0   0.0   (0.3

Exchange effect

   0.3   (0.2  (0.3

 

 

0.4

 

 

 

(0.4

)

 

 

(0.6

)

  

 

  

 

  

 

 

Total at December 31

   46.1   39.5   37.7 

 

 

61.6

 

 

 

57.2

 

 

 

56.5

 

Due within one year

   (5.2  (6.7  (6.4

 

 

(4.6

)

 

 

(5.3

)

 

 

(5.2

)

  

 

  

 

  

 

 

Due after one year

  $40.9  $32.8  $31.3 

 

$

57.0

 

 

$

51.9

 

 

$

51.3

 

  

 

  

 

  

 

 

Amounts due within one year refer to provisions where expenditure is expected to arise within one year of the balance sheet date. Remediation costs are recognized in cost of goods sold.

The provisions for remediation represent the Company’s liability for environmental liabilities and asset retirement obligations. The charge for the period in 20172023 represents the accretion expense recognized of $3.5$3.7 million and a further $2.4$5.2 million primarily in respect of changes in the expected cost and scope of future remediation activities. A discount rateThe charges for plant closure provisions are recognized in cost of 8.92% was used in valuing the remediation provision.

goods sold for our reporting segments and within selling, general and administrative expenses for Corporate costs.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Following the Huntsman acquisition, we have recognized $2.8 million of asset retirement obligations as an increase in the value of the tangible assets acquired, which will be depreciated over the remaining useful economic life of those assets.

We recognize environmental remediation liabilities when they are probable and the costs can be reasonably estimated, and asset retirement obligations when there is an obligation based on a legal obligationrequirement, including those arising from a Company promise, and the costs can be reasonably estimated. The Company has to anticipate the program of work required and the associated future expected costs, and comply with environmental legislation in the countries in which it operates or has operated in. The Company views the costs of vacating our Ellesmere Port site as contingent upon if and when it vacates the site because there is no present intention to do so.

78


Remediation expenditure utilized

Expenditure utilizing plant closure provisions of $2.4was $4.9 million, $2.7$4.2 million and $2.6$5.3 million in 2017, 20162023, 2022 and 2015,2021, respectively.

Note 13.14. Fair Value Measurements

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes a mid-market pricing convention for valuing the majority of its assets and liabilities measured and reported at fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated or generally unobservable. The Company primarily applies the market approach for recurring fair value measurements and endeavors to utilize the best available information. Accordingly, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. The Company is able to classify fair value balances based on the observability of those inputs. The Company gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy Levels. In 2017,2023, the Company evaluated the fair value hierarchy levels assigned to its assets and liabilities, and concluded that there should be no transfers into or out of Levels 1, 2 and 3.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following table presents the carrying amount and fair values of the Company’s assets and liabilities measured on a recurring basis:

   December 31, 2017   December 31, 2016 

(in millions)

  Carrying
Amount
   Fair
Value
   Carrying
Amount
   Fair
Value
 

Assets

        

Non-derivatives:

        

Cash and cash equivalents

  $90.2   $90.2   $101.9   $101.9 

Derivatives (Level 1 measurement):

        

Other current and non-current assets:

        

Foreign currency forward exchange contracts

   1.1    1.1    0.0    0.0 

Interest rate swaps

   1.5    1.5    0.4    0.4 

Liabilities

        

Non-derivatives:

        

Long-term debt (including current portion)

  $218.4   $218.4   $268.8   $268.8 

Finance leases (including current portion)

   5.9    5.9    4.5    4.5 

Derivatives (Level 1 measurement):

        

Other non-current liabilities:

        

Foreign currency forward exchange contracts

   0.0    0.0    0.6    0.6 

Non-financial liabilities (Level 3 measurement):

        

Stock equivalent units

   13.6    13.6    9.8    9.8 

 

December 31, 2023

 

 

December 31, 2022

 

(in millions)

 

Carrying
Amount

 

 

Fair
Value

 

 

Carrying
Amount

 

 

Fair
Value

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives (Level 1 measurement):

 

 

 

 

 

 

 

 

 

 

 

 

Other current and non-current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Emissions Trading Scheme credits

 

$

4.8

 

 

$

4.8

 

 

$

2.7

 

 

$

2.7

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives (Level 1 measurement):

 

 

 

 

 

 

 

 

 

 

 

 

Other current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward exchange
   contracts

 

 

1.0

 

 

 

1.0

 

 

 

0.5

 

 

 

0.5

 

Non-financial liabilities (Level 3 measurement):

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition-related contingent consideration

 

 

23.4

 

 

 

23.4

 

 

 

 

 

 

 

The following methods and assumptions were used to estimate the fair values of financial instruments:values:

Cash and cash equivalents: The carrying amount approximates fair value because of the short-term maturities of such instruments.

Long-term debt and finance leases: Long-term debt principally comprises the term loan and revolving credit facility, which are shown net of deferred finance costs that have been capitalized.Emissions Trading Scheme credits: The fair value of long-term debt approximates to the carrying value, as the discounting to its present value is offsetdetermined by the interest rate swaps. Finance leases relate to certain fixed assets in our fuel specialties and oilfield services businesses. The carrying amountopen market pricing at the end of long-term debt and finance leases approximates to the fair value.reporting period.

Derivatives: The fair value of derivatives relating to foreign currency forward exchange contracts and interest rate swaps are derived from current settlement prices and comparable

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

contracts using current

79


assumptions. Foreign currency forward exchange contracts primarily relate to contracts entered into to hedge future known transactions or hedge balance sheet net cash positions. The movements in the carrying amounts and fair values of these contracts are largely due to changes in exchange rates against the U.S. dollar. Interest rate swaps relate

Acquisition-related contingent consideration: Contingent consideration payable in cash is discounted to contracts taken out to hedge interest rate risk on a portion of our credit facilities borrowing.

Stock equivalent units: Theits fair values of stock equivalent units are calculatedvalue at each balance sheet date using eitherdate. Where contingent consideration is dependent upon pre-determined financial targets, an estimate of the Black-Scholes or Monte Carlo method.fair value of the likely consideration payable is made at each balance sheet date. The contingent consideration payable at December 31, 2023 has been calculated based on the latest forecast.

Note 14.15. Derivative Instruments and Risk Management

The Company has limited involvement with derivative instruments and does not trade them. The Company does use derivatives to manage certain interest rate, foreign currency exchange rate, and raw material cost exposures and greenhouse gases emission allowances, as the need arises.

The Company enterspreviously entered into interest rate swap contracts to reduce interest rate risk on its core debt. As at December 31, 2017,2023 and 2022, there were no interest rate swaps with a notional value of $149,000,000 were in place. Fixed interest rates payable under the interest rate swaps vary from 1.42% to 1.67%. Interest rate swaps were previously in place to hedge interest rate risk on the term loan are for a notional value that matchesmatched the repayment profile of the term loan. These interest rate swap contracts have been designated as hedging instruments, and their impact on other comprehensive loss for 2017 was a gain of $1.1 million (2016 – gain $0.4 million).

The Company enters into various foreign currency forward exchange contracts to minimize currency exchange rate exposure from expected future cash flows. As at December 31, 2017,2023, foreign currency forward exchange contracts with a notional value of $79.2$156.5 million were in place (December 31, 2022 $161.1 million), with maturity dates of up to one year from the date of inception. These foreign currency forward exchange contracts have not been designated as hedging instruments, and their impact on the income statement for 20172023 was a loss of $0.9$4.0 million (2016(2022 – gain $4.4$0.7 million).

As at December 31, 20172023 and December 31, 20162022, the Company did not hold any raw material derivatives.

The Company participates in the new United Kingdom Emissions Trading Scheme (“UK ETS”) which was launched on January 1, 2021. Emissions trading schemes work on the ‘cap and trade’ principle, where a cap is set on the total amount of certain greenhouse gases that can be emitted by sectors covered by the scheme. This limits the total amount of carbon that can be emitted. Within this cap, participants receive free allowances and/or buy emission allowances at auction or on the secondary market which they can trade with other participants as needed. As at December 31, 2023, the Company held UK ETS credits of $4.8 million (December 31, 2022 – $2.7 million).

The Company sells a range of specialty chemicals to major oil refineriesrefiners and chemical companies throughout the world. Credit limits, ongoing credit evaluation and account monitoring procedures are intended to minimize bad debt risk. Collateral is not generally required.

Note 15.16. Commitments and Contingencies

Operating leases

The Company has commitments under operating leases primarily for office space, motor vehicles and various items of computer and office equipment. The leases are expected to be

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

renewed and replaced in the normal course of business. Rental expense was $5.5 million in 2017, $5.2 million in 2016 and $4.5 million in 2015. Future commitments under non-cancelable operating leases are as follows:

(in millions)

    

2018

  $4.3 

2019

   3.5 

2020

   2.8 

2021

   2.2 

2022

   1.6 

Thereafter

   5.9 
  

 

 

 
  $20.3 
  

 

 

 

Environmental remediation liabilities and asset retirement obligations

Commitments in respect of environmental remediation liabilities and asset retirement obligations are disclosed in Note 1213 of the Notes to the Consolidated Financial Statements.

80


Capital commitments

The estimated additional cost to complete work in progress at December 31, 2023 is $33.7 million (2022 – $37.7 million).

ContingenciesInternally developed software

The estimated additional cost to complete work in progress at December 31, 2023 is $8.9 million (2022 – $25.0 million).

Contingencies

Legal matters

While weWe are involved from time to time in claims and legal proceedings that result from, and are incidental to, the conduct of our business including business and commercial litigation, employee and product liability claims,claims.

As previously reported in the first quarter of 2023, we have lodged a civil and criminal legal claim and insurance claim related to a misappropriation of inventory in Brazil and as a consequence we have written-off $7.4 million of our inventory to cost of goods sold in our financial statements. In the second quarter of 2023, we have incurred additional charges of $8.0 million as we exited the Brazilian trading relationship associated with the inventory misappropriation. The costs incurred in the second quarter include $5.0 million to cost of goods sold and $3.0 million to selling, general and administration costs. A corresponding asset for the potential legal or insurance recoveries has not been recorded for the resulting financial losses arising from this matter.

In addition, unrelated to the Brazil matter, in the unlikely event there are no material pending legal proceedings to which the Company or any of its subsidiaries is a party, or of which any of their property is subject. It is possible however, that an adverse resolution of an unexpectedly large number of such individual itemsclaims or proceedings with an adverse resolution, this could in the aggregate have a material adverse effect on the results of operations for a particular year or quarter.

Guarantees

Guarantees

The Company and certain of the Company’s consolidated subsidiaries are contingently liable for certain obligations of affiliated companies primarily in the form of guarantees of debt and performance under contracts entered into as a normal business practice. This includes guarantees of non-U.S. excise taxes and customs duties. As at December 31, 2017,2023, such guarantees which are not recognized as liabilities in the consolidated financial statements amounted to $3.5$6.2 million (December 31, 20162022$4.7$7.0 million). The remaining terms of the fixed maturity guarantees vary from approximately 1 month to 9 years, with some further guarantees having no fixed expiry date.

Under the terms of the guarantee arrangements, generally the Company would be required to perform should the affiliated company fail to fulfill its obligations under the arrangements. In some cases, the guarantee arrangements have recourse provisions that would enable the Company to recover any payments made under the terms of the guarantees from securities held of the guaranteed parties’ assets.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The Company and its affiliates have numerous long-term sales and purchase commitments in their various business activities, which are expected to be fulfilled with no adverse consequences material to the Company.

81


Note 16.17. Stockholders’ Equity

 

  Common Stock   Treasury Stock 

 

Common Stock

 

 

Treasury Stock

 

(number of shares in thousands)

  2017   2016   2015   2017 2016 2015 

 

2023

 

 

2022

 

 

2021

 

 

2023

 

 

2022

 

 

2021

 

At January 1

   29,555    29,555    29,555    5,483   5,453   5,263 

 

 

29,554.5

 

 

 

29,554.5

 

 

 

29,554.5

 

 

 

4,789

 

 

 

4,781

 

 

 

4,959

 

Exercise of options

   0    0    0    (296  (152  (152

 

 

 

 

 

 

 

 

 

 

 

(113

)

 

 

(55

)

 

 

(185

)

Stock purchases

   0    0    0    17   182   342 

 

 

 

 

 

 

 

 

 

 

 

11

 

 

 

63

 

 

 

7

 

  

 

   

 

   

 

   

 

  

 

  

 

 

At December 31

   29,555    29,555    29,555    5,204   5,483   5,453 

 

 

29,554.5

 

 

 

29,554.5

 

 

 

29,554.5

 

 

 

4,687

 

 

 

4,789

 

 

 

4,781

 

  

 

   

 

   

 

   

 

  

 

  

 

 

At December 31, 2017,2023, the Company had authorized common stock of 40,000,000 shares (2016 – 40,000,000)(2022 - 40,000,000).

Note 17.    Stock-Based18. Share-Based Compensation Plans

Stock option plans

The Company has five activetwo stock option plans, two ofthe Omnibus Long-Term Incentive Plan and the ShareSave Plan 2008 under which provide for the grant of stock options to employees, one provides for the grant of stock options to non-employee directors, and another provides for the grant of stock options to key executives on a matching basis provided they use a proportion of their annual bonus to purchase common stock in the Company on the open market or from the Company. The fifth plan is a savings plan which provides for the grant of stock options to all Company employees provided they commit to make regular savings over a pre-defined period which can then be used to purchase common stock upon vesting of the options.it currently grants awards. The stock options have vesting periods ranging from 24 months2 to 65 years and in all cases stock options granted expire within 10 years of the date of grant. All grants are at the sole discretion of the Compensation Committee of the Board of Directors. Grants may be priced at market value or at a premium or discount. The aggregate number of shares of common stock reserved for issuance which can be granted under the plans is 2,640,000.2,550,000.

The fair value of stock options is measured on the grant date using either the Black-Scholes model, or in cases where performance criteria are dependent upon external factors such as the Company’s stock price, using a Monte Carlo model. The following weighted average assumptions were used to determine the grant-date fair value of options:

    2017  2016  2015 

Dividend yield

   0.96  1.38  1.03

Expected life

   5 years   5 years   5 years 

Volatility

   25.3  25.1  25.5

Risk free interest rate

   1.50  0.91  1.05

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following table summarizes the transactions of the Company’s stock option plans for the year ended December 31, 2017:

    Number of
Options
  Weighted
Average
Exercise
Price
   Weighted
Average

Grant-Date
Fair Value
 

Outstanding at December 31, 2016

   570,994  $20.38   $21.68 

Granted – at discount

   79,664  $0.00   $61.39 

      – at market value

   18,843  $70.60   $16.84 

Exercised

   (295,809 $27.04   $14.98 

Forfeited

   (16,026 $13.18   $25.93 
  

 

 

    

Outstanding at December 31, 2017

   357,666  $13.74   $35.69 
  

 

 

    

At December 31, 2017, there were 62,102 stock options that were exercisable, 8,577 had performance conditions attached.

The Company’s policy is to issue shares from treasury stock to holders of stock options who exercise those options, but if sufficient treasury stock is not available, the Company will issue previously unissued shares of stock to holders of stock options who exercise options.

The stock option compensation cost for 2017, 2016 and 2015 was $4.2 million, $3.3 million and $3.7 million, respectively. The total intrinsic value of options exercised in 2017, 2016 and 2015 was $2.9 million, $2.8 million and $2.4 million, respectively.

The total compensation cost related to non-vested stock options not yet recognized at December 31, 2017 was $5.6 million and this cost is expected to be recognized over the weighted-average period of 1.90 years.

In 2017, the Company recorded a current tax benefit of $3.0 million in respect of stock option compensation.

The cash tax benefit realized from stock option exercises totaled $0.3 million, and $0.2 million in 2016 and 2015, respectively.

No stock options awards were modified in 2017, 2016 or 2015.

Stock equivalent units

The Company awards Stock Equivalent Units (“SEUs”) from time to time as a long-term performance incentive. SEUs are cash settled equity instruments conditional on certain performance criteria and the fair value is linked to the Innospec Inc. share price. SEUs have vesting periods ranging from 11six months to 45 years and in all cases SEUs granted expire within 10 years of the date of grant. Grants may be priced at market value or at a premium or discount. There is no limit to the number of SEUs that can be granted. As at December 31, 20172023 the liability for SEUs of $13.6$23.2 million is locatedincluded in accrued liabilities in the consolidated balance sheetssheet, where they will remain until they are cash settled.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The fair value of SEUs is measuredre-measured at theeach balance sheet reporting date using either the Black-Scholes model, or in cases where performance criteria are dependent upon external factors such as the Company’s stock price, using a Monte Carlo model.

Compensation cost

The following assumptions were used to determinecompensation cost recorded for stock options was $8.0 million, $6.7 million and $4.4 million for 2023, 2022 and 2021, respectively. The compensation cost for stock options is based on the grant-date fair value of SEUs atand spread evenly over the balance sheet dates:vesting period.

82

       2017          2016          2015     

Dividend yield

   1.09  0.98  1.12

Volatility

   25.4  25.2  24.6

Risk free interest rate

   1.98  1.47  1.31

The following table summarizes the transactions of the Company’s SEUs for the year ended December 31, 2017:

   Number
of SEUs
  Weighted
Average
Exercise Price
   Weighted
Average
Grant-Date
Fair Value
 

Outstanding at December 31, 2016

   279,815  $3.77   $33.40 

Granted – at discount

   180,249  $0.00   $62.76 

      – at market value

   5,530  $70.60   $16.84 

Exercised

   (48,277 $4.28   $30.65 

Forfeited

   (16,975 $0.00   $34.81 
  

 

 

    

Outstanding at December 31, 2017

   400,342  $3.10   $46.65 
  

 

 

    

At December 31, 2017, there were 44,636 SEUs that were exercisable, 39,705 had performance conditions attached.

The chargescompensation cost recorded for SEUs arewas $13.5 million, $24.2 million and $3.1 million for 2023, 2022 and 2021, respectively. The compensation cost for SEUs is spread over the life of the award subject to a revaluation to the fair value at each quarter.quarter end. The revaluation may result in a charge or a credit to the income statement in theeach quarter dependent upon our share price movements and other performance criteria.

Forfeits are accounted for as an adjustment to the charge in the period in which the forfeits occur.

Transactions in the period

The fair value of each stock option or SEU granted in the year was estimated on the date of grant using the Black-Scholes option-pricing model and where appropriate the Monte Carlo simulation model. These models utilized the following weighted average assumptions to determine the grant-date fair values of the share-based compensation granted in the year:

 

2023

 

 

2022

 

 

2021

 

Dividend yield

 

 

1.16

%

 

 

1.27

%

 

 

1.17

%

Expected life

 

4 years

 

 

5 years

 

 

5 years

 

Volatility

 

 

39.7

%

 

 

39.8

%

 

 

40.2

%

Risk free interest rate

 

 

4.47

%

 

 

2.90

%

 

 

0.45

%

The dividend yield was based on our recent history of dividend payouts. The expected life was determined based upon historical exercise experience. The volatility was determined based upon the historical daily stock price volatilities. The risk free interest rate was based on the U.S. Federal Reserve 3 year interest rate at the grant dates, which approximates to the expected term of the options.

The following tables summarizes the transactions of the Company’s share-based compensation plans for the year ended December 31, 2023.

 

 

Number of
shares

 

 

Weighted
Average
Grant-Date
Fair Value

 

Nonvested at December 31, 2022

 

 

757,040

 

 

$

69.0

 

Granted

 

 

159,322

 

 

$

94.4

 

Vested

 

 

(210,702

)

 

$

66.6

 

Forfeited

 

 

(52,769

)

 

$

76.1

 

Nonvested at December 31, 2023

 

 

652,891

 

 

$

75.2

 

 

Number of
shares

 

 

Weighted
Average
Exercise
price

 

 

Weighted-Average Remaining Contractual Term (years)

 

Outstanding at December 31, 2022

 

 

864,518

 

 

$

20.1

 

 

 

 

Granted

 

 

159,322

 

 

$

9.8

 

 

 

 

Exercised

 

 

(267,297

)

 

$

4.2

 

 

 

 

Forfeited

 

 

(54,767

)

 

$

7.9

 

 

 

 

Outstanding at December 31, 2023

 

 

701,776

 

 

$

24.8

 

 

 

3.3

 

Exercisable at December 31, 2023

 

 

48,885

 

 

$

29.2

 

 

 

4.3

 

83


Other disclosures

As at December 31, 2023, there was $21.3 million of total unrecognized compensation cost for 2017, 2016 and 2015 was $6.6 million, $4.7 million and $4.9 million, respectively. related to nonvested share-based compensation arrangements. That cost is expected to be recognized over a weighted-average period of 1.7 years.

The total intrinsic value of share-based compensation plans outstanding at December 31, 2023 was $69.1 million. The total intrinsic value of share-based compensation plans exercisable at December 31, 2023 was $4.6 million. The total intrinsic value of share-based compensation plans exercised, was approximately $27.9 million in 2023 and $18.1 million in 2022.

The total cash paid for SEUs exercised was approximately $16.8 million in 2017, 20162023 and 2015$15.0 million in 2022. The total fair value of share-based compensation that vested was $1.7$14.0 million $1.8in 2023 and $13.0 million and $2.4 million, respectively.in 2022.

The weighted-average remaining vesting periodgrant-date fair value of non-vested SEUsshare-based compensation plans granted during 2023, 2022, and 2021 was $94.4, $60.2, and $84.8, respectively.

The Company recorded a current tax charge of $0.3 million in 2023, a current tax charge of $0.7 million in 2022 and a current tax benefit of $1.3 million in 2021, in relation to stock option compensation. This amount is 1.73 years.inclusive of excess tax benefits.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Note 18.19. Reclassifications out of Accumulated Other Comprehensive Loss

Reclassifications out of accumulated other comprehensive loss (“AOCL”) for 20172023 were:

(in millions)  Amount
Reclassified
from AOCL
  Affected Line Item in the
Statement where
Net Income is Presented

 

 

 

 

 

Details about AOCL Components

   

 

Amount
Reclassified
from AOCL

 

 

Affected Line Item in the
Statement where Net
Income is Presented

Foreign currency translation items:

   

Liquidation of subsidiary

  $1.8  Loss on liquidation of
subsidiary

Defined benefit pension plan items:

   

 

 

 

 

Amortization of prior service credit

  $(1.0 See(1) below

Amortization of prior service cost

 

$

0.5

 

 

See (1) below

Amortization of actuarial net losses

   5.0  See(1) below

 

 

(2.1

)

 

See (1) below

  

 

  

 

 

(1.6

)

 

Total before tax

   4.0  Total before tax

 

 

0.3

 

 

Income tax expense

   (0.7 Income tax expense
  

 

  
   3.3  Net of tax
  

 

  

Total reclassifications

  $5.1  Net of tax

 

$

(1.3

)

 

Net of tax

  

 

  

(1)

These items are included in the computation of net periodic pension cost. See Note 9 of the Notes to the Consolidated Financial Statements for additional information.

(1)
These items are included in the computation of net periodic pension cost. See Note 10 of the Notes to the Consolidated Financial Statements for additional information.

84


Changes in accumulated other comprehensive lossAOCL for 2017,2023, net of tax, were:

(in millions)

  Derivative
Instruments
   Defined
Benefit
Pension
Plan Items
  Cumulative
Translation
Adjustments
  Total 

Balance at December 31, 2016

  $0.3   $(46.0 $(80.5 $(126.2
  

 

 

   

 

 

  

 

 

  

 

 

 

Other comprehensive income before reclassifications

   0.9    0.0   44.0   44.9 

Amounts reclassified from AOCL

   0.0    3.3   0.0   3.3 

Actuarial net gains arising during the year

   0.0    39.5   0.0   39.5 
  

 

 

   

 

 

  

 

 

  

 

 

 

Net current period other comprehensive income

   0.9    42.8   44.0   87.7 
  

 

 

   

 

 

  

 

 

  

 

 

 

Balance at December 31, 2017

  $1.2   $(3.2 $(36.5 $(38.5
  

 

 

   

 

 

  

 

 

  

 

 

 

(in millions)

 

Defined
Benefit
Pension
Plan Items

 

 

Cumulative
Translation
Adjustments

 

 

Total

 

Balance at December 31, 2022

 

$

(58.4

)

 

$

(86.8

)

 

$

(145.2

)

Other comprehensive income/(losses) before reclassifications

 

 

 

 

 

15.9

 

 

 

15.9

 

Amounts reclassified from AOCL

 

 

(1.3

)

 

 

 

 

 

(1.3

)

Actuarial net gains/(losses) arising during the year

 

 

(17.5

)

 

 

 

 

 

(17.5

)

Net current period other comprehensive income/(losses)

 

 

(18.8

)

 

 

15.9

 

 

 

(2.9

)

Balance at December 31, 2023

 

$

(77.2

)

 

$

(70.9

)

 

$

(148.1

)

Reclassifications out of AOCL for 2022 were:

(in millions)

 

 

 

 

 

Details about AOCL Components

 

Amount
Reclassified
from AOCL

 

 

Affected Line Item in the
Statement where
Net Income is Presented

Defined benefit pension plan items:

 

 

 

 

 

Amortization of prior service cost

 

$

0.5

 

 

See (1) below

Amortization of actuarial net losses

 

 

0.5

 

 

See (1) below

 

 

1.0

 

 

Total before tax

 

 

 

(0.2

)

 

Income tax expense

Total reclassifications

 

$

0.8

 

 

Net of tax

(1)
These items are included in the computation of net periodic pension cost. See Note 10 of the Notes to the Consolidated Financial Statements for additional information.

Changes in AOCL for 2022, net of tax, were:

(in millions)

 

Defined
Benefit
Pension
Plan Items

 

 

Cumulative
Translation
Adjustments

 

 

Total

 

Balance at December 31, 2021

 

$

10.7

 

 

$

(57.6

)

 

$

(46.9

)

Other comprehensive income/(losses) before reclassifications

 

 

 

 

 

(29.2

)

 

 

(29.2

)

Amounts reclassified from AOCL

 

 

0.8

 

 

 

 

 

 

0.8

 

Actuarial net gains arising during the year

 

 

(69.9

)

 

 

 

 

 

(69.9

)

Net current period other comprehensive income/(losses)

 

 

(69.1

)

 

 

(29.2

)

 

 

(98.3

)

Balance at December 31, 2022

 

$

(58.4

)

 

$

(86.8

)

 

$

(145.2

)

85


Note 19.20. Recently Issued Accounting Pronouncements

In March 2017,December 2023, the FASB issued ASU 2017-07, Compensation-Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. ASU 2017-07 requires companies to present the service cost component of net benefit cost in the same line items in which they report compensation cost. Companies will present all other components of net benefit cost outside operating income, if

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

this subtotal is presented. The new standard is effective for annual periods beginning after December 15, 2017, including interim periods within those fiscal years. The Company has determined the Standard will impact the operating subtotal as reported in the Company’s consolidated statements of income with a reduction to operating income of $4.7 million and a corresponding increase in other non-operating income for the year ended December 31, 2017.

In February 2016, the FASBFinancial Accounting Standards Board issued Accounting Standards Update (ASU) 2016-02, RevisionNo. 2023-09, Improvements to Lease Accounting, which amends ASC Topic 842, Leases. TheIncome Tax Disclosures (Topic 740). This guidance establishes new income tax disclosure requirements in addition to modifying and eliminating certain existing guidance. Under the new guidance, entities must consistently categorize and provide greater disaggregation of information in the rate reconciliation. They must also further disaggregate income taxes paid. This ASU requires lessees to recognize a right-of-use asset and a lease liability for virtually all of their leases (other than leases that meet the definition of a short-term lease). The new standard is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early2024, although early adoption is permitted. The Company intends to adopt the new standard must be adopted using a modified retrospective transition method,on January 1, 2025. We are currently evaluating the impact of adopting this new accounting guidance on our consolidated financial statements, including accounting policies, processes and provides for certain practical expedients. Transition will require applicationsystems, but we do not expect the adoption of the new guidance at the beginning of the earliest comparative period presented. The Standardthis ASU will have a material impact on our consolidated balance sheet. The most significant impact will be the recognition of Right-of-use assets and lease liabilities for operating leases. The Company is still assessingCompany’s disclosures.

In November 2023, the effect of the standard on its ongoing financial reporting.

In May 2014, the FASBFinancial Accounting Standards Board issued Accounting Standards Update (ASU) 2014-09,Revenue from Contracts with CustomersNo. 2023-07, Improvements to Reportable Segment Disclosures (Topic 606)280). This guidance is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this ASU 2014-09 is based on principles that govern the recognition of revenue at an amount an entity expects to be entitled when products are transferred to customers. The new standard will become effective for annual reporting periodsfiscal years beginning after December 15, 2017. ASU 2014-09 may be applied retrospectively to each prior period presented in the financial statements (full retrospective approach) or retrospectively with the cumulative effect of initially applying the standard recognized as an adjustment to the opening balance of retained earnings as of the date of2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption (modified retrospective approach).is permitted. We will adopt the new revenue standard on January 1, 2018 utilizing the modified retrospective approach. We have spent significant time evaluating, analyzing and documenting the expected impact of ASU 2014-09 on our financial statements. We have performed a detailed review of key contracts representative of our different businesses and product lines, reviewing various industry publications, and comparing our current accounting policies to the principles and requirements outlined in the new Standard. Our assessment at this stage is that we do not currently expect the new revenue recognition standardadoption of this ASU will have a material impact on our financial statements upon adoption.the Company’s disclosures.

Note 20.21. Related Party Transactions

Mr. Patrick S. Williams has been an executive director of the Company since April 2009 and has been a non-executive director of AdvanSix, a chemicals manufacturer, since February 2020. In 2023, the Company purchased product from AdvanSix for $0.4 million (2022 – $0.5 million; 2021 - $0.4 million). As at December 31, 2023, the Company owed $0.0 million to AdvanSix (December 31, 2022 – $0.0 million).

Mr. Robert I. Paller has been a non-executive director of the Company since November 1, 2009. The Company has retained and continues to retain Smith, Gambrell & Russell, LLP (“SGR”), a law firm with which Mr. Paller holds a position. In 2017, 2016 and 20152023, the Company incurred fees payable to SGR of $0.4$0.3 million, $0.5 million and $0.3 million, respectively.(2022 - $0.3 million; 2021 - $0.1 million). As at December 31, 20172023, the Company owed $0.0 million to SGR (December 31, 2022 – $0.0 million).

Mr. David F. Landless has been a non-executive director of the Company since January 1, 2016 and is a non-executive director of Ausurus Group Limited which owns European Metal Recycling Limited (“EMR”). The Company has sold scrap metal to EMR in 2023 for a value of $0.1 million (2022 - $0.1 million; 2021 – $0.6 million). A tendering process is operated periodically to select the best buyer for the sale of scrap metal by the Company. As at December 31, 2016, the Company did not have any amounts outstanding due to SGR.2023, EMR owed $0.0 million (December 31, 2022 – $0.0 million).

86


NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Note 21.    Subsequent Events

The Company has evaluated subsequent events through the date that the consolidated financial statements were issued, and has concluded that no additional disclosures are required in relation to events subsequent to the balance sheet date.

Item 9Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9AControls and Procedures

Item 9A Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Based on an evaluation carried out as of the end of the period covered by this report, under the supervision and with the participation of our management, our Chief Executive Officer and our Chief Financial Officer concluded that the Company’s “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) were effective as of December 31, 2017.2023.

Management’s Report on Internal Control Over Financial Reporting

Our management, including the Chief Executive Officer and the Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting (within the meaning of Rule 13a-15(f) under the Securities Exchange Act of 1934). The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

Internal control over financial reporting includes those policies and procedures that:

pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that our receipts and expenditures are being made only in accordance with authorization of our management and directors; and

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the consolidated financial statements.

Due to its inherent limitations, management does not believe that internal control over financial reporting will prevent or detect all errors or fraud. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

On December 8, 2023, the Company acquired QGP Química Geral S.A. (“QGP”). As permitted by related SEC staff interpretive guidance for newly acquired businesses, management has excluded QGP from its assessment of the effectiveness of the Company’s internal control over financial reporting. QGP represents less than 2% of the total assets of the Company, excluding goodwill and other intangible assets, and less than 1% of the total revenues of the Company, as of and for the year ended December 31, 2023.

Based on criteria inInternal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission the evaluation of our management,

including the

87


Chief Executive Officer and the Chief Financial Officer, concluded that the Company did maintain effective internal control over financial reporting as of December 31, 2017.2023.

Our independent registered public accounting firm KPMG Audit Plc,PricewaterhouseCoopers LLP, has audited our consolidated financial statementsConsolidated Financial Statements and the effectiveness of our internal control over financial reporting as of December 31, 2017.2023. Their report is included in Item 8 of this Annual Report on Form 10-K.

Changes in Internal Controls over Financial Reporting

The Company is continuously seeking to improve the efficiency and effectiveness of its operations and of its internal controls. This is intended to result in refinements to processes throughout the Company.

On December 30, 2016 we acquired the European Differentiated Surfactants business from Huntsman (“Huntsman”). We excluded the operations of Huntsman from the scope of our Sarbanes-Oxley Section 404 management report on internal controls over financial reporting as of December 31, 2016. As at December 31, 2017, we have completed the implementation of an internal control structure for the acquired operations including a new information system platform. In connection with this implementation, the Company has updated its internal controls over financial reporting, as necessary to accommodate modifications to its business processes and accounting procedures.

There were no other changes to our internal control over financial reporting which were identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Securities Exchange Act of 1934, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Item 9BOther Information

Item 9B Other Information

(a) None.

(b) None.

Item 9C Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable.

PART III

Item 10Directors, Executive Officers and Corporate Governance

Item 10 Directors, Executive Officers and Corporate Governance

The information set forth under the headings “Re-Election“Election of Twotwo Class II Directors”, “Information about theDirectors,” “Corporate Governance – Board of Directors,Committees – Audit Committee– Audit Committee Financial Expert,” “Information about the Executive Officers” and “Section“Delinquent Section 16(a) Beneficial Ownership Reporting Compliance”Reports” in the Proxy Statement for the Annual Meeting of Stockholders to be held on May 9, 201810, 2024 (“the Proxy Statement”) is incorporated herein by reference.

The Board of Directors has adopted a Code of EthicsConduct that applies to the Company’s directors, officers and employees, including the Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer. Any stockholder who would like to receive a copy of our Code of Ethics,Conduct, our Corporate Governance Guidelines or any charters of our Board’s committees may obtain them without charge by writing to the General Counsel and Chief Compliance Officer, Innospec Inc., 8310 South Valley Highway, Suite 350, Englewood, Colorado, 80112, e-mailinvestor@innospecinc.com investor@innospec.com. These and other documents can also be accessed via the Company’s web site,www.innospecinc.com.website, www.innospec.com.

The Company intends to disclose on its’its websitewww.innospecinc.com.www.innospec.comany amendments to, or waivers from, its’ Code of EthicsConduct that are required to be publicly disclosed pursuant to the rules of the SEC or NASDAQ.Nasdaq.

Information regarding the Audit Committee of the Board of Directors, including membership and requisite financial expertise, set forth under the headings “Corporate Governance – Board Committees – Audit Committee” in the Proxy Statement is incorporated herein by reference.

88


Information regarding the procedures by which stockholders may recommend nominees to the Board of Directors set forth under the heading “Corporate Governance – Board Committees – NominatingIdentifying and Governance Committee”Evaluating Nominees for Director” in the 2018 Proxy Statement is incorporated herein by reference.

Item 11Executive Compensation

Item 11 Executive Compensation

The information set forth under the headings “Executive Compensation,” “Corporate Governance – Board Committees – Compensation Committee – Compensation Committee Interlocks and Insider Participation” and “Compensation Committee Report” in the Proxy Statement is incorporated herein by reference.

Item 12Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information set forth under the heading “Information About“Who Owns Our Stock? Information about our Common Stock Ownership” in the Proxy Statement is incorporated herein by reference.

Shares Authorized for Issuance Under Equity Compensation Plans

The information set forth in the table under the heading “Equity Compensation Plans” in the Proxy Statement is incorporated herein by reference.

Item 13Certain Relationships and Related Transactions, and Director Independence

Item 13 Certain Relationships and Related Transactions, and Director Independence

The information set forth under the headings “Related“Corporate Governance – Related Person Transactions and Relationships”, “RelatedRelationships,” “Corporate Governance – Related Person Transactions Approval Policy” and “Corporate Governance – Director Independence” in the Proxy Statement is incorporated herein by reference.

Item 14Principal Accountant Fees and Services

Item 14 Principal Accountant Fees and Services

Information regarding fees and services related to the Company’s independent registered public accounting firm, KPMG Audit Plc,PricewaterhouseCoopers LLP, is provided under the heading “Principal Accountant Fees and Services” in the Proxy Statement and is incorporated herein by reference. Information regarding the Audit Committee’s pre-approval policies and procedures is provided under the heading “Audit Committee Pre-approval Policies and Procedures” in the Proxy Statement and is incorporated herein by reference.

PART IV

Item 15Exhibits and Financial Statement Schedules

Item 15 Exhibits and Financial Statement Schedules

(1)
Financial Statements

The Consolidated Financial Statements (including Notes) of Innospec Inc. and its subsidiaries, together with the report of PricewaterhouseCoopers LLP (PCAOB ID 00876) dated February 14, 2024, are set forth in Item 8.

(2)
Financial Statement Schedules

Financial statement schedules have been omitted since they are either included in the financial statements, not applicable or not required.

89


(3)
Exhibits

2.1

(1)Financial Statements
The Consolidated Financial Statements (including notes) of Innospec Inc. and its subsidiaries, together with the report of KPMG Audit Plc dated February 15, 2018, are set forth in Item 8.
(2)Financial Statement Schedules
Financial statement schedules have been omitted since they are either included in the financial statements, not applicable or not required.
(3)Exhibits
  2.1

Amended and Restated Share and Asset Purchase Agreement, dated as of December 22, 2016, by and between Huntsman Investments (Netherlands) B.V. and Innospec International Ltd (Incorporated by reference to Exhibit 2.1 of the Company’s Form 8-K on January 3, 2017).

3.1

  3.1

Amended and Restated Certificate of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 of the Company’s Form 10-K on March 16, 2006)February 19, 2020).

3.2

  3.2

Amended and Restated By-laws of the Company (Incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K on November 13, 2015).

3.3

Innospec Inc. 2018 Omnibus Long-Term Incentive Plan (Incorporated by reference to Exhibit 10.1 to the Registrant’s Form 8-K filed May 10, 2018).

10.1

3.4

Innospec Inc. ShareSave Plan 2008 (as amended and restated) (Incorporated by reference to Exhibit 10.2 to the Registrant’s Form 8-K filed May 10, 2018).

4.1

Description of Common Stock (Incorporated by reference to Exhibit 4.1 of the Company’s Form 10-K on February 19, 2020).

10.1

Executive Service Agreement of Mr. PJPhilip J. Boon dated June 1, 2009 (Incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K on May 27, 2009). *

10.2

Executive Service Letter to Mr. Philip J. Boon dated October 15, 2015 (Incorporated by reference to Exhibit 10.24 of the Company’s Form 10-K on February 17, 2016). *

10.2

10.3

Contract of Employment, Mr. Ian McRobbie (Incorporated by reference to Exhibit 10.23 of the Company’s Form 10-K on March 28, 2003). *

10.4

10.3

Contract of Employment, Dr. Catherine Hessner (Incorporated by reference to Exhibit 10.26 of the Company’s Form 10-K on March 31, 2005). *

10.4Contract of Employment, Mr. Patrick Williams, dated October 11, 2005, (Incorporated by reference to Exhibit 99.1 of the Company’s Form 8-K on October 12, 2005)and Executive Service Agreement dated April 2, 2009. (Incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K on April 3, 2009). *

10.5

10.5

Contract of Employment, Mr. Ian Cleminson, dated June 30, 2006 (Incorporated by reference to Exhibit 99.2 of the Company’s Form 8-K on June 30, 2006). *

10.6

10.6

Innospec Inc. Performance Related Stock Option Plan 2008 (Incorporated by reference to Appendix A of the Company’s Proxy Statement on April 1, 2011).*

10.7

10.7

Innospec Inc. Company Share Option Plan 2008 (Incorporated by reference to Appendix B of the Company’s Proxy Statement on April 1, 2011). *

10.8

10.8

Innospec Inc. Non EmployeeNon-Employee Directors’ Stock Option Plan 2008 (Incorporated by reference to Appendix C of the Company’s Proxy Statement on April 1, 2011). *

10.9

10.9

Innospec Inc. SharesaveShareSave Plan 2008 (Incorporated by reference to Appendix D of the Company’s Proxy Statement on March 31, 2008). *

10.10

10.10

Innospec Inc. Executive Co-Investment Stock Plan 2004, as amended by the First Amendment 2006 (Incorporated by reference to Exhibit 10.10 of the Company’s Form 10-K on February 17, 2012). *

90


10.11

10.11

Contract of Employment, Mr. David E. Williams, dated September 17, 2009 (Incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K on September 14, 2009). *

10.12Form of Indemnification Agreement for individual who is an officer (Incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on February 27, 2014).

10.12

10.13

Form of Indemnification Agreement for individual who is a director (Incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed on February 27, 2014).

10.13

10.14

Form of Indemnification Agreement for individual who is an officer and director (Incorporated by reference to Exhibit 10.3 of the Company’s Form 8-K filed on February 27, 2014).

10.14

10.15

Employment contract for Brian Watt (Incorporated by Reference to Exhibit 10.4 of the Company’s Form 10-Q filed on May 7, 2014). *

10.16Innospec Inc. 2014 Long-Term Incentive Plan (Incorporated by Reference to Exhibit 10.5 of the Company’s Form 10-Q filed on May 7, 2014). *

10.15

10.17

Increase Confirmation Letter,$250,000,000 Multicurrency Revolving Facility Agreement with various lenders dated JulyMay 31, 2014, among the Company, certain subsidiaries of the Company, and U.S. Bank N.A.2023 (Incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on July 31, 2014).

10.18Second Amendment and Restatement Agreement, dated November 6, 2015, relating to the Facility Agreement dated December 14, 2011 as previously amended and restated on August 28, 2013 (Incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K on November 9, 2015).

10.19Executive Service Letter to Mr. Philip J Boon dated October 15, 2015 (Incorporated by reference to Exhibit 10.24 of the Company’s Form 10-K on February 17, 2016). *
10.20Third Amendment and Restatement Agreement with various lenders, dated December 14, 2016, which amends and restates the Company’s credit facility agreement dated December 14, 2011, as amended and restated on August 28, 2013 and November 6, 2015 (Incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K on December 16, 2016).
10.21Settlement Agreement made and entered into as of February 26, 2016 between Innospec Fuel Specialties LLC and Mr. Patrick J McDuff (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K on March 3, 2016). *
12.1Computation of Financial Ratios (filed herewith).
14The Innospec Inc. Code of Ethics (as updated) (Incorporated by reference to Exhibit 14 of the Company’s Form 10-K on February 17, 2012).
16Letter regarding change in certifying accountant dated June 17, 2011 (Incorporated by reference to Exhibit 16.110.2 of the Company’s Form 8-K on June 17, 2011)1, 2023).

10.16

Innospec Inc. 2018 Omnibus Long-Term Incentive Plan (Incorporated by reference to Exhibit 10.1 to the Registrant’s Form 8-K filed May 10, 2018).

21.1

10.17

Innospec Inc. ShareSave Plan 2008 (as amended and restated) (Incorporated by reference to Exhibit 10.2 to the Registrant’s Form 8-K filed May 10, 2018)

10.19

Innospec Inc. Nonqualified Deferred Compensation Plan.* (Incorporated by reference to Exhibit 10.19 to the Registrant’s Form 10-K filed February 22, 2022)

21.1

Principal Subsidiaries of the Registrant (filed herewith).

23.1

23.1

Consent of Independent Registered Public Accounting Firm, KPMG Audit PlcPricewaterhouseCoopers LLP (filed herewith).

31.1

31.1

Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

31.2

31.2

Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

32.1

32.1

Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).

32.2

32.2

Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).

97.1

Innospec Inc. Clawback Policy (filed herewith).

101

INLINE XBRL Instance Document and Related Items.TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT

104

Cover Page Interactive Data File – The cover page XBRL tags are embedded within the inline XBRL document.

*Denotes a management contract or compensatory plan.
* Denotes a management contract or compensatory plan.

91


Item 16Form 10-K Summary

Item 16 Form 10-K Summary

Not Applicable.

92


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

INNOSPEC INC.

By:

By:

/s/ PATRICK S. WILLIAMS

(Registrant)

Patrick S. Williams

Date:

President and Chief Executive Officer

February 15, 201814, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated as of February 15, 2018:14, 2024:

/s/ MILTON C. BLACKMORE

Milton C. Blackmore

Chairman and Director

/s/ PATRICK S. WILLIAMS

Patrick S. Williams

President and Chief Executive Officer (Principal Executive Officer); Director

/s/ IAN P. CLEMINSON

Ian P. Cleminson

Executive Vice President and Chief Financial Officer

/s/ CHRISTOPHER J. PARSONSGRAEME BLAIR

Christopher J. Parsons

Graeme Blair

Head of Group Finance (Principal Accounting Officer)

/s/ HUGH G. C. ALDOUS

Hugh G. C. Aldous

Director

s/ KELLER ARNOLD

Keller Arnold

Director

/s/ DAVID F. LANDLESS

David F. Landless

Director

/s/ LAWRENCE J. PADFIELD

Lawrence J. Padfield

Director

/s/ ROBERT I. PALLER

Robert I. Paller

Director

/s/ JOACHIM ROESERLESLIE J. PARRETTE

Joachim Roeser

Leslie J. Parrette

Director

/s/ CLAUDIA POCCIA

Claudia Poccia

Director

93


105

94